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iv  0EXECITVE  SMLORY
While  a private  sector  exists  in  every  society,  the  nature  of its  involve-
ment in family  planning  service  delivery,  varies  widely  across  countries.  This
paper  reviews  the role  of the  private  sector  in family  planning  and  discusses
how  much  more  of the  demand  for  cr't-  ception  can  be met  through  the  private
sector,  thereby  reducing  goveromer  subsidies  for  contraception.
Government  has  historically  ta..  n  a leading  role  in  the  provision  of
family  planning  in  developing  countries  based  on the  rationales  of the  negative
externalities  of high  population  growth,  the  unaffordability  or inaccessibility
of private  contraceptive  services,  the  lack  of  monetization  of certain  groups,
and  the  lack  of information  on contraception  of populations  outside  the  sphere
of private  sector  providers. Shifts  in income,  accessioility  and  monetization
have  mitigated  to some  extent  the  applicability  of these  rationales  for  public
subsidies  for  family  planning  in  developing  countries.
Public  family  planning  investment  is  meant  to reach:  (1)  those  who cannot
afford  the  commercial  contraceptive  prices  or the  medical  attention  that
accompanies  some  forms  of contraception;  or (2)  those  who are  deterred  from
contraception  because  of a lack  of information,  motivation  or income. The
danger  of expansive  public  programs  is that  they  are  difficult  to scale  back
for  political  reasons,  and  government  then  becomes  the  providet  for  anyone
choosing  to  obtain  subsidized  contraceptives,  even  those  who  would  and  could
buy  from  the  commercial  sector.
Reductions  in government  resources  for  family  planning  and  rising  demand
for  services  has  placed  an increasing  number  of governments  in the  position  of
having  to select  what services  or populations  to subsidize.  Government  will
need  to reduce  and  modify  its  role  by targeting  subsidies,  and  regulating  the
delivery  of services  through  private  channels  if it is  to afford  to  meet  the
needs  of low income  couples. Indeed  from  an economic  efficiency  perspective,
government  should  not  be subsidizing  consumers  or providers  where  either  would
act identically  without  government  intervention.  Some  evidence  exists  which
suggests  that  private  sector  delivery  of  health  and family  planning  is less
costly  because  it is  more  efficient,  having  fewer  employees  and  lower  operating
costs  per  patient. Government  can  harness  the  private  sector  to  achieve  the
same  ends  by stimulating  private  sector  investment  through  incentives,  and
ensuring  quality  control  through  regulation.
Private  Investment  in  Family  Planning
The  private  sector  is  already  involved  in  multiple  facets  of family
planning  from  research  and  development  to  production  to  distribution  and
delivery. There  is very  little  public  production  of contraceptive  products,
although  private  production  is increasingly  occurring  in  developing  countries.
Private  production  is  divided  between  the  pharmaceutical  industry's  wanufacture
of medical  products  (e.g.,  oral contraceptives,  spermicides)  and  production  of
nonmedical  supplies  (condoms).  Oral  contraceptives  are  produced  in  marny
developing  countries  under  direct  licenses  to one  of the  developed  countries'
pharmaceutical  corporations.  The  volume  of production  to  meet  even  minimal
viefficiency  in the  production  of nonmedical  products  is  so high (700,000  condoms
per  year  and  one  million  IUDs),  however,  that  a large  domestic  or international
market  must  exist  to  warrant  the  establishment  of  a production  plant  in  a given
country.
A number  of factors  affect  the  profitability  of the  private  contraceptive
market. Among  the  most important  are  household  income  levels  and  consumer
demand  for  family  planning. Government  policy  on earnings  repatriation,  the
likelihood  of devaluation,  the  possibility  of nationalization,  tax  and tariff
levels,  as  well as policies  regarding  patent  protection,  product  pricing,
advertising  of contraceptives  and  FDA-equivalent  screening  affect  the
attractiveness  of for-profit  investment  in  family  planning.
Aiother  critically  important  element  in private  delivery  of family
planning  is the  role  of the  government  in  delivering  family  planning. Private
sales  of contraceptives  often  decline  dramatically  with the  introduction  of
public  services. Recent  experience  from  Kenya  and  Nigeria  irdicates  that
private  markets  can  be all  but  eliminated  with  the  establishment  of strong
public  programs,  particularly  where  prevalence  is  low.  In  other  countries,
like  Indonesia  and  Thailand,  the  success  of public  programs  may  have
effectively  stifled  the  growth  of the  private  sector  in  spite  of  a growing
ability  and  willingness  of contraceptive  users  to  pay for  services.
Public  and  Private  Collaboration
Public  and  private  collaboration  is  often  seen  by the  contraceptive
industry  as the  only  means  of retaining  a presence  in some  markets,  although
collaboration  such  as that  in  Nigeria  where  government  provides  che  commodities
and the  private  distribution  networks  distribute  for  both  public  and  private
sources-show  promise  For  a  more  mutually  beneficial  arrangement.
Contraceptive  social  marketing  (CSM)  programs  where  subsidized  products  are
distributed  by the  private  sector  with  heavy  advertising  and  promotion
supported  by the  government  or  donors  appears  to  be an attractive  and
productive  arrangement,  especially  where  the  commercial  market  is small.
Evaluation  of the  relative  importance  of CSM's  components  and  net impact  have
not  been  well studied,  however.
Sources  and Pricing  of Contraceptives
Private  providers  of family  planning  services  include  private  physicians
and  midwives  (either  in  solo  practice,  at clinics  or hospitals)  and
pharmacists.  Among  private  providers  of family  planning,  pharmacies  are  the
most important  source. While  many  women  receive  their  first  contraceptives
from  physicians  or public  clinics,  resupply  is commonly  sought  at pharmacies.
Some  evidence  suggests  that  there  is  little  difference  in the  relative
effectiveness  of different  suppiiers  of contraception  in terms  of the
reliability  of supplies  and  the  accuracy  of information  offered  potential
acceptors.
The  major  source  of  contraceptives  for  couples  in  developing  countries
varies  by method  and  country. The  private  sector  (for-profits  and  NGOs)  is
currently  serving  the  majority  of contraceptors  in the  developing  world  who
viirely  on resupply  methods. Government-is  typically  the  most important  supplier
of clinical  methods,  especially  in  Asia  and  parts  of Latin  America,  and  is
heavily  relied  upon in rur&l  areas  in  some  countries.
In terms  of location,  government  is  a major  provider  in  urban  areas  of
Asia and  Africa,  and in rural  areas  outside  of  Africa,  while  NGos  are  major
providers  in rural  Africa. Older  women  are  more likely  to  use  public  clinics,
possibly  because  they  were introduced  and  have strong  ties  to the  clinics. As
would  be predicted,  income  and  education  are correlated  with greater  reliance
on commercial  suppliers.
The  level  of reliance  on government  sources  tends  to vary  more  by country
than  across  location  within  countries. Asian  countries  such  as  Thailand,
Bangladesh  and  Sri  Lanka  are  heavily  government  dependent,  while in  countries
like  Lebanon  and  Egypt  government  is  a  minor  player. NGOs  are  particularly
active  in a few  countries,  especially  in  Africa  and in  some  parts  of  South
America,  and  in others  play  no role  at all.
The reasons  for  the  discrepancies  in  degree  of reliance  on  private  sources
across  countries  is  difficult  to  explain. Differences  in  public  program
quality,  investment  and  scope  obviously  will  play  a role,  as  will the  existence
of incentives  and  disincentives  to  private  investment  in family  planning.
These  characteristics  are  probably  as important  as income  levels  in helping  to
explain  country  differences,  otherwise  users  in  a country  like  Bolivia  would  be
more reliant  on government  than  they  are,  while  users  in  Thailand  and  Tunisia
would  more  frequently  use  private  sources.
The  subsidies  users  receive  also  vary  markedly  across  countries. The
limited  available  information  suggests  that  government  subeidies  benefit  a
large  segment  of the  user  population  in  Jamaica  and  Thailaid. Given  the  income
l1'els  of these  two  countries,  it is  not  clear  that  the  current  subsidy  level
is required  to keep  contraceptive  use  high.  The  amount  and  extent  of subsidy
that  is  needed  cannot  be determined,  but  as household  incomes  rise,  in  general,
public  subsidies  should  be phased  down  as household  ability  and  willingness  to
pay for  family  planning  services  increases.
The  pricing  of contraceptives  varies  across  brands  for  the  same  products,
and identical  brands  are  priced  differently  across  countries,  even in  regions
with strong  socioeconomic  similarities  and  geographic  proximity. Thus  there  is
evidence  that  commercial  providers  charge  what  the  market  will  bear  in  any
given  context. NGO  prices  tend  to  be significantly  lower  than  commercial
prices,  and in  many  countries  NGOs  offer  free  services,  as do most  government
programs.
Efforts  to Stimulate  Growth  of the  Private  Sector
The review  of experience  with  private  sector  projects  includes  the
following  kinds  of projects:  (1)  those  that  offer  family  planning  as an
employee  benefit;  (2)  social  marketing  projects;  and (3)  those  that  promote
private  sector  investment  in family  planning. Forty  one  projects  are reviewed
based  on published  documentation.  Few  have  been  carefully  evaluated.
viiiThe  employee  benefit  programs  that  covered  family  planning  services  began
in  the  1950s  in Indian  factories. These  were  generated  by management  as  a
means  of socializing  and  increasing  the  well  being  of employees. Such  programs
emerged  elsewhere,  particularly  in  Asia,  offering  incentives  such  as life
insurance  to recipients  of sterilization,  paid leave  and  health  care  for
acceptors,  and  preferences  in  access  to factory-offered  services  such  as loans.
At the  same  time,  some  factories  introduced  disincentives  such  as limiting
access  to services  after  the  third  or fourth  child,  limiting  maternity  leave
for  high  parity  women,  and  in some  cases  firing  employees  with continued  high
fertility.
Since  the  initial  Indian  programs,  most efforts  in  this  area  have  been
assisted  by the  International  Labor  Organization  in  collaboration  with the
United  Nations  Fund  for  Population  Activities  and international  NGOs.  In
general  these  projects  offer  free  contraceptive  services  and  supplies  paid for
by  donors  or employers.
T'.e  social  marketing  of contraceptives  has  been  ongoing  for  wel.  -rer  two
decades. These  programs  subsidize  contraceptive  commodities  prior  to  distribu-
tion  aita  often  use  existing  distribution  systems  to reach  contraceptors.
Recent  CSM  innovations  to  harness  the  private  sector  more intensively  include
training  and  supplying  itinerant  traders  in  Ghana  to  deliver  commodities  in
outlying  communities,  and  an existing  commercial,  brand-specific  marketing
regime  in the  Dominican  Republic  in collaboration  with a  major  pharmaceutical
firm. The  private  sector's  distribution  and retail  establishments  have  also
been  used  to  deliver  contraceptives  in  other  countries  to supply  a new,
subsidized  product  to the  commercially  available  products.
Promotion  of self  sufficient  private  sector  activity  and  investment  is  a
relatively  new  concept  and two  USAID  projects  are  experimenting  with
alternative  approaches.  These  have involved  the  following  kinds  of efforts:
using  cost  benefit  analysis  to  convince  private  companies  to add  family
planning  to employee  benefits  without  any  outside  subsidy  for  commodities  as in
Peru  and  Zaire;  taking  the  investment  risk  of  newly  established  family  planning
clinics  for  a limited  period,  and  offering  MD training  and  access  to
contraceptive  commodities  at cost  in  Mexico;  working  with  NGOs  to improve  their
management  and financial  standing  in  Thailand  and Indonesia;  and,  assessing  the
private  market  for  sterilization  in  Jakarta. These  projects  typically  do not
involve  donated  contraceptives,  but  assist  providers  lower  their  costs  for  both
operations  and  commodities.  The  experiments  are  establishing  the  structure  for
self  sufficiency  from  the  start,  and typically  target  low  income  households
although  not the  poorest  groups.
Most  of the  private  sector  projects  track  users  from  the  onset  of the
project,  but  almost  all fail  tcG  account  for  substitution  away from  other
sources. The  effectiveness  and  efficiency  of  most of these  programs  is  not
known,  although  some  evidence  on the  .rwer  fertility  or  higher  contraceptive
prevalence  of beneficiaries  relative  .o  the rest  of the  country  or baseline
users  has  been  shown  in  some  of the  early  projects. The  higher  income  and
education  of these  target  or beneficiary  populations  will  have  a bearing  on
acceptance  and  on the  generalizability  of success  to other  groups. Moreover,
only  the  most recent  projects  determine  the  demand  for  contraceptive  services
within  the  plant  or community  prior  to the  establishment  of a program. One
company  measured  the  net financial  benefit  of the  family  planning  program  and
ixestimated  a scvings  in  employee  benefits  of  $189.85  per  averted  birth,  and  a
total  savings  of  about  $59,190  b-tween-1972  and  1976  not  counting  the  cost  of
contraceptives.
Other  important  elements  in  harnessing  the  private  sector  include  removing
barriers  to  private  investment,  and  contracting  out  elements  of  public  programs
to  lower  cost  private  providers.  Taiwan  reimburses  private  physicians  for  IUD
insertions  and  sterilization,  and  Korea  reimburses  for  sterilization.  The
Korean  government  offers  tax  exemption  for  employers  who  offer  family  planning,
and  the  Malaysian  government  has  stipulated  that  maternity  leave  is  not
mandatory  for  women  who  already  have  three  or  more  surviving  children.  The
relative  savings  from  these  initiatives  is  not  knownl,  but  offer  areas  for
possible  action  as  an  alternative  to  direct  public  provision.  Incentives  are
central  to  encouraging  the  private  sector  to  help  achieve  public  objectives.
Issues  that  Need  to  be  Addressed
The outstanding  issues  regarding  the  efficiency  and  effectiveness  of  these
private-oriented  programs,  who uses  them,  how much they  are  subsidized  or  need
to  be,  and  the  possible  adverse  effects  of  an  unchecked  private  sector  role
remain  to  be  addressed.  These  issues  are  key  to  reaching  public  and  donor
objectives  through  identifying  appropriate  types  of  public-private
collaboration,  and  through  developing  incentives  for  private  sector  investment
in  family  planning.
Other  options  exist  to  promote  the  demand  for  private  services  such  as
insurance  coverage  for  family  planning,  means  testing  for  subsidized  products
and  adoption  of  public  reimbursement  systems.  At  the  same  time,  assistance  to
private  investors  in  management,  access  to  loan  capital,  tax  relief  and
reductions  of  impediments  could  enhance  the  attractiveness  of  investments  in
this  area  and  increase  the  number  and  kinds  of  sources  for  contraception.
Government  can  also  promote  a  greater  private  sector  role  through  adoption  of  a
reimbursement,  voucher,  or  capitation  arrangement  for  family  planning  services,
contracting  out  and  privatizing  services,  and  expanding  social  marketing
initiatives.
The  major  gaps  include  the  following:  First,  a striking  lack  of
evaluation  of  private  and  public  sector  investments  and  the  performance  of  each
in  achieving  their  objectives  and  at  what  cost  currently  exists.  Second,  the
determinants  of  private  sector  use  are  very  poorly  understood  but  are  key  to
understanding  how  to  target  subsidies  and  design  appropriate  programs.  Third,
the  cost  and  cost  effectiveness  of  programs  is  unknown  and  yet  they  are  the
basis  upon  which  the  rationale  for  promoting  the  private  sector  must  rest.
Last,  the  limitations  of  the  private  sector  in  meeting  contraceptive  demand  as
well  as  the  necessary  oversight  and  regulatory  function  of  government  in
ensuring  ethical  and  proper  performance  by  private  entities  are  not  well
understood  or  specified.
Thus  some experimentation  and  evidence  exists  on  the  role  and  importance
of  the  private  sector.  What  needs  to  be  determined  is  what  elements  work  and
at  what  cost,  how  to  achieve  objectives  most  efficiently,  and  how  much  of  the
market  the  private  sector  can  effectively  serve.
x
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A private  sector  exists  in  every  society,  although  donors  and  governments
Lhve  often  overlooked  the  fact  in  family  planning. Traditional  healers  and
midvives  outside  the  private  sector  have  provided  family  planning  advice  and
services  to  women  throughout  history. As  a public  health  intervention,  and
under  the  prevailing  view that  the  private  sector  is inadequate  to  the  social
goal  of promoting  reductions  in  birth  rates  in  developing  countries  as well  as
the  suspicion  of private  sector  motives,  famity  planning  has  evolved  as a
heavily public  intervention.  Whether  that  pattern  is  or  was  appropriate  is  open
to  question,  but  to  date the  issue  has  received  little  critical  evaluation.
The first  issue  of importance  is the  definition  of the  private  sector  and
privatization.  The  private  sector  consists  of nongovernment  actors  that
produce,  distribute,  or retail  contraceptives  or family  planning  services
through  various  means. These  private  groups  encompass  both  nongovernmental
organizations  (NGOs)  as  well  as private  firms,  shops,  or distribution  networks;
however,  these  two  entities,  NGOs  and  for-profit  groups,  are  quite  distinct  in
their  objectives,  operation,  and  benchmarks  of  success.
The range  of private  family  planning  providers  includes  private  physicians,
private  hospitals,  clinics,  dispensaries  or outlets,  private  family  planning
associations,  nonprofit  health  providers,  pharmacies,  shops  selling  contracep-
tives,  vending  machines,  and traditional  healers. The  delivery  mechanisms  for
contraceptives  include  an  additional  method  that  is  both  public  and  private:
social  marketing.  The  importance  of social  marketing  in the  provision  of
contraceptive  services  is  SUC!.  that  it  needs  to  be included  here  as another
method  of reaching  contracepting  couples. These  three  modes  of delivery,  for-
profit,  NGO  and  social  marketing,  while  all  are  non-public  are  quite  different:
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- the  for-profit  sector  functtons  entirely  outside  the  public
sector,  relies  exclusively  on  market  forces,  and  returns  on
investment.  For-profit  firms  invest  in  producing  or distrib-
uting  contraceptives  and  family  planning  services  in response
to  consumer  demand,  and  are  dependen;  upon  adequate  financial
returns  for  survival. Investment  in  family  planning  indicates
that  the  investment  is potentially  profitable.  The for-profit
sector  is  necessarily  affected  by  government  through  regula-
tion  and  legal  constraints.  The for-profit  sector  may  also  be
affected  by large  procurement  or  distribution  contracts
negotiated  vith  international  donors  or  governments  that
affect  production,  cost  and  ultimately  pricing  decisions.
Consumer  demand,  pricing,  political  and  economic  stability,
and  regular  and  reliable  access  to  supply  inputs  are  key
elements  in  determining  profitability;  vithout  these,  returns
may  be inadequate  to  attract  or  keep  private  investors.
Excessive  governmental  oversight  can  also  be  discouraging  to
private  entrepreneurs  because  it  raises  the  cost  of  doing
business  add therefore  of the  product  to  consumers,  in this
case  contraceptives  and-family  planning  services.
- the  nongovernmental  organizations,  although  not  purely  market
driven  (and  sometimes  not  at all  affected  by  markets),
typically  offer  a product  for  a specified  price;  subsidies
from  external  sources  often  supplement  revenues,  vhich
modifies  the  nature,  incentives,  and  operation  of NGO
activities.  Altruism  and  charity  drive  some  NGOs and the  need
to  cover  costs  or  ensure  efficiency  of  operation  are  generally
not  binding  constraints  although  some  cost  recovery  is
typically  expected. In many  cases,  the  objectives  of  NGOs  and
governments  are  very  similar  in  the  family  planning  area:
increasing  prevalence.  Effectiveness  in  achieving  this
objective  is therefore  the  major  measure  of success,  although
the  net  effect  of program  success  is typically  assessed
vithout  evaluating  the  impact  (e.g.,  reductions)  occurring  at
other  sources  of contraceptive  services.  Thus the  financial
constraints  of for-profits  do not  define  the  activities  of
NGOs.
- social  marketing  is  a hybrid  of public  and  private  investments
that  uses  market  incentives  to  distribute  and  market  supplies
and  services  through  private  channels,  but  provides  a public
subsidy  up-front  that  covers  some  of the  cost  of contracep-
tives  and  up to the  total  cost  of  advertising,  management,  and
administration. 1
1.  See  Binnendijk  (1985),  Behrman  (1985),  Levis  (1985),  Chester  (1986)  and
Sheon  et  al. (1987)  for  additional  details  on social  marketing  of
contraceptives  in  developing  countries.
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Privatization  means  "to  turn  over  a Federal  (i.e.,  public)  activity,  or
part  of  a Federal  activity,  to  a non-Federal  entityl,  and]  alloving  Government
to  provide  services  vithout  necessarily  producing  them"  (PPSS,  1984). Privati-
zation  of public  services  such  as family  planning  is  different  from  private
activity  that  occurs  in response  to  market  forces. Privatizat!ln  means  that  the
government  hires  the  private  sector  for  a discrete  task  or set  of tasks. This
can  take  the  form  of contracting  out,  monopoly  franchises,  management  contracts,
or  vouchers.
For  example,  government  can  contract  vith  a family  planning  clinic  or
organization  to  provide  family  planning  services  in  its  hospitals  (contracting
out);  or  allov  a private  family  planning  group  to  provide  all  contraceptive
services  in  a given  area  and  not  allow  other  providers  to  operate  legally
(monopoly  franchise); 2 Similarly,  the  public  sector  can  provide  services  but
contract  out  elements  such  as billing  or  accounts  to  a  private  organization
(management  contract);  and,  as an  alternative  to  providing  services  directly,
government  could  provide  couples  in  need  of family  planning  subsidies  with
vouchers  that  reimburse  private  providers  for  providing  voucher  holders  vith
contraceptive  services  at lov  or zero  price.
Equally  important  to  the  definition  of the  private  sector  and family
planning  is  vhat  it is  not. Private  sector  activity  does  not  include  paying
private  entities  to  undertake  tasks  or  activities  that  vould  be  undertaken
anyway  vithout  government  intervention  or investment.  For  example,  paying
companies  to  undertake  feasibility  studies  is  a questionable  endeavor  vhere  the
benefits  have  clear  financial  benefits  to  a firm,  management  is  avare  of the
2. This is  less  typical  in femily  planning,  but  in  other  public  services  such
as electricity  and  vater  supply  vhere  economies  of scale  are  particularly
important,  monopoly  francnises  are  more  common  in  both  the  developed  and
developing  countries.
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benefits,  and the  firm  could  and  would  carry  out the  study  even  if  donor  funding
vere  not  available. In this  case  the  public  sector  is  subsidizing  a private
entity  for  a  task  from  which  the  company  vill  profit. The  subsidy  is therefore
unnecessary,  an inappropriate  use  of government  resources,  and  does  nothing  to
promote  private  enterprise.
Supporting  studies  that  demonstrate  the  value  of  providing  family  planning
to  employees,  or  of adding  contraceptives  to the  range  of products  offered  by
purveyors  of pharmaceutical  products  provides  firms  or entrepreneurs  with
information  about  a product  not  previously  offered  to  consumers.  It is  quite
different  than  either  subsidizing  an  already  planned  activity  or  paying  a firm
to  undertake  a feasibility  study  vhere  the  benefits  to them  are  already  clear.
The  point  of private  sector  promotion  in family  planning  is to  encourage
private  individuals,  companies,  and  groups  to invest  in  an area  that  has
historically  been  dominated  by the  public  sector. In  ensuring  broad  access  to
free  family  planning  services,  donors  and  governments  have  assumed  avay  the  role
of the  private  sector  for  all  but  the  highest  income  groups. This  pattern  may
have  produced  disincentives  to  private  activity  in  family  planning  that  might
have  flourished  othervise.  If so,  government  is  extending  subsidies  beyond  the
target  group  of those  who  require  a subsidy  to  afford  contraception.  Moreover,
crowding  out  the  private  sector  reduces  consumer  options  and  the  number  of
outlets  for  family  planning  services. In  other  vords,  government  can  make
private  investment  sufficiently  difficult  that  expansion  Is unprofitable.
It can  be  argued  that  subsidization  may  have  undermined  the  private  sector.
Social  marketing  efforts,  vhich  have  not  received  careful  evaluation,  may  vell
have  cut  into  private  provision  of contraceptives  at commercial  outlets  and  in
effect  have  subsidized  couples  vho  neither  need the  subsidy  nor  make  a decision
to  contracept  based  on the  availability  of  a less  expensive  product. There  is
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some  evidence  to  suggest  that  government  subsidies  crowded  out  private  invest-
ment  in the  Dominican  Republic's  social  marketing  effort.
The  private  sector  is  already  an  active  participant  in  family  planning
through  its  production  and  distribution  of contraceptives.  Multinational
companies  that  produce  contraceptives  are  represented  in  virtually  all
developing  countries.  Their  presence  suggests  an existing  or potential  market
for  contraceptive  products,  which  means  that  some  critical  proportion  of the
population  has the  income  and  the  need  for  privately  provided  contraceptives.
The  qu' cion  is,  how  much  of the  potential  demand  can  be  satisfied  by the
private  market? How  sensitive  are  various  segments  of the  population  to  contra-
ceptive  prices? Are there  location  and  price  tradeoffs?  Hcr  big is  the  market
for  contraceptive  products  priced  at marginal  cost  or above? Can  private
providers  price  discriminate  sufficiet.tly  to  meet the  demand  of  high  as well  as
moderate  income  couples? In  other  words,  how  much  can  the  private  sector  do to
meet  the  demand  for  contraceptives?  Is there  an economic  rationale  for  subsi-
dizing  the  initial  development  of  private  distribution  systems? The  issue  of
this  paper  is to  explore  the  current  role  of the  private  sector  in family
planning  and  assess  how  much  more  the  private  sector  can  take  on that  will
relieve  the  government  from  having  to  provide  services. In  so  doing  many  of
these  topics  are touched  on but  fev  of the  empirical  questions  are  satisfac-
torily  answered.
The  Role  of  Government  in  Family  Planning  Provision
The  historical  rationale  for  public  involvement  in family  planning  provi-
sion  is  based  on the  negative  externalities  associated  with  high  rates  of
population  growth,  and therefore  the  divergence  between  social  and  private
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benofits  of large  families;  the  low  incomes  and  level  of monetization  in  most
developing  countries;  and,  the  lack  of  adequate  information  regarding
contraception.
Although  of externalities  provide  major  rationale  for  government
intervention  in  providing  family  planning  is  still  valid,  although  the  recent
National  Academy  of Sciences  review  of existing  evidence  on the  consequences  of
high  fertility  suggests  that  the  private  benefits  of family  planning  use  exceed
the  social  benefits  (NAS,  1986). The  report  points  out,  however,  that  "vhen
negative  externatlities  exist,  a  minimum  policy  prescription  vould  include  the
subsidized  provision  of family  planning  services"  (NAS,  1986:84). Incomes  and
monetization  have  developed  rapidly  since  the  1960s  and  no longer  provide  a
logical  basis  for  government's  subsidization  of services  in  most  countries.
The information  gap  calls  for  improving  couples'  information;  provision  of
contraceptive  services  as a  vehicle  for  information  dissemination  suggests  that
family  planning  is  a  merit  good. Merit  goods  are  goods  or services  that  while
not  demanded  are  perceived  by  government  as important  to  improving  quality  of
life. Moreover,  merit  goods  are  consumed  in insufficient  quantities,  and
government  must  provide  consumers  vith incentives  (e.g.,  subsidized  products,
easier  access)  to  raise  their  consumption.  Government  subsidies  serve  to  alter
consumer  preferences  over  the  long  term  through  the  satisfaction  of merit  vants
(e.g.,  contraceptive  services),  and  in  effect  provide  information  through
experience  (Levis,  1981). Therefore,  public  subsidies  caun  promote  consumption
of merit  goods,  since  consumption  provides  information.
As a merit  good,  family  planning  is  promoted  to  encourage  couples  to  use  a
product  for  their  enhanced  private  vell  being. Increased  consumption  of a meri
good  (family  planning)  may  also  increase  social  velfare  through  lower  fertility
that  reduces  the  negative  externalities  associated  vith  high  rates  of population
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grovth. If family  planning  is  subsidized  because  it is  defined  as a merit  good,
subsidies  should  be phased  out  once  the  value  of  contraception  becomes  apparent
and  is Internalized  by the  the  target  population.  The  private  market  then
becomes  the  appropriate  sources  of contraceptive  services. The  continued  effort
to  address  the  social  benefit  of family  planning  due to  negative  externalities
associated  with  high  fertility  requires  the  continued  presence  of government
services.
As a practical  matter,  it is  unclear  how  relevant  any  of these  criteria  are
(or  were,  ir  some  instances)  to  a number  of  developing  countries.  These
rationales  huaie  fueled  the  expansion  of  subsidies  to  family  planning  by  donors,
governments,  NGOs,  and  other  groups,  without  ever  testing  whether  the  private
sector  could  handle  the  production,  distribution,  and  marketing  of  contracep-
tives  to  any  segment  of the  market  other  than  the  very  vell  off.
Subsidies  are  considered  essential  under  the  assumptions  outlined  above.
Although  the  reasoning  early  on may  have  been  sound,  much  of the  developing
world  has  come  a long  way  over the  past  few  decades,  and  the  private  sector-has
grown  and  matured. Meanwhile,  incomes  have  risen  and  a middle  class  has  emerged
in  a number  of countries,  calling  into  question  the  need  for  the  subsidies  they
may  receive  through  government  provided  or subsidized  family  planning  services.
Family  planning  is  viewed  as a social  good,  a service  that  the  population
should  have  access  to  in  order  to  control  fertility.  In  most  developing
countries  there  is  an  added  benefit  to investing  in family  planning,  and that  is
the  reduction  in  health  care  costs  related  to  both  maternity  (for  unplanned
births)  and  treatment  of botched  abortions.  Because  health  care,  particularly
inpatient  care,  is typically  free  in  developing  countries,  government  bears  the
cost  of both  services. Thus  family  planning  can  serve  to  lover  those  costs.
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As the  demand  for  family  planning  and  incomes  rise,  government's  role
should  shift  accordingly  to  promote  and  regulate  the  private  sector  to  serve
those  able  and  villing  to  pay  for  services. Government  can then  concentrate
resources  on those  for  vhom family  planning  is  a merit  goods  or those  who  cannot
afford  private  prices.
The  basic  premise  regarding  government's  role  is that  neither  consumers  nor
providers  should  be  subsidized  where  either  would  act identically  vithout
government's  intervention.
The  Economics  of Private  Sector  Family  Planning  Delive2y
The  private  sector  has  played  a central  role  in family  planning  from  the
development  of contraceptive  methods,  to their  manufacture,  to  their  delivery.
In the  developing  vorld,  delivery  of contraceptives  has  meant  establishing  or
building  on distribution  netvorks  to  physicians,  clinics  and  retail  outlets  that
provide  family  planning  services. Low  marginal  costs  of distribution  where
pharmaceutical  companies  are  already  operating  has  alloved  piggybacking  on
existing  networks  to  distribute  contraceptives.
The  desire  to  maximize  profits,  vhich  drives  for-profit  firms,  results  in:
designing  packaging,  information  and  products  that  respond  to  consumer
preferences,  maximum  efficiency  of operation  to  keep  costs  at a minimum,  and
charging  the  price  that  maximizes  profits--the  one  that  equals  marginal  costs
under  conditions  of perfect  competition. 3 The  pricing  implied  by profit
maximization  suggests  that  the  for-profit  sector  cannot  meet  the  contraceptive
needs  of low  income  households.
3.  Under  monopoly  conditions,  price  exceeds  the  level  where  marginal  revenue
equals  marginal  cost;  however,  contraceptive  monopolies  are  becoming  less
common  as  markets  expand  and the  number  of  providers  increases  in  response.
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Because  for-profit  entities  invest  in family  planning  to  earn  profits,  their
Incentive  to  keep  costs  to  a minimum  are  very  strong. Evidence  from  the  U.S.  and
elsevhere  indicates  the  consistently  lover  costs  of private  versus  public  health
care  service  costs  (see  Levis,  1987  for  a summary  of these). Because  it is
similar  to  and  often  delivered  vith  health  care,  family  planning  costs  are likely
to  shov  a  similar  pattern;  hovever,  family  planning  specific  data  are  not
available. Private  services  are  more  efficiently  run,  have  fever  employees,  and
lover  operating  costs  per  patient  served. Thus  private  manufacture  and  delivery
are  preferable  to  public. Hence  government's  regulation  of the  private  sector
and  privatization  of  contraceptive  service  delivery  will  be more  efficient,  that
is,  costs  will  be lover,  other  things  equal. 4
For-profit  entities  set  prices  at vhat  the  market  vill  bear. So to  maximize
profits  in the  family  planning  business,  the  number  of  users  and the  price  are
traded  off. Thus  unlike  government  vith  a  social  objective  of maximizing  the
number  of continuing  users,  private  investors  vill  raise  the  price  to  where  their
returns  vill  be highest  even  though  that  may  mean  a decrease  in  the  number  of
users. If lovering the  price  raises  the  number  of consumers  but  reduces
earnings,  then  private  entities  vill  prefer  to  raise  prices;
Earnings  from  contraceptive  sales  are  the  incentive  vhich  retains  private
companies  in the  market. If  profits  are  too  lov  or nonexistent,  then  no private
firm  vould  remain,  unless  the  long  term  potential  of the  contraceptive  market  vas
perceived  as  valuable. Thus  the  operating  climate  for  private  business  is
critical  to  continued  operation  of for-profit  investors.  A number  of  operating
impediments,  from  restricted  marketing  of ethical  products  (prescription  drugs,
for  example)  to  price  controls  to foreign  exchange  controls,  vill  impede  private
4. This  assumes,  hovever,  that  government  can  effectively  oversee  and  regulate
the  private  sector.
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activity. These  public  sector  restrictions  raise  the  cost  of doing  business
thereby  discouraging  investment,  and  ultimately  raising  costs  to  consumers.
Using  the  Private  Sector  to  Meet  Pamily  Planning  Needs
The  arguments  for  a  greater  private  sector  role  in  delivering  family
planning--that  government  need  not  provide  for  all  users,  and the  greater
efficiency  of.private  versus  public  providers--should  also  include  the
argument  by  Cross  (1986)  that  government  will  not  be  able to  afford  to  meet  all
demand given  projected  rises  in the  size  of the  reproductive  aged  population  in
the  developing  vorld  in the  next  decade,  and the  increasingly  constrained  govern-
ment  budgets. If the  private  sector  is  not  stimulated,  growing  demand  will  not
be  able to  be  met. Moreover,  without  government  efforts  to  reduce  barriers  to
for-profit  investments  in  family  planning,  services  may  be too  costly  for  many
users.
Government  has  a key  role  in  both  stimulating  private  activity  and in
reducing  extraneous  costs  (e.g.,  price  controls,  tariffs,  exchange  rate  controls)
for  private  investment.  Only  government  can  ensure  a conducive  investment
climate,  and it is through  government  incentives  and  removal  of disincentives
that  private  investment  can  flourish. This  issue  is  discussed  in  detail  in
Section  V belov.
The  private  sector  can  meet  family  planning  demand  through  direct  marketing,
contracts  with  government  (e.g.,  privatization),  or partnerships  with the  public
sector. As discussed  belov,  the  first  and  last  are  the  most  common  forms  of
private  activity. Privatization  is most  commonly  achieved  through  grants  to  NGOs
vhose  philosophies  are  often  similar  to  governments'.  Moreover,  such  grants  are
to  continue  existing  NGO  operations,  they  are  not  directed  to  carrying  out  a
specific  activity  for  the  public  sector. Greater  efforts  to  expand  direct
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private  sector  provision  and  harness  the  (potential)  efficiency  of privatization,
particularly  among  for-profit  entities,  should  be  priorities.
As already  mentioned,  the  for-profit  sector  is  an efficient  producer  and
distributor  of contraceptives  and  family  planning  services. NGOs  are  a hybrid
betveen  public  and  for-profit  entities. Vithout  the  need to  generate  profits  and
often  driven  by social  objectives  to  do  good,  NGOs  are  probably  less  efficient
than  the  private  sector,  but  their  commitment  to  social  goals  may  serve  to
motivate  employees  and raise  their  efficiency  above  that  of  government.  The
absolute  or relative  efficiency  of  NGOs is  simply  not  known,  however. 5 And
although  its  pricing  strategies  may  make  services  more  accessible,  population
coverage  is  often  spotty,  many  NGOs are  not  able to  expand  rapidly  enough  either
geographically  or in  numbers  served,  and its  lack  of incentive  to trade  off  users
and  costs  can  raise  the  cost  of operation  considerably.  Moreover,  to the  extent
that  they  rely-on  government  for  support,  they  too  will  be victims  of budget
constraints  and  cut  backs. Thus  although  NGOs  are  and  should  be  a fixture  of
family  planning  provision,  they  have  already  been  assisted  in the  past,  and;  more
importantly,  cannot  take  on the  entire  supply  burden  anticipated  for  the  coming
decades. Thus  it is  essential  that  some  efforts  be made  by governments  and
donors  to promote  greater  for-profit  involvement  in family  planning  delivery.
This  paper  focuses  on the  for-profits,  although  where  relevant  and  possible  NGOs
are included.
5.  Levis  (1985)  addresses  this  issue,  concluding  that  there  is  a dearth  of
knowledge  and  documented  experience,  vhich  prevents  any  conclusions  on the
efficiency  or  general  effectiveness  of  NGOs.
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Study  Outline
The  paper  is  divided  into  six  sections. The  next  section,  Section  II,
discusses  the  characteristics  of  private  sector  supply,  vith  a strong  emphasis  on
for-profit  producers  and  distributors  of  contraceptives.  Section  III
describes  the  distribution  of users  across  sources  and  addresses  the  issue  of
pricing  at public,  for-profit,  and  NGO  sources  of family  planning  services. In
Section  IV the  experience  to  date  with  private  sector  approaches  is outlined  to
provide  a sense  of vhat  has  been  and  is  currently  going  on in  public  and  donor
efforts  to  harness  and  collaborate  vith  the  private  sector. Section  V presents
alternative  means  for  government  and  donors  to  promote  private  sector  activity  in
family  planning,  and  suggests  some  of the  costs  of a  greater  private  sector  role.
The final  section  summarizes  and  concludes  the  paper.
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II.  CHARACTRISTICS  OP THE FOR-PRO'IT
PRIVATE  SECTOR  IN  PAMILY  PLANNING 0
This  section  addresses  the  issues  surrounding  the  supply  of contraceptive
products  and  services. Demand  and  utilization  vill  be  discussed  in the  next
section. Private  sector  involvement  in  family  planning  spans  the  gamut  including
research  and  development  into  nev  or improved  contraceptive  products  and techno-
logies;  production  and  packaging  of contraceptive  products;  the  distribution  of
products  to  government  and  commercial  outlets;  and, the  direct  provision  of
services  through,  retailers,  private  clinics  and  hospitals.  The information  and
analysis  presented  in this  section  come  from  extant  data  sources  and  from  discus-
sions  vith  executives  of  multinational  pharmaceutical  firms  that  produce  or
market  their  products  in  the  developing  world. All  evidence  presented  here  is
derived  from  the  indicated  source  or obtained  from  confrential  interviews.
Production
Producers  can  be categorized  into  two  general  groups. The first  group  is
pharmaceutical  manufactures  that  produce  a line  of ethical/medical  prescription
products  in  addition  to  contraceptives;  the  second  group  consists  of firms
specializing  in  non-medical  contraceptive  methods  like  the  condom. This
demarcation  is  not  exact  because  some  of the  former  firms  produce  ethical  and
non-ethical  contraceptive  products. Table  II.1  contains  a list  of the  major
multinational  producers  that  export  to the  developing  vorrd,  along  with the
location  of their  corporate  headquarters,  countries  where  production  facilities
are  located,  and the  range  of  products  produced.
In  general,  producers  are  American  and  European  multinational  corporations
that  have  local  subsidiaries  or direct  licensing  agreements  with  local
6.  Nongovernmental  organization  characteristics  are  provided  in  Levis  (1985).
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Table  II.1
Manufacturers  and  Their  Production  Sites
for  Contraceptives  by  Method
Partial  List
of Production  Contraceptive
Sites  in  Products
Manufacturers  Developing  World  Marketed  Notes
Organon  Mexico,  Brazil,  Several  Oral  Purpo-ted  to  be  one  of
(Holland)  Venezuela,  Contraceptives,  the ...rgest  suppliers  to
Argentina,  IUDs,  the  commercial  market  in
Indonesia,  injectable,  developing  countries.
Korea,  Pakistan,  implants,  Has  very  export-oriented
Bangladesh,  policies  with  emphasis  on
India,  Thailand  research  and  development.
Schering  Ag  Ir Almost  every  Oral  Is purported  to  be one  of
Vest  Germany  majt marketing  Contraceptives  the  largest  supplier  to
coustry,  e.g.,  injectable,  IUDs  commercial  markets  in the
Brazil,  Mexico,  developing  world.
Venezuela,
Thailand
Syntex  Mexico,  Brazil  Oral  Von  USAID  procurement
(U.S.)  Contraceptives  contracts  of 100  million
injectable  pill  cycles  per  year
until  early  1980s  when
procurement  fell  by
approximately  one  half
due to  phase  out  of dona-
tions  to  Indonesia. Vas
alwarded  to  CSM  procure-
ment  contract  for  orals
for  the  next four  years
Vyeth  In  almost  every  Oral  One  of the  largest
(U.S.)  major  marketing  Contraceptives  suppliers  to  public
country,  e.g.,  sector  programs  in the
The Philippines,  developing  world. Von
Pakistan,  Peru,  USAID  contract  to  supply
India,  Turkey,  orals  to  the  public
South  Korea,  sector  for  1988  to  1993.
Chile,  Colombia,  The  contract  specifies  a
Argentina,  minimum  of 30 million
Uruguay,  Mexico,  pill  cycles;  1988
Brazil  supplies  are  expected  to
be  56 million  cycles.15
Table  II.1  (cont'd)
Partial  List
of Production  Contraceptive
Sites  In  Products
Manufacturers  Developing  Vorld  Mxrketed  Notes
Ortho  Mexico,  Brazil,  Oral  Contracep-  Has  USAID  contract  to
(U.S.)  Argentina  tives,  spermi-  supply  foaming  tablets
cides,  foaming  (Conceptrol)  to  the
tablets,  developing  world.
Jellies,  foams,
Ansell  Inc.  Malaysia,  Condom  Has  been  sole  winner  of
(Australia)  Thailand  USAID  procurement
contracts  for  last  4-5
years  due  to large  produ-
ction  capacity  in the
U.S.  Supplied  about  400
million  condoms  last
year.
London  Rubber  Philippinesb  Condom,  Durex  product  used  in
Industries  Diaphragm  some  CSM  programs.
(Durex)  Dominate  commercial
(Great  Britain)  condom  markets  of Africa.
Sagami  Rubber  Malaysiab  Condom  Because  of size  of
Industry  domestic  market  for
(Japan)  condoms,  Japan  has
greatest  production
capacity. Of the  three
large  Japanese  producers,
Sagami  is the  largest
international  supplier  of
condoms.
Eisai  Co.,  Ltd.  Foaming  Tablet  Neo  Sampoon,  Eisai's
(Japan)  foaming  tablet,  is the
major  spermicide  donated
by international  donors
and  is used  in  many
social  marketing  efforts.
Holland  Rantos  Diaphragm
Corp.  (Holland)
Finishing  IUD  Supplied  2.6  million
Enterprises  Copper  T's to  USAID  last
(U.S.)  year. Sold to  UNFPA  as
well.
a.  Most  production  of oral  contraceptives  in the  developing  world  relies  on importing
the  active  ingredient.
b.  Data  are  not  available  but  given  the  worldwide  pattern  of condom  production,  it is
likely  that  these  firms  also  have  pro4uction  facilities  in  India  and  South  Korea.16
affiliates  In  developing  countries.  While  production  operations  are  located  all
around  the  vorld,  the  bulk  of production  still  takes  place  in the  developed
vorld. This  is  not the  case  for  all  firms. For  example,  Schering  Ag  does  most
of its  manufacturing  in  developing  countries,  especially  in the  newly  industri-
alized  countries.  Manufacturers  hoping  to  vin  USAID  procurement  contracts  (which
can  be sizeable)  have  an incentive  to  locate  production  within  the  United  States
because,  except  for  rare  circumstances,  the  commodities  provided  as a part  of the
contracts  must  be  produced  in the  United  States. Production  takes  place
worldwide  mainly  through  subsidiaries  of  multinational  corporations  and to  a
lesser  degree  by independent  producers.
Vhile  both  multinational  corporations  and  local  manufactures  are involved  in
the  production  of contraceptive  products,  the  former  play  a dominant  role  due  to
the  important  technological  component  in ethical  contraceptive  production  and  the
strong  economies  of  scale  in the  production  of many  contraceptive  products.
These  multinational  firms  handle  most  of the  research  and  development  for
contraceptive  products  although,  private-public  sector  collaboration  takes  place
through  agreements  vith  organizations  like  The  Population  Council,  PIACT,  W.H.O.,
and  Family  Health  International  that  have  been  predominantly  funded  by  USAID.
There  are  several  reasons  that  production  facilities  are  located  in the
developing  vorld.
First,  some  pharmaceutical  companies  believe  that  they  will  have  an
advantage  over  other  competitors  in  local  markets  if they  locate  production
domestically.  Local  production  has  a big  impact  on public  sector  sales;  even
bigger  than  its  impact  on  commercial  sales  according  to  another  pharmaceutical
firm. Second,  developing  country  governments,  like  Ind6nesia,  that  purchase  a
high  volume  of contraceptive  products  annually  to  supply  their  public  sector
family  planning  component  find  it  advantageous  to  purchase  locally  because
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foreign  exchange  is  at a  premium. Thus these  countries  may  be  willing  to  offer  a
firm  incentives  like  tax  breaks  or purchase  commitments  to  induce  it to  produce
locally.  Third,  some  countries,  like  India,  have  such  restrictive  import
policies  (marketing  is  forbidden  unless  there  is  local  production)  that  it
becomes  imperative  to  produce  vithin  a country  if  a co.npany  wishes  to  do business
In that  market. Fourth,  in  some  of the  newly  industrializing  countries  where
chemical  and  pharmaceutical  industries  are  burgeoning,  costs  of delivering
products  vithin  the  country  as well  as to the  other  countries  in  the  region  are
lover  than  the  costs  of producing  further  away  and  bearing  high transportation
costs.
The production  of condoms  for  export  to the  developing  world  is  handled
minly by three  companies--an  Australian  owned  firm  with  major  production
facilities  in the  United  States,  Ansell  Inc.;  a British  concern,  London  Rubber
Industries;  and,  a  Japanese  firm,  Sagami  Rubber. These  companies  have
subsidized/joint  venture  agreements  with  several  third  world  countries.  In
addition,  independent  production  takes  place  on a sizeable  scale  in  India,  China,
and  South  Korea. 7
while  condoms  are  produced  in  20 countries  worldwide,  almost  all  of the
condom  production  takes  place  in  Japan,  the  United  States,  China,  the  United
Kingdom,  India  and  South  Korea. One  third  of the  condom  production  capacity  is
located  in the  developing  world. Within  the  developing  world,  the  People's
Republic  of  China  has the  largest  production  capacity. Other  developing
countries  with  large  production  capacity  are  Malaysia,  Brazil,  Argentina,  and
hexico  vith  capacities  of  one  million,  700,000,  500,000  and  60,000  gross
respectively  (where  one  gross  is  144  condoms)  (Sherris  et.  al,  1982).
7.  The technology  for  mass-producing  condoms  is interchangeable  with  that  of
latex  gloves  and  given  overcapacity  in the  former  and  shortages  of the
(Footnote  7  Continued  on  Next  Page
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Due to  the  capital  intensive  nature  of condom  production  and  significant
economies  of scale  In  production,  efficient  factories  must  produce  on the  order
of 70 million  condoms  annually--vhich  means  there  'iould  have to  be  700,M00
couples  using  the  condom  for  contraception  (assuming  100  condoms  per  one  couple
year  of protection)  vithin  the  domestic  market .o  ensure  profitability  (assuming
no exports)  (Sherris  et.  al,  1982). This is  one  reason  that  production  is
concentrated  in  a fev  countries.  While  condom  production  is  capital  intensive,
the  packaging  of  condoms,  which  constitutes  about  one  half  of the  vholesale
price,  is  a labor-intensive  process. Local  packaging  of imported  condoms  occurs
in  Bangladesh,  Thailand  and  El Salvador  and  in  other  countries  as part  of their
social  marketing  programs. Increasingly,  the  packaging  of contraceptives  is
shifting  tovard  the  developing  vorld,  and,  social  marketing  programs  almost
alvays  have  a local  packaging  component.
Host  production  of  diaphragms  is located  in the  United  States  and the  United
Kingdom;  Ortho,  London  Rubber  Company  and  Holland-Rantos  Company  supply  to  family
planning  programs  (Sherris  et.  al,  1984). Although,  vere  demand  for  the  product
higher  in the  developing  world  vhere  it  accounts  for  a miniscule  share  of
contraceptive  users,  diaphragms  could  be economically  produced  in  developing
countries  in  a less  capital  intensive  vay than  it  is produced  vithin  the
developed  vorld.
Production  of oral  contraceptives  takes  place  throughout  the  developing
vorld  vith  plants  in  Mexico,  Brazil,  the  Philippines,  Indonesia,  Pakistan,  India
Bangladesh  to  name  a fev  countries.  This  list  suggests  the  diversity  of
production  location,  although  African  countries  are  notably  missing  from  the
(Footnote  7 Continued  from  Previous  Page)
latter,  some  of the  condom  capacity  may  be transferred  to  latex  gloves,
given  rising  demand  due  to the  threat  of AIDS.
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list. No oral  contraception  production  currently  takes  place  in  sub-saharan
Africa  outside  of South  Africa  although  there  are  plans  for  plant  location  in  one
or two  countries.  As mentioned  earlier,  factories  in the  developing  world  are
usually  subsidiaries  of  multinational  corporations  due to  the  sophisticated
nature  of  oral  contraceptive  production.
Vhen  oral  contraceptives  are  produced  in the  developing  world,  the  "active
ingredient"  (the  synthetic  hormones)  is  usually  produced  by the  home  factory  and
imported  except  in  cases  such  as Indonesia  vhere  special  arrangements  have  been
made  to  manufacture  the  active  ingredient  locally  and  supply  it to the  government
for  use  in the  domestic  production  of orals. The  conversion  of the  active
ingredient  into  progestin,  compounding,  tabletting  and  packaging  complete  the
production  process. Some  countries,  like  Mexico,  have  the  basic  raw  material  for
the  production  of orals  (and  the  lov-wage  labor  force  to  extract  the  raw
material)  and  have  domestic  production  of the  active  ingredient  and thus  have  no
need  to import  the  active  ingredients  (Sollins  and  Belsky,  1970). The  socially
marketed  oral  contraceptives,  like  condoms,  are  often  repackaged  in-country.
Injectables  like  Depo  Provera  are  produced  in  Belgium  and  in  a few  Latin
American  and  Asian  countries  (Liskin  et.  al,  1983). Depo  Provera  cannot  be
exported  from  the  United  States  because  it  has  not  gained  approval  of the  US Food
and  Drug  Administration  (FDA). The  implants  developed  by  The  Population  Council,
Norplant,  are  produced  in Scandinavia.
IUDs  and  IUD  inserters  are  produced  in  China,  India,  and  Mexico. IUDs  have
been  produced  in  India  for  more than  a decade  and  Copper  T devices  have  been
produced  in  Mexico  and  are  scheduled  to  be produced  in  Brazil,  China,  India,  and
Indonesia  (Liskin  et.  al,  1982). Finishing  Enterprises,  an  American  firm,
produces  the  Copper  T's that  are  purchased  in  bulk  by  USAID. Last  year,  USAID
purchased  2.6  million  Copper  T's.  PROMED,  an independent  Brazilian  firm,  also
produces  Copper  T's.
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It is  estimated  that  to  be efficient,  a plant  must  produce  one  million  IUDs
per  year. Vith  joint  production  and  the  sharing  of fixed  costs  of production,
this  number  can  decline  (Liskin  et.  al,  1982). A sizeable  industrial  labor  force
seems  to  be an important  consideration  in  location  decisions  by-multinationals.
Because  some  IUD  technology  has  resulted  from  private  and  public  collaboration,
the  chosen  licensed  distributors  of the  product  are  often  held to  price
restrictions  set  by the  developing  agency. For  example,  the  Population  Council,
when  arranging  for  production  and  distribution  of its  IUDs  will  sometimes  set
limits  on prices  that  can  be charged. This  has  resulted  in large  disparities
between  private  and  public  sector  prices  and  has  been  said  to lead  to  reduced
incentives  to  promote  products  vhere  prices  are  set  artificially  low.
Vaginal  spermicides  are  produced  by many  of the  multinational  pharmaceutical
firms. In the  developing  vorld,  one  of the  most  popular  of these  products  is  a
foaming  tablet,  due  perhaps  to its  robustness  in tropical  conditions  and  its  ease
of  use. The  Neo Sampoon  foaming  tablet  has  been  the  most  widely  used;  it is
manufactured  by a  Japanese  firm  and  has  been  used  as a social  marketing  product
and  marketed  under  other  names. Neo  Sampoon  was  the  main  spermicide  donated  to
developing  country  governments  by  all  donor  agencies  until  recently  when  USAID
started  to  donate  a comparable  American  brand  to its  recipient  countries. The
vaginal  suppositories  produced  in  Colombia  together  with  Neo  Sampoon  attained
sales  levels  on a par  vith  condom  sales  but  fell  short  of oral  contraceptive
sales  (Sherris  et.  al,  1984).
Incentives/Disincentives  for  Production  and  Marketing
The  economic,  social  and  political  environment  of a particular  country
influence  the  decisions  of individual  private  firms  with  regard  to  production,.
marketing  and  pricing  of  contraceptive  products  in that  country. The incentives
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and  disincentives  affecting  each  of these  decisions  will  be  discussed  in turn,  in
spite  of the  fact  that  they  are  clearly  intereependent.  Clearly  history  also
plays  an important  role  in influencing  production  and  marketing  location  and
success. For  example,  The  London  Rubber  Company  has  been  a major  exporter  of
condoms  to  anglophone  Africa  due  its  long  standing  involvement  in the  region
(Black,  1973).
There  are  certain  attributes  of domestic  markets  that  affect  the  potential
market  for  all  private  producers,  vhile  there  are  others  that  affect  producers
differentially.  Among  the  key  factors  that  affect  all  firms,  are  the  income
levels  of the  population  in  a particular  country,  the  consumer  demand  for
contraception,  whether  contraceptives  are  reimbursed  through  the  social  security
system  or through  private  health  insurance  schemes,  tariffs  and taxes  on imported
products  and  pharmaceuticals,  exchange  controls,  the  distribution  and  retail
outlet  networks,  speed  of approval  for  ethical  prescription  products  by  local  FDA
equivalents,  and restrictions  on advertising  and  marketing.
Additionally,  the  size  and  skills  mix  of the  labor  force  influences  the
economic  feasibility  of  domestic  production.  The  concentration  of production  in
the  newly  industrialized  countries  is  partly  a reflection  of their  developed
industrial  labor  forces.
Macroeconomic  conditions  also  affect  earnings  and  viability  of production
facilities  in  developing  countries.  According  to  one  multinational  corporation,
as the  Mexican  economy  has  declined  over  the  last  few  years,  multinational
contraceptives  producers  in  Mexico  have  suffered  serious  financial  losses.
Demand  for  contraceptives  dropped  off  with  declines  in  income,  and  with the
sharply  devalued  peso  the  value  of repatriated  earnings  declined  precipitously.
This  almost  led  to  plant  shut  downs.
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Government  pricing  policies  vith  r_espect  to  contraceptives  can  dissuade
companies  from  producing  in  certain  countries.  Where  government  has  set  price
ceilings  on contraceptive  products  during  periods  of  high  inflation,  it  can  be
impossible  to  meet  costs  as the  revenue  received  for  the  product  remains  constant
vhile  costs  rise. Yhen  contraceptive  prices  are  set  by the  government,
underlying  changes  in  costs  can  not  alvays  be translated  into  higher  prices,
vhich  leads  to  unprofitable  market  situations  and  disincentives  to  continued
production,  much  less  new  investment.
A country's  tariff  structure  influences  whether  local  production  is  likely
to  be profitable.  Production  incentives  vill  depend  on the  tariffs  on both
finished  contraceptive  products  and  on imported  inputs  to  contraceptive
production.  Hany  countries  have  tariffs  on imported  contraceptive  products,  vit
the  objective  of raising  revenue,  reducing  imports  to  conserve  foreign  exchange,
and/or  protecting/encouraging  domestic  production.  This situation  can  backfire,
hovever. Ghana  had  a 50 percent  tariff  on imported  condoms  and  a lengthy
licensing  process  to  provide  protection  to  its  domestic  rubber  industry.
Hovever,  this  has  not  stimulated  a domestic  condom  industry--to  date  no
multinational  has located  a condom  factory  there  and thus  the  tariff  serves  to
raise  the  commercial  price  of condoms  and  may  discourage  firms  from  marketing
their  product  vithin  the  country  (Black,  1973). In  Turkey,  high  tariffs  on
condoms  have  led  to  videspread  smuggling  of condoms. In  Colombia,  in the  early
1970s,  import  duties,  exchange  controls  and  other  legal  importation  requirements
vere  so burdensome  that  almost  all  condoms  vere  smuggled  into  the  country  and  ha
prices  that  greatly  exceeded  prevailing  international  prices  (Arthur  D. Little,
1972).
Higher  tariffs  on imported  contraceptives  can,  hovever,  serve  to induce
firms  to  locate  plants  vithin  countries  vhere  the  private  market  is  estimated  to
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be large  and  potential  profits  are  gre3lt.  In 1972,  some  multinationals  did the
tabletting  and  packaging  of orals  in the  Philippines  due  reportedly  to the
relatively  higher  import  duties  on finished  than  less  processed  products  (Arthur
D. Little,  1972).
Hovever,  some  countries  also  have  tariffs  on imported  raw  material  inputs
that  increase  the  cost  of production  in  that  country. This can  be a real  deter-
rent,  especially  to  oral  contraceptive  production.  One rav  input  into  oral
contraceptive  production  is  not found  in  many  countries  (Sollins  and  Belsky,
1980),  and  if it  has  to  be imported  and  is subject  to  a tariff,  the  domestic
costs  of production  will  rise. Reportedly  one  of the  fev  countries  at this  time
vithout  tariffs  on either  the  imported  rav  material  or  oral  contraceptives  is the
Philippines.
Very  damaging  to  private  production  of contraceptives  is government
restrictions  on foreign  exchange  movements  and  the  repatriation  of  earnings.
Governments  that  restrict  the  repatriation  of earnings  reduce  incentives  for
multinational  corporations  to  locate  plants  vithin  developing  countries.  Vhile
some  firms  have  been  able  to  reduce  the  impact  of  such  disincentives  by svapping
costs  and  earnings  on  a vorldvide  basis,  or by reinvesting  domestically,  these
restrictions  have  served  as a deterrent  to  private  sector  expansion  in  some
developing  countries.
Another  deterrent  to  domestic  production  is the  risk  of the  government
either  creating  a subsidized  competing  factory  or purchasing  from  other  sources.
A multinational  built  a plant  in India  with the  understanding  that  the  public
sector  vould  purchase  its  output  only  to  have  the  public  sect  or subsequently  set
up its  own  plant. Further,  the  threat  of nationalization  is said  to  have
deterred  firms  from  locating  production  in  countries  where  that  threat  is  real.
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Location  of Contraceptive  Markets
For  firms  that  lack  production  facilities  vithin  a particular  country,  the
decision  to  market  products  and  make  investments  in that  country  depends  on the
size  and  potential  profitability  of sales  to  both  public  and  private  sectors.
Because  so many  couples  in  much  of the  developing  vorld  rely  on the  public  sector
for  contraceptives,  sales  to the  public  sector  are  quite  important  to
pharmaceutical  producers  (the  public/private  sector  breakdown  is  given  in  Table
III.1).  Private  companies  vie  to  vin  contracts  from  USAID,  UNFPA,  other  inter-
national  donors  or local  governments  to  supply  the  public  sector  clinics.
Some  firms  have  argued  that  they  just  meet  marginal  costs  when  supplying  to
donors  and  governments  at vell  belov  vholesale  market  prices  and that  they  do  not
cover  research  and investment  costs  on these  transactions.  In  part,  the
economies  of scale  in  production  allov  them  to  sell  to  public  entities  at a
reduced  rate. Other  firms  say  that  they  are  able  to  defray  their  fixed  costs
through  commercial  sales. Further,  some  firms  take  a longer  run  viev  and  believe
that  the  pay  off to  investments  made  in  developing  country  markets  over  the  past
fev  decades  vill  occur  in the  coming  years  as these  markets  grow  and  are
committed  to  long  available  products. Other  firms  have  stated  that  it  becomes
difficult  to  "break  into"  a nev  market  vhen  other  firms  are  already  vell-
established.
Firms  that  supply  contraceptives  to the  public  sector  may  have advantages
over  competitors  at  gaining  a foot-hold  in the  private  sector. There  is  evidence
from  the  last  round  of the  Contraceptive  Prevalence  Surveys  (CPS)  that  in  some
countries,  vhile  most  vomen  obtain  their  initial  supply  of the  pill  from  a
clinic,  they  are  most  likely  to  have  obtained  their  pill  resupply  from  a pharmacy
(Tunisia  CPS, 1983). Thus the  type  of  oral  contraceptives  (color,  size,  brand
and  hormone  mixture)  provided  in the  public  sector  are  likely  to  be in  greater
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demand  in the  private  sector,  other  things  equal,  than  other  pills  on the  market.
Evidence  that  users  remain  loyal  to  a product  comes  from  the  Eastern  Caribbean
vhere  new,  public  free-pill  programs  are  being  launched. Potential  users  are
undermining  the  potential  successes  of the  nev  program  by rejecting  the  USAID
supplied  orals  in favor  of the  long  standing  pharmaceutical  products  marketed
commercially  by Schering  Ag.
Some  private  firms  also  complain  that  some  of their  commodities  that  are
sold  at  concessionary  prices  to  the  public  sector  have  found  their  vay  into
retail  outlets  where  they  compete  unfairly  with  the  firm's  commercial  products  as
they  carry  deep  discounts.  Problems  have  been  reported  specifically  in  Thailand
and  Costa  Rica.  Firms  feel  that  this  direct  competition  in  the  commercial  sector
greatly  undermines  their  commercial  sales.
Government  Regulations  and  Contraceptive  Sgupplies
Government  imposes  a wide  range  of restrictions  on contraceptive  marketing
and  distribution.  The  private  sector  provision:  of family  planning  is  affected
not  only  by the  macroeconomic  context  but  also  by policies  on pharmaceuticals,
and  policies  specifically  aimed  at controlling  the  contraceptive  market.
Kacroeconomic  Constraints.  A number  of macroeconomic  factors  are  important
in  determining  marketing  success. The  government's  pricing,  tariff,  and  taxation
policies  influence  the  profitability  of commercial  sales,  as  already  mentioned.
High  tariffs,  taxes,  and  price  ceilings  reduce  the  margin  that  private  producers
can  gain  by  exporting  and  can  result  in  significant  black  markets  for
contraceptives  to  circumvent  high  cost  restrictions.  Price  ceilings,
particularly  prevalent  in  Latin  America,  erode  profitability  in the  face  of rapid
inf  lation  and  devaluations.
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Exchange  controls  and  limitations  on the  repatriation  of  earnings  reduce  the
incentives  of both  importers  to  import  contraceptives  and  exporters  to  export
contraceptives,  thus  reducing  the  size  of the  commercial  market. Importers  are
allocated  a limited  amount  of foreign  exchange  and  will  ci.ose  to  purchase  the
imported  products  that  enjoy  the  highest  mark  up.  Because  other  pharmaceutical
products  enjoy  greater  profit  margins  in  some  African  countries,  importers  may
not  place  a high  premium  on importing  contraceptive  products  when foreign
exchange  is  scarce  and  may  lead  to  erratic  and  lover  supplies  of imported
contraceptive  products  in  Nigeria  (Black,  1972,  1973).
When  exporting  products  to  different  countries,  producers  prefer  to  realize
their  profits  in  hard  currency. Multinationals  produce  and  maintain  research,
marketing  and  managerial  expertise  at their  home  bases,  vhose  costs  must  be  at
least  partially  met  by repatriated  profits  (unless  profits  generated  from
domestic  sales  totally  defray  these  costs). Further,  investment  opportunities
may  nat  be lucrative  enough  in these  developing  countries,  so that  repatriation
restrictions  are  strong  investment  disincentives.
Advertising  Constraints.  Due  to the  sensitive  and  private  nature  of
contraception,  governments  often  forbid  active  advertising  for  family  planning
products.  Further,  advertising  on ethical  products  is  often  restricted.  In other
countries,  no  brand  name  advertisement  is  permitted,  making  only  general  message
promotion  legal. This  can  lead  to  reduced  demand  due to  lack  of information  and
thus  to  reduced  earnings  opportunities  for  commercial  sales. While  the  demand
for  contraceptive  products  depends  to  some  extent  on the  income  level  and
socioeconomic  status  of  a population,  an  avareness  and interest  in family
planning  among  couples  of reproductive  age  also  affects  demand. To the  extent
that  marketing  and  advertising  can  raise  awareness  and  increase  willingness  to
pay  for  contraception  because  of better  information  about  the  contraceptive
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market,  restrictions  on  advertising  and  marketing  limit  the  growth  of the  private
sector.
In some  countries,  exceptions  have  been  made  to these  rules,  especially  in
the  interests  of contraceptive  socia'  marketing  programs. Most  social  marketing
programs  have  a promotional  component.  These  promotional  activities  vary  from
point  of purchase  displays,  radio,  print  or television  ads  and  messages,  to
staged  eventstgeared  to  draw  attention  to the  benefits  of child  spacing  and
family  planning. Some  private  firms  have  used  magazine  advertisements  in some
developing  countries  although  there  is  little  e-idence  of private  advertising  of
family  planning  products  in the  developing  world. An advertisement  for  a vaginal
suppository  in  Colombia  vhich  did  not  apparently  directly  refer  to  family
planning  but  instead  emphasized  feminine  hygiene  (Arthur  D. Little,  1972)
reportedly  did  better  than  a competing,  non-advertised  product,  but it  also  had  a
much  lover  price  (Sherris,  1984).
For-profit  firms  believe  that  direct  brand  advertising  and  marketing  of
family  planning  through  the  mass  media  may  not  be  a profitable  venture  in (some)
developing  countries.  They  believe  that  while  they  would  bear the  costs  of the
campaign,  the  benefits  vould  likely  be spread  across  all  commercial  firms  and
might  also  lead  to  increased  demand  for  contraception  from  the  public  sector,
especially  in countries  where  modern  methods  of contraception  are  not  widely
known  or used. They  believe  that  vhile  loyalty  to  their  brand  might  be enhanced
by raising  the  demand  for  contraceptive  products,  they  vould  be underwriting  a
rise  in the  overall  level  of contraceptive  demand  including  that  of their
competitors  and the  free  service. To the  extent  that  this  is  private  gains  fall
short  of the  private  costs,  subsidization  vould  be necessary  to  make  advertising
profitable.  No study  exists  in the  developing  world  that  carefully  documents  the
effect  of easing  advertising  restrictions  or the  effect  of private  brand
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advertising  on the  demand  for  other  brands. Further,  some  firms  believe  that  the
size  of  an advertising  program  may  have  to  be  so large  to  have  an impact  that  it
vould  require  an investment  that  is  larger  than  any  one  firm  vould  undertake  on
its  own.
Some  pharmaceutical  firms  that  market  ethical  products  have  detailers  that
market  the  product  line  to  local  physicians  and  pharmacists.  The  detailers  use
informative  (on  contraindications  and  product  attributes)  and  promotional
material  to  inform  doctors  about  their  products. This  form  of marketing  is
common  throughout  the  vorld. Free  samples  are  sometimes  provided  to  encourage
restocking.  One firm  gives  samples  to  both  public  and  private  physicians  under
the  assumption  that  MDs  vho  prescribe  one  product  in their  public  practice  will
use the  same  product  in their  private  practice  as vell. Other  firms  restrict
their  activity  to  stocking  commercial  outlets.
Detailing  and  sampling  can  be a very  expensive  undertaking  for  firms  and
accounted  for  an estimated  50 percent  of the  retail  price  of oral  contraceptives
in  the  Philippines,  Iran  and  Colombia  in  1971  (Arthur  D. Little,  1972). One
major  recommendation  of that  study  was  for  detailing,  sampling  and  promotion  of
family  planning  to  be  handled  by the  government  or a  nonprofit  entity  so that
costs  could  be lovered. Although  there  is  no  more  recent  published  data  on the
cost  of detailing  and  sampling,  it is  unlikely  that  the  high  reported  share  of
the  retail  price  absorbed  by  detailing  and  sampling  in the  1972  study  is  still
relevant  today. One  firm  argues  that  detail  costs  are  very  high  vhen  a product
is  relatively  nev,  but  that  they  decline  thereafter,  so that  the  findings  In 1972
might  be reflecting  the  novelty  of the  product  at the  time.
Evidence  on the  effect  of receiving  contraceptive  literature  along  vith
contraceptive  purchases  at drugstores  is that  sales  of contraceptive  products
rise. Pamphlets  vere  given  to  60  drugstores  that  described  the  proper  use  and
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effectiveness  of condoms,  suppositories,  and  oral  contraceptives  and  could  be
distributed  to  customers  making  contraceptive  purchases  (Bailey  and  Zambrano,
date). Sales  data  on these  three  products  were  collected  before  and  after  the
introduction  of the  pamphlets  at  60 drugstores.  The pamphlets  were  introduced  at
only  30  of the  drugstores  and the  other  30  vere  paired  with  the  30  experimental
drugstores  as a way  of measuring  substitution  toward  the  experimental  drugstores.
Comparing  the  sales  at the  experimental  drugstores  before  and  after  the  pamphlets
vere  added,  the  researchers  found  that  sales  of condoms  and  suppositories
increased  significantly  while  pill  sales  increased  only  slightly. The  control
drugstores  experienced  no significant  change  in  sales  over  this  period.
Analysis  of the  sales  of the  paired  control  drugstores  indicated  that  in 2
of 16,  4  of 10  and  6 of 11  pairs,  sales  of  suppositories,  oral  contraceptives  and
condoms  respectively  fell  but that  overall,  there  vas  only  a  net  decrease  in the
condom  sales  of the  control  drugstores.  Because  the  data  are  strictly  from
retail  sales,  it is  difficult  to  evaluate  how  much  switching  across  methods  or
across  supply  sources  occurred  and  therefore,  it is  difficult  to  conclude  vhat
the  net  impact  this  sort  of program  has  on  overall  contraceptive  use  and  births
prevented,  but  it  does  seem  that  the  use  of pamphlets  can  increase  use  of condoms
and  suppositories.  This  suggests  that  retailers  could  play  a bigger  role  in
providing  contraceptives  if they  gave  customers  method-specific  information.
Legal  Constraints.  Obtaining  product  approval  from  the  local  country's  Food
and  Drug  Administration  equivalent  is  a precondition  for  -being  able to  sell  a
product  in  most  local  markets. This  can  be  a long  process,  especially  for  nev
products. In  many  countries,  havirg  A,;rican,  British,  or  Svedish  FDA  approval
suffices. Social  marketing  programs  have  been  able  to  expedite  the  approval
process  for  socially  marketed  products,  but  products  destined  strictly  for
commercial  outlets  may  face  long  delays  gaining  approval. Delays  have  been
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experienced  recently  In  getting  injectables  on the  market  in  some  developing
countries,  for  example,  because  they  have  failed  to  gain  USFDA  approval. Firms
complain  that  it can  be difficult  to  add  nev  orals  to the  market  vith  different
compounds  even  though  they  may  be  more  appropriate  for  some  vomen.
Commercial  sales  may  also  be hindered  by laws  governing  the  distribution  of
contraceptive  products  and  provision  of services. These  laws  designate  personnel
vho  are  authorized  to  provide  contraceptive  services  and they  specify  vhere  these
services  can  be provided. Many  countries  -require  that  oral  contraceptives  be
purchased  only  vith  a prescription  from  a physician  (Isaacs  et.  al,  1984).
Despite  the  potential  quality  benefits  of  a prescription  requirement,  it  serves
to  reduce  access. This  requirement  is  not  enforced  across  all  countries.
Physician  to  population  ratios  are  almost  alvays  lover  than  pharmacy  or
midvife  to  population  ratios,  especially  in rural  areas,  so that  requiring  a
prescription  to  purchase  orals  vill  make  obtaining  contraceptives  more  costly  and
difficult.  Given  that  travel  time  represents  an economic  cost  and  serves  to
deter  use,  the  more  outlets  from  vhich  contraceptive  products  can  be purchased,
the  lover  vill  be the  cost  of  obtaining  contraceptives  for  users,  other  things
equal. Indeed,  the  social  marketing  programs  specifically  seeks  to increase  the
points  of access  as  vell  as the  affordability  of nonclinical  family  planning
methods.
Another  deterrent  to  private  contraceptive  marketing  in  developing  countries
is  absence  of patent  protection,  vhich  reduces  potential  profits  from  commercial
sales  of patented  products. In  Mexico,  the  absence  of patent  protection
reportefly  led  to  lov  prices  and to  nearly  30  brands  of oral  contraceptives  (many
of them  duplicates  under  different  names)  available  on the  commercial  market  at
the  same  time  (Sollins  and  Belsky,  1970). Questions  have  been  raised  about  the
quality  of some  of the  locally  manufactured  imitations,  but  demand  did  appear  to
grov  under  the  competitive  supply  conditions.
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While  the  absence  of  patent  protection  can  often  stimnulate  domestic  produc-
tion,  the  net  impact  on  the  size  of  the  comercial  sector  is  not  clear  a  priori.
The  competition  and  resulting  low  prices  may  attract  consumers  while  variable
quality  may  deter  use. The  size  of  the  market  may  not  be  very  different  although
the  share  accorded  each  producer  is  likely  to  be  affected.  Without  patent
protection,  local  firms  are  unlikely  to  have  sufficient  incentive  in  the  long  run
to  invest  in  research  and  development  and  to  develop  nev  products  and
multinationals  may  find  a  chaotic  market  that  is  consequently  unprofitable.
Public  and  Private  Sector  Relationships  and  Roles
The  effect  that  the  public  family  planning  system  has  on  the  size  of  the
comercial  sector  has  not  been  examined  scientifically  across  countries  or  over
time  vithin  one  country.  Past  analyses  of  the  role  of  the  commercial  sector
(Sollins  and  Belsky,  1970;  Arthur  D.  Little,  1972)  have  focused  on  the  condom  and
the  pill  because  they  have  been  the  most  important  commercial  products  in
developing  countries.  In  the  1970  study  of  Sollins  and  Belsky,  the  commercial
sector  vas  shown  to  have  a  larger  share  of  the  condom  and  oral  market  in  5  of  the
6  countries  studied,  while  this  pattern  prevailed  in  2  of  the  3  markets  analyzed
by  Arthur  D.  Little.  Analysis  presented  in  Section  III  of  more  recent  data
reinforces  the  method  dominance  of  the  pill  and  condom  in  private  sector  family
planning  provision  in  the  developing  world.
Vaginal  spermicides  have  been  groving  increasingly  important  in  the
developing  vorld,  vhich  suggest  an  even  broader  role  for  the  commercial  sector  as
these  methods  are  inexpensive  and  conducive  to  commercial  distribution.  IUD
insertions  and  sterilizations  have  traditionally  been  provided  by  the  public
sector  in  developing  countries,  although  higher  income  women  have  obtained  these
services  from  private  doctors  or  clinics.  Of  course,  private  voluntary  organi-
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zations  have  been  key  providers  of these  services  in some  parts  of the  vorld,
like  Latin  America.
The  common  perception  is  that  the  public  and the  commercial  sectors  serve
different  clientele. Public  sector  users  are thought  to  be less  educated  and
have  lover  incomes  than  their  commercial  counterparts.  Thus,  expanding  services
offered  through  the  public  sector  should  not  have  an impact  on commercial  sales.
Hovever,  there  is  reported  evidence  from  private  providers  that  in  some
countries,  as the  public  sector  expands,  the  commercial  sector  shrinks. Recent
experience  in  Kenya  has  been  cited  as  a particularly  dramatic  case  where  a public
program  has  almost  eliminated  the  private  market  and  multinationals  have  pulled
back  significantly.  This  seems  especially  true  in  countries  vhere  contraceptive
prevalence  is  lov. Further,  as already  mentioned,  the  public  sector  supplies  can
find  their  way  into  commercial  outlets  offering  unfair  competition  to  the
commercially  distributed  products  and  cutting  down  on commercial  sales.
The introduction  of free  government  services  in  Nigeria,  for  example,  vas
folloved  by large  reductions  in the  commercial  sales  of one  firm. Vhile  some  of
the  reduction  in  demand  might  have  been  related  to  Nigeria's  economic  downturn,
the  total  number  of  acceptors  did  not  change. The  increased  availability  of free
contraceptives  caused  this  firm  to  close  down  its  subsidiary.
According  to  extensive  discussion  vith  managers  and  distributors,  each
firm's  success  in  marketing  and  selling  its  contraceptive  line  in  a particular
country  seems  to  depend  on a number  of factors. A firm's  relationship  with  the
government  in  that  country,  hovever,  seems  to  be  a  key influence  on the  firm's
long  term  success  in the  private  market.
For  instance,  in  Nigeria,  Sterling  Nigeria,  (a subsidiary  of Sterling  Drug),
established  a cooperative  relationship  vith  the  government  by  handling  the
distribution  of  donated  contraceptive  products  to  regional  public  sector  family
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planning  clinics. This  has  placed  that  firm  in  a position  to  break  into  the
market  in  other  vays.  Sterling  is  reportedly  contemplating  construction  of a
condom  factory  in  Nigeria. Because  Sterling  is  distributing  contraceptives  to
private  clinics  and  pharmacies  throughout  the  country,  it may  have  an advantage
over  other  commercial  producers  in  the  future.
In the  1970's,  USAID  donated  millions  of pill  cycles  per  year to  Indonesia.
Because  USAID'  vas  phasing  out  the  free  commodities  and  moving  Indonesia  into  a
loan  category,  the  Indonesian  government  vas  concerned  about  ensuring  future  oral
contraceptive  supplies  at a lov  cost. A private  American  pharmaceutical  company
provided  technical  assistance  to the  BKKBN  (the  Indonesian  Family  Planning
Association)  to  set  up a plant  to  produce  oral  contraceptives.  This  firm  vas
well-positioned  vithin  Indonesia  because  its  product  had  been  supplied  by USAID
for  many years.
The  distribution  of  contraceptives  is  handled  in  developing  countries  by
public  and  private  distribution  networks--the  latter  are  sometimes  truly  local
operations  vhile  other  times  they  are  subsidiaries  of  multinational  pharmaceu-
tical  companies. Private  distribution  networks  of  vholesalers  reach  both  private
and  public  outlets. Most  pharmaceutical  companies  that  sell  contraceptive
products  in  a country  also  sell  a broader  line  of pharmaceutical  products  and
have  either  developed  their  own  distribution  network  or rely  on and  use  existing
vholesale  networks.
The  public  sector  has  relied  on  private  vholesaler  distribution  netvorks  In
the  developing  world  to transport  contraceptive  products. In  Nigeria,  as  already
mentioned,  a  private  firm  distributes  contraceptives  to  public  sector  clinics
vith  no  apparent  complaints  from  the  government.  In  Tunisia,  hovever,  until
1983,  the  private  vholesaler  network  of  grossistes  or  repartiteurs  distributed
subsidized  government  contraceptives  to  pharmacies  along  vith  their  other
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pharmaceutical  products. The  National-Office  of Family  Planning  in  Tunisia  (the
OYPP)  believed  that  it  vas too  difficult  to  account  for  stocks  of contraceptives
moving  through  the  private  wholesaler  system  and  that  there  vere  too  many  stock
disruptions,  so they  set  up their  own  distribution  system  to  deliver
contraceptives  to  family  planning  clinics  and  pharmacies.
A recent  study  (Ronco  Consulting  Corp.,  1986)  has taken  a preliminary  look
at the  relative  costs  of  delivery  for  the  ONFP  and the  private  distributors  and
has  concluded  that  the  private  distributors  have  lover  costs  than  the  ONFP  due to
more  efficient  delivery  operations.  The  study  results  vere tentative  because  the
cost  estimates  vere taken  from  different  years,  the  sample  of ONFP  and  private
distributor  operations  vas  small,  and  assumptions  had to  be  made  about  valuing
products  delivered  through  the  ONPFP.  Thus,  distribution  to  commercial  outlets
has  been  handled  by government  and  for-profit  entities  with  different  results.
Vhile  most  contraceptive  social  marketing  programs  entail  the  sale  of subsidized
contraceptives  at for-profit  outlets,  some  use  private  transport  networks  vhile
others  rely  on  an in-house  distribution  staff. The  governments  that  have  taken
over  all  or part  of the  distribution  have  claimed  that  relying  on private
distribution  led  to  inadequate  sales  or  shortages. On the  other  hand,  the
government  distribution  may  be less  cost  effective.
Contraceptive  Social  Karketing
The  presence  and  slant  of a contraceptive  social  marketing  (CSM)  program  can
affect  commercial  sales  in  either  direction. Social  marketing  entails  the
subsidized  distribution  of contraceptives  through  the  private  sector  along  vith
market  research  and  advertising  in  an  attempt  to raise  awareness  of and  villing-
ness to  pay  for  contraception.  The  private  sector's  distribution  networks  are
used to  expand  the  points  of access  to  contraceptives.  There  are  many  social
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marketing  models  that  vary  by type  of  management  structure  employed  to  handle  the
project,  type  of  products  marketed,  type  of distribution  methods  used,  and  by
retail  outlets  chosen  as points  of  purchase.
Five  recent  reviev  articles  summarizing  CSH  experiences  were  cited  in the
introduction  to this  study. The  most  recent  (Sheon,  Schellstede  and  Derr,  1987)
indicates  that  CSM  has  been  tried  in  almost  30  countries  and that  about  one  third
of these  countries  currently  has  a  CSH  program.  Programs  in  Colombia,  Jamaica,
Bangladesh,  Egypt,  and  Nepal  covered  more than  twenty  percent  of contracepting
couples  in 1984  according  to  Binnendijk  (1986). These  may  be  overstatements,
however,  because  they  are  generated  from  program  data  and  not  from  demand
studies. Because  program  data  rely  on  vholesale  level  volumes  and  because  of
vastage  and  disappearance  of  CSH  products  beyond  that  point,  the  retail  volumes
are  likely  to  be  lower.
Social  marketing  programs  often  aim  to  exploit  existing  distribution
networks  to  expand  points  of purchase  and  reach  more  potential  contraceptive
users. A current  example  of hov  private  networks  can  be  used is the  SOMARC
project  in  Zimbabve,  launched  in 1986,  seeking  broader  distribution  of the
condom. A commercial  distributor,  Geddes  Ltd.  that  already  distributes
deodorants  to  supermarkets  is  going  to  distribute  condoms  to  petrol  stations,
bars,  supermarkets,  and  bottle  stores.
The  condom  has  been  the  most  common  socially  marketed  product,  vith  oral
contraceptives,  vaginal  spermicides,  injectables  and  IUDs  following  in  order  of
number  of programs  that  have  used them. The  first  CSH  program  had its  inception
in  1967  in  India  vith  Nirodh,  the  name  chosen  for  the  socially  marketed  condom.
Not  only  has  there  been  increasing  product  diversification  in  socially  marketing
attempts,  but  programs  have tried  to  reach  self-sufficiency  and  have  added  more
brands  of the  same  product;  high  and  low  dose  pills  or lubricated  and  unlubri-
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cated  condoms,  for  example. Vhen the  Sri  Lankan  program  gained  financial  self-
sufficiency  (excluding  donatad  commodities)  It  came through  higher  prices  and
lover  sales. Indeed,  the  proportion  of  married  vomen  of reproductive  age  coverec
through  CSH  declined  (Chester,  1986).
Each  one  of the  reviev  articles  concludes  that  insufficient  evaluation  has
been  undertaken  on the  consequences  and  cost-effectiveness  of CSM  programs  and
that  the  impact  that  CSM  has  on the  comercial and  public  sectors  has  not  been
adequately  analyzed. The  presence  of  a CSK  program  can  be  detrimental  or bene-
ficial  to the  comercial sector  depending  upon  effectiveness  of the  program  at
raising  overall  demand  for  contraceptives  and the  degree  of substitution  that
occurs  avay  from  the  comercial sector  tovard  the  socially  marketed  products  that
are  subsidized.
Private  firms  believe  that  they  can  gain  from  the  consciousness  raising
achieved  by the  advertising  and  promotion  components  of social  marketing  and
through  enhanced  avareness  that  contraceptives  can  be obtained  at retail  outlet
However,  some  firms  have  noticed  a strong  correlation  between  the  establishment
of  social  marketing  products,  and  large  reductions  in commercial  sales  in  some
countries.
The  received  visdom  is that  in  countries  vhere  contraceptive  prevalence  is
lov,  the  CSM program  is likely  to  have  a positive  impact  on contraceptive  use
overall  with  little  substitution  away  from  other  sources  (Sherris  et.  al, 1985).
The  Bangladeshi  program  is  cited  as a successful  model  and  the  fact  that  both
government  and  CSN  provision  (the  role  of the  unsubsidized  commercial  sector  is
insignificant  in  Oangladesh)  of  condoms,  foaming  tablets  and  oral  contraceptives
grev  over  a nine  year  period. Further,  in the  case  of oral  contraceptives,  wherE
the  commercial  sector  does  cover  a substantial  proportion  of users,  there  is
evidence  that  the  increases  in  CSh  program  sales  vas  not  associated  with
decreases  in  pill  use from  other  sources  (Schellstede,  1986).
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Bangladeshi  surveys  in  1983  and  1985  asked  pill  users  the  brand  name(s)  of
their  oral  contraceptive.  This  survey  found  that  pill  use  increased  for  all
brands  from  government,  CSH  and  commercial  sources. The  proportion  using  both
CSH  and  commercial  pills  increased  while  the  proportion  using  government  pills
decreased.  Vhile  it  is  difficult  to  ascertain  vhat  would  have  happened  to the
volume  of commercial  sales  in the  absence  of the  socially  marketing  effort,  this
suggests  that  they  vere  at least  not  hindered  by the  CSH  program  and  may  have
been  helped  by it.
Contraceptive  social  marketing  in  countries  xn  which  contraceptive
prevalence  is  high  and  where  the  commercial  sector  plays  a more  important  role
may  have  less  of an overall  impact  on  contraceptive  prevalence  because  of
substitution  avay from  government  and  commercial  sources. Further,  there  is  some
evi4ence  that  vhen  higher  income  groups  are targeted,  as they  were in  Colombia,
there  may  be  greater  substitution  avay  from  commercial  products  (Binnendijk,
1985).
In  Sri  Lanka,  the  Preethi  condom  vas  launched  as  a socially  marketed  product
in 1973. A survey  of Preethi  users  one  year  and  one  half  after  the  advent  of the
program  suggested  that  65  percent  vere  new  contraceptors.  The remaining  35
percent  was  divided  among  those  who  had  used  oral  contraceptives,  IUDs,
traditional  method  and  other  condom  brands  (Davis  and  Louis,  1977). An estimated
four  percent  had  switched  to the  Preethi  brand  from  another  condom  brand.
Evidence  from  the  Dominican  Republic  suggests  that  commercial  sales  can
decline  substantially  after  a socially  marketed  product  is introduced.  The
SOMARC  project  together  vith the  Dominican  Republic  government  chose  to  market
Hicrogynon,  a Schering  Ag brand  of oral  contraceptives  as the  social  marketing
product. The commercial  price  of Microgynon  was  cut in  half  and  it  was  promoted
through  local  advertising  channels. After  the  launch  of Microgynon  as the  social
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marketing  product,  Schering  experienced  a decline  in its  commercial  sales  of
other  oral  contraceptives.  Overall,  however,  Schering's  sales  have  increased  ten
fold. The  net  returns  are  higher  because  of the  high  volume  generated  by the
lover  price  even  though  their  other  commercial  products  have  suffered.
This  particular  social  marketing  strategy  has  the  effect  of placing  a single
private  company  in a  strong  position  in the  family  planning  market  for  decades
come. While  the  private  sector  is  being  used to  increase  contraceptive
prevalence,  private  sector  competition  may  have  been  undermined.  While  the  cos
of promoting  an already  existing  and  vell-accepted  product  are  likely  to  be lover
than  the  costs  of promoting  and  gaining  acceptance  for  a new  product,  the  long-
lasting  advantage  given  to  one  firm  has troubling  implications  on the  free  mark
and  competition  among  firms,  and  may  afford  that  firm  great  bargaining  pover  in
that  market  in the  future.
SOKARC  is  considering  providing  generic  advertising  geared  tovard  increasi
contraceptive  sales  to lov  income  households  in  Panama. SOKARC  vould  handle  th
advertising  and  promotion.  It is  not  clear  if the  commercial  firms  vould  lover
their  prices  or provide  nev  contraceptives  at lower  prices. This type  of
experiment  deserves  careful  evaluation  to  test  the  hypotheses  of the  for-profit
contraceptive  companies  vith  respect  to the  benefits  of subsidized  advertising.
Private  Health  Care  Providers
Private  Physicians.  Private  physicians  constitute  the  primary  source  of
contraceptive  services  for  vomen  in the  developed  vorld. In the  developing
vorld,  hovever,  the  public  sector  and  pharmacies  are the  most  important  sources
of contraceptive  services,  folloved  by private  clinics. A recent  reviev  article
(Tsui  and  Donaldson,  1987)  presents  an overviev  of the  role  that  private
physicians  and  clinics  have  played  in family  planning  in the  developing  vorld.
l.p:1FWaly  P1lavAin  Papet  (v*ili39
There  seems  to  be little  study  of hov  to  mobilize  the  u  eAoployed  or underemployed
physicians  that  abound  in  some  parts  of the  Middle  East  and  Latin  America  who  are
potentially  valuable  providers  of family  planning.
Information  generated  through  the  Contraceptive  Prevalence  Surveys  and
summarized  in  Tsui  and  Donaldson  (1987)  produced  rural/urban  breakdowns  by  source
of contraception.  The  average  percent  across  22 of the  more  recent  surveys  of
rural  users  obtaining  supplies  from  private  clinics  is 13  percent  vhile  for  urban
contraceptive  users  the  figure  was  18  percent. The three  CPS  countries  where  the
private  clinics  seem  to  be providing  services  for  the  largest  proportion  of  users
vere  Korea,  The  Dominican  Republic,  and  Bolivia. Private  clinics  were  serving
over  thirty  five  percent  of  users  in  both  rural  and  urban  areas  in those
countries.
The issue  of vhether  contraceptive  users  in  a particular  country  shift  from
the  public  sector  to  the  private  sector  over time  or  whether  shifts  occur  vithin
the  private  sector  between  private  clinics  and  other  private  sources  of supply  as
not  been  addressed  in  any  depth. Tsui  and  Donaldson  (1987)  indicate  that  there
is  evidence  from  Mexico  that  vhile  private  physicians  and  public  clinics  are
primary  initial  providers  of contraceptive  services, pharmacies  become  the
primary  points  of resupply. Further,  the  1983  CPS  in  Tunisia  asked  current
contracepting  women  where  they  originally  obtained  their  current  method  and  vhere
they  obtained  their  most  recent  supply. Private  Doctors  provided  the  original
supply  of the  pill,  condom  and  vaginal  method  to  eight,  seven  and fourteen
percent  of women  using  that  method  respectively,  while  they  provided  the  most
recent  supply  to  only  four,  four  and  seven  percent  respectively.  The net  gainers
seem  to  be the  pharmacists  vho  were  much  more  likely  to  have  provided  the  most
recent  supply  of these  methods  than  to  have  provided  the  initial  supply.
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Jones  (1984)  probes  the  distribution  of contraceptive  methods  provided  by
private  physicians  or clinics  in a  subset  of developing  countries  from  the  World
Fertility  Survey. An erratic  pattern  emerged  from  this  data. In the  Dominican
Republic,  three  quarters  of  all  sterilizations  and  one  fifth  IUD  insertions  vere
performed  by  private  physicians.  Private  clinics  provided  relatively  more
injectables  than  other  methods  in  Peru,  Costa  Rica,  and  Panama  while  they  covered
a significant  proportion  of pill  users  in  Haiti  and  Malaysia.
Other  Health  Providers.  One  of the  major  research  questions  in the  area  of
private  physicians  has  been  to  what  extent  do the  quality  of services  suffer  when
non-physicians  handle  family  planning  tasks  that  have  traditionally  been  in the
hands  of physicians.  This  question  may  be emphasized  because  of its
practicality--when  physicians  are  in short  supply  and  many  couples  do not  have
access  to their  services,  what  are the  consequences  of  allowing  more  abundantly
available  health  personnel  to  take  over  some  of their  responsibilities.
Traditional  midwives  (i.e.,  unlicensed  midwives  or birth  attendants)  are
major  health  care  providers  in the  developing  world. They  are  particularly
dominant  in the  delivery  of babies. Many  projects  have  attempted  to  broaden  the
role  played  by  midvives  so that  they  either  refer  couples  to  clinics  or  dispense
contraceptives  directly  to  clients. A recent  review  of these  projects  (Simpsons-
Hebert  et.  al, 1980)  concludes  that  the  results  are  mixed.
Traditional  midwives  seem  to  be more  effective  providers  of family  planning
services  when  they  distribute  contraceptives  compared  to  when they  only  do
referrals.  A Nicaraguan  program  allowed  midwives  to  purchase  contraceptives  and
other  medical  supplies  at subsidized  prices  and  then  sell  them  to  their  clients.
A study  in the  program  area  indicated  that  use  of  oral  contraceptives  had  douibled
after  two  years. Further,  there  is  evidence  that  the  incentives  for  trained
midwives  to  actively  recruit  family  planners  depends  upon the  economic  returns  to
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them--in  relatively  morp  iuccessful  programs  in  Malaysian  and  Nicaraguan,
midvives  received  compensation,  in  the  former  from  the  program,  in  the  latter,
from  clients.  Since  many  traditional  oidwives  receive  remuneration  from
deliveries,  to  an  extent,  family  planning  acceptance  reduces  their  potential
business.  Many  different  remuneration  methods  have  been  tried,  but  the  Malaysian
program  is  the  only  one  in  vhich  midvives  are  paid  based  on  their  recruitment  of
family  planninig  acceptors  which  is  verified  by  supervisors.  No  pro4ects  have
recompensed  midvives  on  the  basis  of  continuation  rates  or  paid  them  based  on  the
amount  she  forgoes  from  not  attending  a  birth  attributable  to  a  couple  year  of
protection.
A study  by  Bailey  et.  al  (1982)  examined  the  pattern  on  side  effects,
continuation  and  pregnancy  rates  associated  vith  obtaining  oral  contraceptives
from  pharmacists,  private  physicians,  and  the  public  sector.  They  found  no
significant  differences  between  the  continuation  and  pregnancy  rates  that
prevailed  for  women  vho  had  initially  obtained  their  orals  from  one  of  the  three
sources.  No  systematic  difference  emerged  in  terms  of  side  effects  either.  In
fact,  they  found  that  for  one  subgroup,  older,  higher  parity  vomen,  continuation
rates  vere  higher  for  pharmacy  users  than  for  those  vho  had  obtained  their
supplies  from  either  of  the  two  other  sources.  They  concluded  that  this  sub-
group,  either  vere  more  highly  motivated  contraceptors  or  had  interacted  more
vith  their  pharmacist.
The  family  planning  services  of  nurses  and  physicians  vere  compared  in  a
Bogota  study  (Einhorn  and  Trias,  1978).  Vhile  there  vas  no  difference  in  the
continuation  or  pregnancy  rates  or  in  the  incidence  of  side  effects  of  vomen  vho
had  seen  a  nurse  compared  to  vomen  vho  had  seen  physicians,  the  array  of  methods
chosen  by  these  two  groups  of  vomen  vas  quite  different.  Those  vho  sav
physicians  vere  generally  prescr4bed  more  effective  methods  (the  pill, IUD,  or
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sterilization)  than  those  who  saw  nurses. Physicians  inserted  relatively  more
IUDs  than  the  nurses  while  the  nurses  compensated  by  having  more  users  of
contraceptive  foam. Nurses  prescribed  the  less  effective  methods  on an inter-
mediate  basis;  their  clients  tended  to  return  to the  clinic  for  anothe:  visit  at
which  time  many  began  taking  oral  contraceptives.
The  effectiveness  of IUD  insertions  by midwives  was  compared  to that  of
physicians  in  'Turkey  and the  Philippines  (Eren,  Ramos  and  Gray,  1983). The
authors  found  no difference  in the  IUD  expulsion  rate  of  women  attended  to  by
midvives  compared  to  physicians.  They  did find  that  a higher  proportion  of women
experiencing  expulsions  inserted  by midwives  chose  to  have  reinsertions  compared
to the  vomen  vhose  expulsed  IUDs  had  been  inserted  by physicians.  The  authors
hypothesize  that  there  may  have  been  a higher  level  of trust  felt  toward  midwives
than  doctors.
The incentives  and  impediments  for  private  sector  growth  in  family  planning
production  and  distribution  are  manifold. While  anecdotal  evidence  abounds  on
policies  that  are thought  to  constrain  private  sector  growth,  there  is  little
hard  evidence  on  how  much  change  would  result  from  changes  in  different  policies.
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III. DEMAND  FOR  PRIVATE  SECTOR  PRODUCTS
The traditional  assumption  that  commercial  delivery  of contraceptives
serves  the  urban,  upper  classes  and  sets  charges  that  are  only  affordable  to
that  segment  of the  market  has  never  been  examined. There  is  very  little
information  on the  source  of contraceptive  services,  or  vhat  users  pay  in
developing  countries,  because  most  survey  work  has  focused  on utilization
patterns  and trends. Hov  consumers  get their  services,  vho  pays  for  it,  and the
availability  and  effectiveness  of alternative  sources  of services  are issues
that  have  not  been  addressed  in  any  depth. Donors  and  developing  country
governments  have  concentrated  on developing  public  programs,  and  assessing  their
ability  to  gain  and  retain  users. The  source  of contraceptive  services  has  only
recently  become  an issue  as  donors  and  governments  seek  to  expand  available
resources  for  family  planning  and  health.
How  important  private  sector  sources  are  or could  be to  contraceptive  use
is  a  difficult  issue  to  address. for  instance,  the  existence,  effectiveness  and
funding  of government  family  planning  programs  that  heavily  subsidize  family
planning  services  may  siphon  potential  consumers  avay  from  private  sources. In
this  case,  the  extent  of reliance  on private  sources  may  be more  a function  of
dramatic  price  differentials  than  the  inability  of the  private  sector  to  meet
the  contracepting  needs  of couples. Vithout  price  and  access  to information,  as
vell  as family  planning  source  data,  the  achievements  and  potential  of the
private  sector  cannot  be  accurately  assessed.
Nev  data  make it  possible  to  assemble  some  information  regarding  vhere
couples  obtain  contraceptives,  and therefore  allow  some  conclusions  on the
effective  demand  for  private  family  planning  services. The following  sections
review  existing  data  on  source  of contraceptives,  and,  where  possible,  control
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for  additioual  factors.  The  data  are  taken  largely  from  USAID's  Contraceptive
Prevalence  Surveys  (CPS)  and  Demographic  and  Health  Surveys  (DHS),  although
information  from  more  modest  efforts  are  included  vhere  possible.  It  should  be
pointed  out,  however,  that  this  effort  is  very  preliminary  and  draws  only  on
accessible  data  and  undertakes  little  analysis.
Source  of  Contraceptives  in  Developing  Countries
All  Methods.  In  theory,  individuals  can  obtain  contraceptives  from  a  range
of  sources.  The  availability  of  various  sourc-s  differs  across  countries  and
regions,  and  neither  the  quality  nor  convenience  of  sources  can  be
generalized.  More  important  to  the  task  at  hand,  many  potential  sources  are  not
clearly  distinguished  in  data  collection,  vhich  makes  comparisons  even  more
difficult.  For  example,  some  countries  have  data  on  use  of  NGO  sources  vhile
others  have  lumped  these  into  an  "other"  or  "private"  category.  None  of  the
surveys  make  it  possible  to  distinguish  between  users  of  a  social  marketing  and  a
commercial  product.8
Table  III.1  provides  figures  on  contraceptive  method  source  among  current
users  for  those  countries  for  vhich  1980s  data  are  available.  Where  data  exist
for  multiple  years,  the  most  recent  year  is  used. Contraceptive  prevalence  in
each  of  the  countries  is  listed  to  indicate  vhat  proportion  of  vomen  of
reproductive  age  in  the  country  contracepts  at  all. The  data  in  the  table
suggest  no  particular  pattern  to  sources  of  family  planning.  Some  very  poor
countries  rely  heavily  on  government  facilities,  like  Nepal  (73.9  percent),
Pakistan  (66.8)  and  El  Salvador  (81.5),  while  in  other  countries--such  as
Paraguay  (100  percent),  Bolivia  (93  percent)  and  Egypt  (69.4  percent)--couples
8. CSM  programs  nave  been  successfully  established  in  Bangladesh,  Colombia,
Dominican  Republic,  Eastern  Caribbean,  Egypt,  El  Salvador,  Honduras,  India,
Jamaica,  Nepal,  Mexico,  Sri  Lanka,  and  Thailand.
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Table ZZ2.1
Contraceptive  Mthod.  by  Source  AMag  Current  Usors  for  Selectd  Counttrieu
Cantraceptive  -
trevance  vovrNrnt  Commerciala  no  0th.rb
Country  (Year)  Nationde  (Percent)  (Percent)  (Percent)  (Percent)
Africa
Kenya  (1984)  17  51.3  *.4  32  1.1
Liberia  (19866  6  31.1  1.3  49.2  2.3
Senegal  (1986)  12  4S.0  50.0  - 5.0
aire  (1984)  64.1  28.7  3.6  3.5
Zimbabwe  (1984)  36  42.6  9.2  46.2  2.0
Asia
Bangladesh  (1935)  25
Korea  (1965)  70  58.0c  42.0c
Wepalt(19l)d's  15  73.9  2.7  20.4  2.9
Pakistan  (1965)  9  66.6  26.5  - 6.7
Sri  Lanka  (1967)  55  64.4  7.9  2.9  4.6
Thailand  (1984)e  65  76.0  19.7  0.7  1.6
Latin  Amrica
SaM-dros  7 19S5)  37  34.4  33.6  21.6  10  4
Belse  (1965)  37  36.0  30.0  - 30  0
Dolivia  (1983)  26  7.0  93.0  - -
Drtail  (1986)  65  15.0  65.02
Colombia  ( 1986 )e  66  34.0  43.6  21 .6 h  1.1
Costa  Rica  (1955)  66  66.0  21.5  22.1  1.4
Dominican  Republic  (1966)  46  44.0  44.0  4.0  4.0
Ecuador (1967)  40  37.4  39.2  15.4  6.5
El  Salvador  (1967)  46  49.7  36.1  - 12.2
Guatemla (1983)  25  31.8  16.1  30.3  11.7
Haiti  (1983)  7i  32.9  67.1  - -
Honduras  (1984)  35  27.9  22.0  .32.9  2.4
Jamica (1963)  51  66.9  30.2  - 2.9
Mexico  (1978)  48J  15.6  77.4  0.0  6.4
Panama  (1979)  63  6S.9  23.4  - 10.7
Paraguy  In.d.)  36  - 100.0  -
Peru  (1966)  41  56.0  33.0  - 11.0
Near  Cast
Egypt  (1984)e  30  30.0  69.4  1.3  1.1
tLbanon  (1984)  53  1.2  40.0  56.6  -
Morocco  (1984 )e  26  5$.4  40.0  - 1.6
Tunisia  (1983)  41  77.7  21.4  - 0.6
Source: CPS  CHS: Bogue et  *I. (1967):  U.S. (1967).
a.  icludes  private  physicians,  hoapitals.  pharmacies,  nd  any  other  private,  non-MO.
b.  Unspeciied  source,  may encoepas  tuOt  wben private,  nonprofit$  are  not  a category,
and  my  include  coercial  where  it  Is  not  a  sparate  catetgry.
C.  Source  allocation  date  are  for  1979.
d.  Based  on  nonusers  as  vell  as users.
. includes  currently  mrried  winen  oly.
f.  Thirty  percent  uncertain  as  to  ource  of  contraceptives.
g.  Source  allocation  data  are  tor  1963.
h.  Preotailia  only.
t.  Oly  40  percent  of  usrs use  modern  contraceptive  mthods.
j.  Prevalence  data  ist  tre  1962.
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are  more  likely  to  rely  on  commercial  sources.  Countries  vith  long  standing
government  programs,  particularly  those  in  Asia,  tend  to  have  big  public
programs  that  reach  a  large  segment  of  the  population.  This  reflects  some
combination  of  sound  programs  and  established  clients,  vho  have  no  desire  or
incentive  to  pay  market  prices  for  contraceptives.  The  Egypt  program  is  also  a
long  standing,  vell  supported  endeavor,  but  serves  only  about  28  percent  of
users,  and  couples  rely  much  more  heavily  on  commercial  sources.
NGOs  include  religious  groups,  many  of  vhich  are  active  in  family  planning
delivery  in  Africa,  family  planning  associations  (such  as  Colombia's
Profamilia),  and  other  charitable  organizations.  While  NGOs  vere  included  as  a
separate  category  in  some  countries'  surveys,  it  vas  not  separated  in  a  number
of  them.  Moreover  in  some  countries  like  Zaire,  there  is  likely  to  be  confusion
among  respondents  between  public  and  NGO  sources  since  government  and  private
voluntary  groups  vork  in  tandem,  vith  government  financing  some  of  the  services
and  commodities  and  the  NGOs  delivering  services.  Thus  although  some  countries
differentiate,  comparisons  are  limited  because  of  the  confusion  in  definition.
The  limitations  not  vithstanding,  NGOs  appear  to  play  an  important  role  in  much
of  Africa,  in  NepaJ,  Lebanon  and  a fev  Latin  American  countries.
Clinical  vs.  Nonclinical  Methods.  Government  is  more  Important  as  a
provider  (or,  less  frequently,  a financer)  of  clinical  contraception,  that  is
male  and  female  sterilization  and  IUDs.  Table  III.2  summarizes  the  clinical/
nonclinical  breakdowns  for  the  countries  for  vhich  data  are  avallable.
Government  is  far  more  responsible  for  clinical  as  opposed  to  nonclinical
methods.
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Table  III.2
Contraceptive  Methods  b7 Source  among  Current  Users
by  Clinical  and  Nonclinical  Methods  for  Selected  Countries
Government  Commerciala  NGO  Otherb
Country  (Year)  (Percent)  (Percent)  (Percent)  (Percent)
Africa
Liberia
Clinical  57.0  8.1  33.7  1.2
Nonclinical  23.6  21.3  52.5  2.7
Asia
laingladesh  (1983)
Clinicald  92.0  1.0  --  7.0
Nonclinicale  42.0  56.0  --  4.0
Korea  (1985)
Clinical  83.0  0.0  --  17.0
Nonclinical  13.0  83.0  --  4.0
Thailand  (198 4)C
Clinical  91.9  6.9  0.2  1.0
Nonclinical  64.5  32.2  1.1  2.1
Nepal  (1981)
Clinical  84.2  0.0  15.8  0.0
Nonclinical  49.9  6.4  38.9  4.8
Pakistan  (1985)
Clinical  96.7  0.0  --  3.3
Nonclinical  42.6  48.7  --  8.7
Sri  Lanka  (1987)
Clinical  91.8  2.1-  3.2  2.9
Nonclinical  57.0  29.2  1.9  11.9
Latin  America
Barbados  (1985)
Clinical  77.7  12.7  6.7  3.0
Nonclinical  6.9  44.6  33.7  14.8
Brazil  (1986)
Clinical  52.5  42.7  0.0  4.2
Nonclinical  5.1  82.5  1.4  11.0
Colombia  (198 6)C
Clinical  54.2  14.5  30.1  1.2
Nonclinical  17.3  64.7  16.2  1.7
Dominican  Republic
Clinical  46.4  53.1  0.2  0.3
Nonclinical  35.6  28.2  16.4  19.8
Ecuador
Clinical  46.8  34.9  18.3  0.0
Nonclinical  24.6  47.1  11.5  16.8
E1 Salvador  (1987)
Clinical  64.2  31.1  --  4.7
Nonclinical  22.6  50.9  --  26.4
Peru  (1987)
Clinical  64.5  30.7  --  4.7
Nonclinical  45.1  36.5.  __  18.4
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Table  III.2  Cont'd
Government  Commerciala  NGO  Otherb
Country  (Year)  (Percent)  (Percent)  (Percent)  (Percent)
Near  East
Lcb  non  (1984)
Clinical  1.2  46.4  52.4  0.0
Nonclinical  0.6  78.5  20.6  0.0
Egypt  (1984)c
Clinical  45.4  50.5  3.0  1.1
Nonclinical  19.1  19.4  0.5  1.0
Horocco  (1984)C
Clinical  71.1  27.3  --  1.7
Nonclinical  55.6  42.6  --  1.9
Source: CPS;  DHS;  ESCAP  (1987).
a.  Includes  private  physicians,  hospitals,  pharmacies,  and  any  other  private,
non-NGO.
b.  Unspecified  source, may  encompas*  NGOs  when  private,  nonprofits  are  not  a
category,  and  may include  commercial  vhere  it is  not  a separate  category.
co  IUD  and  male  and female  sterilization.
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The  pattern  is  reversed  for  nonclinical  methods. In  every  country  but  the
Dominican  Republic,  comercial providers  are  the  most important  source  for
resupply  nethods. The  discrepancy  between  clinical  and  nonclinical  methods
provision  Is  consistent  and  quite  large  for  most  countries.  In some  countries
the  difference  in the  proportion  in  each  category  is  dramatic. For  instance,  in
Korea,  government  finances  83  percent  of all  clinical  methods  but  only  13
percent  of nonclinical  methods. Thus  the  aggregated  figures  in  Table  III.1  are
strongly  influenced  by the  distribution  of methods  vithin  each  country.
The  breakdowns  for  NGOs  vary  across  countries  vith  no consistent  pattern
emerging. In  some  countries  (e.g.,  Nepal,  Sri  Lanka,  Liberia  and  Barbados)  NGOs
are  a  more  important  source  of  resupply  methods;  hovever,  in countries  like
Lebanon,  Colombia  and  Liberia,  they  are  a key  source  of clinical  method  supply.
Thus  although  comercial outlets  dominate  the  resupply  methods,  and  government
is the  major  provider  of clinical  contraceptive  methods,  NGOs  appear  to  be the
flexible  provider  that  fills  the  supply  gaps. Alternatively,  NGOs  may  be the
subsidized  competitor  to the  commercial  sector  that  can  claim  users  because  of
their  lov  or zero  prices. Available  data  do not  allow  a resolution  of this
controversy.
Socioeconomic  Characteristics  and  Contraceptive  Source
Vho  uses  public  and  private  services  is  even  less  vell  understood  than  the
aggregate  distribution  of users  across  sources. This  subsection  revievs  the
available  country-specific  data  on contraceptive  source  and location  of
residence;  voman's  age;  voman's  education;  and,  household's/husband's  income/
employment.  Ideally  these  variables  should  be analyzed  jointly  to  control  for
each  set  of factors.  Thus,  this  preliminary  description  merely  sets  the
parameters  of possible  indepth  analysis,  vhich  could  shed  more  light  on the
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question  of vho  uses  vhat  services. Akin  and  Schvartz  (1988)  have  undertaken  a
sultivariate  analysis  for  Thailand  and  Jamaica  that  controls  for  most  of the
determinants  of contraceptive  source  choice,  and  the  results  of this  analysis
are  drawn  upon in  each  of the  subsections  to  place  the  importance  of  each
variable  in  some  context.
Location. Government  is  usually  the  most  important  contraceptive  supplier
for  rural'vomen.  Table  III.3  summarizes  source  of contraception  by urban  and
rural  location. In  every  country  but  Zimbabwe,  government  serves  a  majority  of
rural  contraceptive  users. In the  Asian  and  African  countries  included  in the
table,  government  is  also  the  predominant  source  of contraceptives  in the  urban
areas. In Latin  America  and  the  Near  East,  commercial  sources  serve  close  to
half  or  more  of  all  urban  users. NGOs  outside  of  Africa  are  more  important  as
contraceptive  providers  to  urban  areas,  vhereas  the  African  NGOs  are  more  likely
to  meet  the  modern  contraceptive  needs  of rural  households.
More  focused  evidence  from  Chogoria  Hospital  in rural  Kenya  indicates  the
relative  success  of NGO  programs  in family  planning. Although  the  full  costs  of
the  program  are  not  known,  Chogoria  achieved  a contraceptive  prevalence  among
married  vomen  of reproductive  age  of 34 in 1984,  as opposed  to the  10 percent
figure  for  the  nation  as  a vhole  that  emergel  from  the  1984  Kenya  Contraceptive
Prevalence  Survey. Family  planning  services  are  free  at both  government  health
posts  and  Chogoria  Hospital's  26 clinics  (Chogoria  Hospital  Annual  Report,
1986).
Government  is fulfilling  an important  function  of meeting  the  contraceptive
needs  of rural  vomen  outside  of Africa. If commercial  sources  are in  short
supply  in  rural  sections  of these  countries,  then  public  investment  may  be
critical  to  use. Hovever,  the  available  data  do not  allov  any firm  conclusions,
although  on  average  incomes  tend  to  be lover  in  rural  areas  and therefore
subsidies  are likely  to be  more  needed  and  varranted.
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Table  III.3
Contraceptive  Hethods  by  Source  by  Location  for  Selected  Countries
Government  Commerciala  NGO  Otherb
Country  (Year)  (Percent)  - (Percent)  (Percent)  (Percent)
Africa
Zimbabve  (1984)
Urban  47.9  10.8  39.2  2.1
Rural  37.8  0.7  53.6  1.4
Zaire  (1984)
Urban  56.5  37.1  2.4  4.0
Rural  86.0  4.7  7.0  2.3
Asia
WTepal  (1981)
Urban  64.3  7.3  28.4  0.0
Rural  75.4  1.0  21.9  1.7
Korea  (1979)
Urban  39.4  59.2  0.0  1.4
Rural  73.9  22.2  0.0  3.8
Pakistan  (1985)
Urban  63.9  30.2  --  6.0
Rural  82.8  11.4  --  5.8
Sri  Lanka  (1982)
Urban  66.3  14.0  18.7  1.0
Rural  82.5  6.9  9.6  1.1
Thailand  ( 1984)c
Urtan  65.9  30.7  0.7  2.6
Rural  80.9  17.1  0.7  1.3
Latin  America
Colombia  ( 1 9 8 6)C
Urban  27.2  45.4  26.0  1.4
Rural  58.2  32.2  8.4  1.3
Ecuador  (1987)
Urban  37.6  51.6  8.4  1.9
Rural  42.4  51.0  4.3  2.3
Honduras  (1984)
Urban  57.8  34.9  3.6  3.6
Rural  68.2  19.7  7.6  4.5
Mear  East
Egypt  (1984)c
Urban  24.8  72.4  1.8  1.1
Rural  34.2  64.1  0.5  1.1
Morocco  (1984)c
Urban  50.9  47.6  --  1.5
Rural  69.2  28.5  --  2.4
Source:  CPS;  DHS.
a.  Includes  private  physicians,  hospitals,  pharmacies,  and  any  other  private,
non-NGO.
b.  Unspecified  source,  may  encompass  NGOs  when  private,  nonprofits  are  not  a
category,  and  may  include  commercial  vhere  it  is  not  a  separate  category.
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4gAe Table  III4 reports  on the  age-contraceptive  source  relationship  for
four  countries.  The  figures  shov  an inverse  relationship  between  three  age
groupings  and  use  of free  government  services. Except  in  Thailand,  the
difference  between  those  over  and  under  age  35 is the  most important  distinc-
tion,  vith  those  over  35  much  more  likely  to  use  public  contraceptive  services
than  their  younger  counterparts.  It may  be that  those  vho choose  to  contracept
in the  over  35  age  group  vere  first  served  in  government  family  planning
programs;  however,  without  information  that  allovs  us to  control  for  education
and  income,  it is  difficult  to  attribute  any  other  socioeconomic  factors  to the
consistently  greater  reliance  of  vomen  over  35  on public  sources. The  pattern
of reliance  on  NGOs  is less  systematic.  In  all  cases  but  Colombia,  a  modest
proportion  of contraceptives  are  obtained  at  NGO  outlets;  in the  Colombian  case,
NGO  use  parallels  that  of the  government  sector,  vith  older  women  more  likely  to
use  NGO than  comercial products.
Akin  and  Schwartz  (1988)  in their  logistic  regression  results  for  Thailand
and  Jamaica  found  that younger  vomen  in  both  countries  vere  more  likely  to
obtain  free  (e.g.,  government)  contraceptives  than  older  vomen. This  suggests
that  the  relationship  is  more  complex  and  other  factors,  for  vhich  the
regression  analysis  could  control,  play  an important  role  in  both  affecting  the
decision  to  obtain  free  contraceptives  and  mitigating  the  simple  observed
inverse  relationship  between  use  of government  services  (the  only  ones  that  are
free)  and  age.
Vhen the  age  groupings  in  Table  111.5  are  divided  into  urban  and  rural,  a
similar  pattern  emerges. The  exception  is  urban  Morocco,  vhere  the  youngest
vomen  are  more  likely  to  use  government  contraceptive  sources  than  are  those
aged  25 to  34,  although  this  may  be due  to  a  small  sample  size. One  striking
fact  across  all four  countries  is the  discrepancy  between  urban  and  rural.
Urban  women  are  much  more  likely  to  use  commercial  sources. Whether  this  is  du
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Table  III.4
Source  of  Contraceptives,  by  Age,  for  Selected  Countries
Source  of  Contraceptivesa
Contraceptive  Government  conuercialb  NGO  OtherC
Country  Prevalence  (Percent)  (Percent) (Percent)  (Percent)
Colombia  (1986)
All  Women  40.8  34.0  42.5  22.1  1.4
15-24  32.8  25.1  54.3  19.6  0.9
25-34  50.3  29.0  48.1  21.7  1.2
35+  36.9  45.9  28.1  24.1  1.9
Egypt  (1984)
All  Women  28.7  28.2  69.4  1.3  1.1
15-24  12.4  23.9  75.4  0.4  0.4
25-34  34.6  24.6  72.9  1.5  1.0
35+  33.1  32.8  64.4  1.4  1.4
Morocco  (1984)
All  Women  21.2  58.3  39.9  - 1.8
15-24  16.6  55.1  42.6  - 2.3
25-34  25.5  56.3  42.3  - 1.3
35+  19.7  62.2  35.7  - 2.1
Thailand  (1984)
All  Women  54.0  78.0  19.7  0.7  1.6
15-24  42.1  68.2  27.8  0.9  3.1
25-34  61.2  77.6  20.3  0.9  1.3
35+  52.8  82.7  15.7  0.4  1.2
Source:  CPS; DHS
a.  Sample  is  currently  married  women.
b.  Includes  private  physicians,  hospitals,  pL;rmacies,  and  any  other  private,
non-NGO.
c.  Unspecified  source,  may  encompass  NGOs  when  private,  nonprofits  are  not  a
category,  and  may  include  commercial  where  it  is  not  a  separate  category.
Other  also  includes  don't  know  and  not  stated.
VP:  Table  X11.454
Table  III.5
Source  of Contraceptives,  by  Residence  and  Age, for  Selected  Countries
Source  of Contraceptivesa
Country
Location  Contraceptive  Government  Commercialb  NGO  Otherc
Age  Prevalence  (Percent)  (Percent)  (Percent) (Percen
Colombia  (1986)
Urban
15-24  34.4  19.1  54.1  26.1  0.6
25-34  57.8  23.2  51.4  24.4  1.0
35+  40.6  37.4  32.0  28.1  2.5
Rural
15-24  39.4  40.3  54.8  3.2  1.6
25-34  31.7  55.7  33.0  9.1  2.3
35+  39.4  73.0  15.7  11.2  0.0
Egypt  (1984)
Urban
15-24  23.7  20.3  79.7  0.0  0.0
25-34  49.0  21.4  75.7  2.1  0.8
35+  43.7  29.1  67.5  1.9  1.5
Rural
15-24  7.5  28.7  69.6  0.9  0.9
25-34  22.6  30.5  67.9  0.5  1.2
35.  23.0  39.6  58.7  0.5  1.2
Morocco  (1984)
Urban
15-24  31.1  55.1  44.0  --  0.9
25-34  39.2  46.9  51.7  --  1.5
35+  29.0  54.2  44.0  --  1.9
Rural
15-24  10.1  55.0  40.6  --  4.4
25-34  16.2  71.9  26.8  --  1.4
35+  13.7  73.0  24.5  --  2.4
Thailand  (1984)
Urban
15-24  50.7  43.8  52.4  0.0  3.8
25-34  60.9  59.8  35.4  1.0  3.9
35+  63.7  81.2  17.3  0.7  0.7
Rural
15-24  40.6  73.7  22.3  1.1  3.0
25-34  61.2  81.7  16.8  0.8  0.7
35+  50.6  83.0  15.3  0.3  1.4
Source: CPS;  DHS
a.  Sample  is  currently  married  vomen.
b.  Includes  private  physicians,  hospitals,  pharmacies,  and  any  other  private,
non-NGO.
c.  Unspecified  source,  may  encompass  NGOs  when  private,  nonprofits  are  not  a
category,  and  may  include  commercial  vhere  it is  not  a separate  category.
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to  higher  incomes,  more  acnessible  supply  alternatives,  or lover  quality  public
facilities  cannot  be determined  with  existing  data. The  widest  variation  across
age  groups  and  between  locations  can  be seen  in  Colombia  where  the  difference  in
the  proportion  of urban  vomen  15  to 24  using  public  sources  versus  rural  women
over  age  35 is  a 51ipercentage  point  difference.  This  suggests  a very  hetero-
geneous  supply  system  for  contraceptive  services,  and  reliance  on a range  of
contraceptive  sources  across  the  country.
In  Colombia,  NG0  sources  are  far  more  important  in  urban  than  in  rural
areas,  and  in the  former  they  serve  more  women  under  age  35 than  does  the
government.  And  although  those  35  and  over  are  more likely  to rely  on NGOs  in
rural  areas,  this  is  not  the  case  in  urban  areas.
Rducation. Table  III.6  summarizes  the  relationship  between  educational
attainment  and  source  of contraceptives  for  the  same  four  countries  as well  as
Sri  Lanka  and  Jamaica. As  expected,  education  and  use  of commercial  sources  are
directly  related. Hovever,  in  Jamaica,  vhere  there  is  a separate  breakdovn  for
college,  secondary  school  graduates  are  slightly  more  likely  to  use  commercial
outlets  than  women  who  have  gone  to  college.
The  most  striking  results  in  Table  111.6  are the  proportion  of women  who
rely  on  private  outlets  across  countries.  In Thailand,  where  per  capita  income
in  1984  vas  $860,  vomen  vere  most  likely  to  use  a  government  source  for  contra-
ceptive  services. In  contrast,  Egyptians  vith  a per  capita  income  of $720  rely
most  heavily  on private  sources. Even  among  Egyptian  women  with  no  education,
fever  than  a third  use  government  services.
Dividing  level  of  education  into  urban  and  rural  in  Table  III.7  results  in
a somewhat  different  pattern  of contraceptive  source. The constant  inverse
relationship  between  educational  attainment  and  use  of  government  services  is
veakened,  especially  among  rural  vomen. For  instance  in rural  Morocco,  only
69.6  percent  of uneducated  women  use  public  services,  vhile  100  percent  of those
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Table  III.6
Source  of  Contraceptives,  by  Vomenrs  Education,  for  Selected  Countriesa
Source  of  Contraceptives
Country  Government  Commercialb  NGO  Otherc
Education  (Percent)  (Percent)  (Percent)  (Percent)
Colombia  (1986)
None  64.6  15.4  16.9  3.1
<  Primary  44.5  34.5  19.9  1.1
Primary  Comp.  36.6  34.4  27.2  1.8
Secondary  +  19.2  57.6  22.0  1.2
Egypt  (1984)
None  32.2  65.5  1.2  1.0
<  Primary  32.6  64.7  1.5  1.3
Primary  Comp.  24.7  72.2  1.3  1.9
Secondary  +  15.7  82.2  1.4  0.7
Jamaica  (1984)
<  Primary  90.0  10.0  --  --
Primary  Comp.  59.3  27.3  __  9.4d
Secondary  50.0  .50.0  __  __
College  53.9  46.2  --  --
Morocco  (1984)
None  64.2  33.8  --  2.0
<  Primary  52.1  45.7  --  2.2
Primary  Comp.  40.3  58.4  --  1.2
Secondary  +  29.7  70.3  --  0.0
Sri  Lanka  (1982)
None  94.5  5.5  --
Primary  Comp.  87.8  11.5  --  0.7
Secondary  +  68.1  30.5  --  1.4
Thailand  (1984)
None  77.2  20.5  0.4  1.9
< Primary  80.5  17.6  0.6  1.3
Primary  Comp.  63.1  31.2  2.1  3.5
Secondary  +  62.8  33.1  0.9  3.1
Source: CPS;  DHS;  Akin  (1984)
a.  Sample  is  married  women  for  all  but  Jamaica,  which  is  all  vomen.
b.  Includes  private  physicians,  hospitals,  pharmacies,  and  any  other  private,
non-NGO.
c.  Unspecified  source,  may  encompass  NGOs  vhen  private,  nonprofits  are  not  a.
category,  and  may  include  commercial  where  it is  not  a separate  category.
Other  also  includes  don't  know  and  not  stated.
d.  Includes  NGOs.
PP: Table  11.657
Table  II.7
Source  of  Contraceptives,  by  Vomee'z  Education  and  Area  of  Residence,
for  Selected  Countries
Source  of  Contraceptivesa
Country
Location  Governrment  Co.mercialb  NGO  Otherc
Education  (Percent)  (Percent)  (Percent)  (Percent)
Egypt  (1984)
Urban
None  28.5  68.5  1.9  1.1
< Primary  29.8  66.7  2.3  0.8
Primary  Comp.  26.8  69.9  1.6  1.6
Secondary  +  15.6  82.4  1.4  0.6
Rural
None  36.2  62.2  0.5  1.1
< Primary  36.6  61.9  0.4  1.1
Primary  Comp.  17.1  80.0  0.0  2.9
Secondary  +  16.4  80.6  1.5  1.5
Colombia  (1986)
Urban
None  50.0  15.6  31.3  3.1
<  Pr,mary  37.0  34.7  27.3  0.9
Primary  Comp.  32.6  36.3  28.9  2.1
Secondary  +  17.5  57.9  23.4  1.2
Rural
None  78.8  15.2  3.0  3.0
<  Primary  55.5  34.2  8.9  1.4
Primary  Comp.  58.8  23.5  17.6  0.0
Secondary  +  46.2  53.8  0.0  0.0
Morocco  (1984)
Urban
None  58.7  39.7  --  1.6
<  Primary  51.1  46.0  --  2.8
Primary  Comp.  36.6  62.1  --  1.4
Secondary  +  28.9  71.1  --  0.0
Rural
None  69.6  27.9  --  2.5
<  Primary  55.6  44.4  --  0.0
Primary  Comp.  76.9  23.1  --  0.0
Secondary  +  100.0  0.0  --  0.0
FP:  Table  111.758
Table  III.7  (continued)
Source  of Contraceptivesa
Country
Location  Government  Commercialb  NGO  OtherC
Education  (Percent)  (Percent)  (Percent)  (Percent)
Thailand  (1984)
Urban
None  76.1  23.9  0.0  0.0
<  Primary  71.4  26.8  0.0  1.8
Primary  Comp.  55.2  37.9  3.4  3.4
Secondary  +  56.7  37.5  1.4  4.3
Rural
None  77.5  19.7  0.5  2.3
<  Primary  81.9  16.2  0.7  1.2
Primary  Comp.  68.7  26.5  1.2  3.6
Secondary  +  74.1  25.0  0.0  0.9
Source: CPS;  DHS
a.  Sample  is  currently  married  women.
b.  Includes  private  physicians,  hospitals,  pharmacies,  and  any  other  private,
non-NGO.
C.  Unspecified  source,  may  encompass  NGOs  when  private,  nonprofits  are  not  a
category,  and  may include  commercial  where  it  is  not  a separate  category.
Other  also  includes  don't  knov  and  not  stated.
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with  at least  a secondary  education  obtain  contraceptives  at public  outlets. In
rural  Colombia,  Profamilia  (the  predominant  NGO  source,  the  family  planning
association)  is increasingly  important  as  a source  of contraception  as education
rise,  but  those  vith  at least  secondary  schooling  switch  to  commercial  sources
and  abandon  the  NGO  source  entirely. The  increase  in the  proportion  using
commercial  outlets  jumps  by over  100  percent  between  completed  primary  and
secondary  plus. In contrast,  because  80 percent  of  Egyptian  women  who  have
completed  primary  school  use  commercial  sources,  the  increases  among  those  with
any  additional  education  is  negligible.
These  findings  with  regard  to  education  are  corroborated  by  Akin  and
Schwartz  (1988)  in their  multivariate  analyses  in  both  Jara  ca  and  Thailand.
Thus even  with controls  for  other  characteristics,  education  remains  a powerful
determinant  of private  sector  use. What  is  not  reflected  in the  more  sophisti-
cated  analysis,  however,  is the  level  of reliance  on public  and  private  sources.
Although  increasing  education  generally  means  greater  likelihood  that  a
voman  will  purchase  contraceptives,  vhat the  foregoing  tables  suggest  is that
the  level  of reliance  varies  greatly. Well  managed  and funded  government
programs  such  as  Thailand's  will  capture  a large  segment  of the  market  and
retain  them,  whereas  presumably  less  well  organized  or newer  programs,  such  as
those  in  Egypt,  cannot  reach  even  the  uneducated  population  very  effectively.
Another  explanation  may  be that  Egyptian  women  prefer  not to  use  public  outlets
for  contraceptive  services,  even  if  using  private  sources  involves  paygng  for
contraceptives.
Thus,  in the  aggregate,  more  education  will  mean  less  reliance  on public
outlets,  but  there  are  variations  by location  within  a country  and the  average
proportion  who  use  private  sources  may  even  be  more  important  than  the
differences  in  education.  The  average  reliance  on the  private  sector  may  have  a
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great  deal  to  do with  the  quality  of  public  programs  rather  than  merely  vith the
extent  and  convenience  of commercial  supplies. Comparisons  of Thailand  and
Egypt  suggest  that  this  might  be the  case.
Income. As income  rises,  the  need  for  public  subsidies  is reduced,  and
private  providers  become  more  affordable.  In  general,  private  sources  are
considered  more  convenient,  vith typically  faster  service,  better  ambiance,  and
greater  professional  attention.  Despite  these  amenities,  consumption  patterns
across  countries  is  quite  disparate.  Table  III.8  summarizes  the  relationship
between  employment  status  and  husband's  occupation--as  proxies  for  income--and
source  of contraceptives  in  urban  and  rural  areas. The  predicted  inverse
relationship  betveen  job  categories  and  employment  status  emerges  for  both  Egypt
and  Morocco. Hovever,  the  levels  of use  of government  facilities  in  Morocco  is
almost  double  that  of Egypt  in  all  categories.  In both  countries,  unemployed
households  are  only  slightly  more  likely  to  use  government  sources  than  those  at
the  bottom  of the  skills  ladder,  suggesting  that  these  groups  are  not  very
different  in their  preferences  across  contraceptive  sources,  and  may  be  very
similar  because  they  move  between  the  two  categories  over time.
Table  III.9  shows  the  relationship  between  income  groups  and  source  of
contraceptive  services  for  urban  Jamaica,  and  urban  and  rural  Thailand. In
neither  country  is  there  a consistent  inverse  relationship  between  income  and
use  of  government  sources;  and  in  Thailand,  this  is true  in  both  urban  and  rural
areas. In  urban  areas  those  vith the  highest  incomes  are  the  most  likely  to
take  advantage  of commercial  sources,  but  this  is  not true  in  rural  areas  vhere
the  lovest  income  households  are  the  least  likely  to  use  government  services.
These  data  suggest  that  in  Jamaica  and  Thailand  the  distribution  of  government
subsidies  is  quite  even  across  income  groups,  and  government  is  subsidizing  the
contraception  of most  income  earners,  including  a third  or more  of those  who
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Table  III.8
Source  of  Contraceptives  by  Husband's  Employment  Status,
Husband's  Occupation  and  Area  of  Residence
Country,  Employment  Status,  Government  Commerciala  NGO  Otherb





or  Managerial  20.0  78.4  1.3  .3
Clerical,  Sales  and  Service  26.6  70.1  2.3  1.0
Agriculture  and  Unskilled  31.6  66.1  .9  1.4




or  Managerial  17.6  80.6  1.4  0.3
Clerical,  Sales  and  Service  22.2  74.1  2.7  1.0
Agriculture  and  Unskilled  29.6  67.7  1.4  1.3




or  Managerial  27.9  70.9  1.2  0.0
Clerical,  Sales  and  Service  36.7  61.1  1.3  0.9
Agriculture  and  Unskilled  34.1  64.1  0.2  1.6





or Managerial  43.9  55.1  0.9
Clerical,  Sales  and  Service  53.5  44.7  1.8
Agriculture  and  Unskilled  66.8  30.6  2.6




or  Managerial  42.3  56.6  1.1
Clerical,  Sales  and  Service  51.5  47.2  .6
Agriculture  and  Unskilled  53.1  43.5  3.5




or  Managerial  53.8  46.2  0.0
Clerical,  Sales  and  Service  59.4  37.0  3.6
Agriculture  and  Unskilled  73.0  24.8  2.2
Unemployed  76.3  23.7  0.0
Source:  CPS;  DHS
a.  Includes  private  physicians,  hospitals,  pharmacies,  and  any  other  private,  non-NGO.
b.  Unspecified  source,  may  encompass  NW"s  when  private,  nonporfits  are  not  a  category,
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Table  111.9
Household  Income,  Location,  and  Source
of Contraceptives  for  Jamaica  and  Thailand
Goverment  )w0  Private  Other
(Percent)  (Percent)  (Percent)  (Percent)
Monthly  Income
Urban-Thailand
<  $130  63.2  1.5  33.8  1.5
$130-174  67.6  1.2  30.6  0.6
$174-261  65.0  0.6  32.5  1.9
$261-522  57.4  2.1  38.3  2.1
>  $522  41.9  2.3  46.5  9.3
weekly  Income
Urban-Jamaica
< $12.25  75.0  - 25.0  0.0
$12.26-18.36  68.4  - 15.8  15.8
$18.37-24.50  78.6  - 14.3  7.1
$24-50-40.82  79.1  - 14.0  7.0
> $40.82  66.7  - 33.3  0.0
Rural  - Thailand
< $130  74.3  0.0  21.6  4.1
$130-174  88.9  0.0  11.1  0.0
$175-261  76.8  2.3  20.9  0.0
$262-522  75.0  0.0  18.8  6.3
Source: Akin (1984).
a.  1984  exchange  rate  for  Thailand  was: U.S.  $1  - 23  Baht.
b.  1984  exchange  rate  for  Jamaica  was:  U.S.  $1 - J $4.963
earn  vell  over the  1984  average  per  capita  income  in  each  country  ($1,150  in
Jamaica  and  $860  in  Thailand).
This  brief  analysis  has  highlighted  some  of the  major  factors  vhich  are
hypothesized  to  affect  household  choice  of  contraceptive  source. Although
imperfect,  it  provides  some  sense  of the  characteristics  of public  program  users
across  countries.  Greater  specificity  in  analysis  of existing  data  is
varranted,  as is  more  targeted  and  inter-disciplinary  data  collection  that  can
address  the  range  of  unanswered  questions  regarding  both the  need  and  motivation
for  using  public  programs. For  example,  since  only  outcome  data  are  available,
supply  factors  are  ignored. Supply  may  vell  correlate  with  variables  like
women's  education,  vhich  makes  interpretation  of the  data  difficult  and
comparisons  across  countries  tentative.  A  nascent  commercial  sector  may  explain
heavy  reliance  on government  and  vice  versa. Older  women's  greater  reliance  on
public  sources  may  reflect  supply  constraints  rather  than  the  price  of private
clinical  methods. Without  more  detailed  information,  these  simple  cross  tabula-
tions  can  convey  little  more  than  relationships  betveen  two  components  of a
larger  dynamic. In addition,  none  of the  existing  data  can  satisfactorily
explain  the  wide  differences  in contraceptive  source  preferences  between  Egypt
and  Thailand,  and  none  of the  data  can  help to  explain  who  must  rely  on
contraceptive  subsidies  to  afford  family  planning.
Pricing
The  cash  price  of contraceptives  varies  widely  and  comparisons  are
difficult. Bogue  et al.  (1987)  provides  private  sector  prices  by  contraceptive
method  for  Latin  American  countries  (Table  IIIA.1). These  figures,  however,  are
average  prices  across  all  brands. Schearer  (1985)  has  estimated  a single  price
or price  range  for  contraceptives  from  commercial  sources  for  a number  of
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countries  (Table  IIIA.2). Although  useful  for  general  comparison,  neither
compares  prices  in  public  (vhere  they  exist)  programs,  nor  gives  a sense  of the
range  of prices  for  s1milar  products. This  subsection  discusses  both  hov  much
users  pay  for  specific  services  in  Jamaica  and  Thailand,  and then  compares
public,  NGO  and  pharmacy  prices  for  the  same  products  within  the  Eastern
Caribbean.
Prices  vary  across  methods  and  across  the  products  offered  for  each  method.
For  instance,  in  most  markets  there  are  a  number  of different  brands  each  vith
different  prices  and  packaging,  and  sometimes  vith  a significantly  different
product. Public  programs  typically  offer  a more  limited  choice  of contracep-
tives,  usually  a single  product  for  each  method. The  supplies  of  NGO programs
cannot  be  generalized,  since  some  like  Profamilia  in  Colombia  offer  a full  range
of  contraceptive  products,  vhile  those  in some  of the  Eastern  Caribbean
countries,  for  example,  only  offer  a  single  condom  or  oral  contraceptive.
What  Consumers  Pay  for  Contraceptives.  In both  Jamaica  and  Thailand,
public,  NGO  and  private  contraceptives  are  available  in  both  urban  and  rural
areas,  but  as is typically  the  case,  a broader  range  of services  and  outlets  are
available  in  urban  areas. Table  III.10  shovs  the  distribution  of prices  paid
for  contraceptives  in  urban  and  rural  areas  of Jamaica  and  Thailand. 9
Jamaicans  in  urban  areas  are  far  more  likely  to receive  free  contraceptives  and
are  far  more  heavily  subsidized  than  urban  Thais. In rural  areas  about  the  same
proportion  receive  free  family  planning  services,  but  the  distribution  among
those  vho  pay  indicates  that  on average  rural  Thais  spend  more  for  contracep-
tives  than  do Jamaicans. Given  the  proportion  in  each  country  served  by govern-
ment  programs  (see  Table  III.1),  these  results  suggest  that  Thailand's  public
9.  It should  be noted  that  prices  are  averaged  across  methods,  so the
distribution  of methods  vill  affect  the  relative  levels.
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Table  III.10
Distribution  of  Average  Price  Paid  for
Contraceptives  by  Area  of  Residence
for  Jamaica  and  Thailand
(1984 U.S.  Dollars)
Price  Ran¶jesa  Urban  Rural
Jamaica
Free  50.4  45.5
S.01-.20  17.0  10.1
$.21-.50  17.8  27.0
$.51-2.00  8.8  9.5
>  $2.00  6.0  7.9
Thailand
Free  29.3  46.8
$0-$.47  11.3  13.2
$.48-$1.10  15.4  8.8
$1.11-$4.26  14.1  12.2
> $4.26  29.9  19.0
Source: Akin,  1984.
a.  See  Table  111.9  for  exchange  rates  used
for  conversions.
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programs  charge  nominal  fees  for  contraceptives.  In Jamaica,  all  government
family  planning  services  are  free.
Table  III.11  provides  additional  detail  for  both  countries  on the  distribu-
tion  of  prices  paid,  by  method. Male  sterilization  in  Thailand  and  IUDs  in  both
countries  are  most frequently  obtained  from  free  sources. Since  clinical
methods  are  far  more  costly  than  resupply  methods,  this  reliance  on subsidized
services  makes  financial  sense  from  both  individuals'  and  societies  perspective.
Vhat  is  surprising  is  the  small  proportion  of female  sterilizations  that  art
obtained  for  free  in  Thailand,  as it too  is very  expensive.  Given  the  distribu-
tion  of expenditure  for  female  sterilization  in  Thailand,  it is  clear  that  the
vast  majority  of vomen  pay  for  their  own  operation,  vith  little  or  no subsidy
from  the  government.  This  also  suggests  a strong  demand  for  tubal  ligation  in
the  country.
Condoms  are  heavily  subsidized  in  Jamaica,  with  74  percent  receiving  them
for  free  and  96 percent  for  under  $.20  apiece. 10 No user  pays  more than  S-50
per  condom. In  Thailand,  30  percent  receive  free  condoms  and  80 percent  pay
less  than  $.47  for  the  product. Twenty  percent  of  users  spend  over  $1.10  per
condom,  suggesting  a broad  market  in  Thailand. In both  countries,  the  pill  is
the  least  subsidized  and  by far  the  most  popular  form  of resupply  contraception.
In  Jamaica,  only  about  18  percent  receive  free  oral  contraceptives,  vhile  34
percent  do in  Thailand. The level  of subsidy.  however,  is,  on  average,  much
higher  for  orals  contraceptive  users  in  Jamaica  when  compared  to  Thailand. In
Jamaica,  75  percent  of oral  users  pay  less  than  $.47;  in  Thailand  58 percent  pay
under  $.50. This  again  suggests  that  public  programs  in  Thailand  subsidize
family  planning,  but  may  require  some  form  of copayment  from  users,  othervise
private  products  are  very  inexpensive.
10.  All  quoted  prices  are in  U.S.  dollars.
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Table  111.11
Distribution  of Prices  Paid  by Method  for  Jamaica  and  Thailand




Price  Rangesa  Condom  IUD  Injection  Pill  zation  zation
Jamaica
Sample  Size  (77)  (43)  (194)  (303)  N/A  N/A
Free  74.0  93.0  72.2  18.2  N/A  N/A
<.20  22.1  0.0  3.1  24.1  N/A  N/A
$.21-.50  3.9  0.0  15.5  32.7  N/A  N/A
S.51-2.00  0.0  7.0  0.0  18.2  N/A  N/A
> $2.00  0.0  0.0  9.3  6.9  N/A  N/A
Thailand
Sample  Size  (40)  (49)  (101)  (298)  (36)  (343)
Free  30.0  65.3  12.9  33.6  75.0  31.2
< $.47  50.0  0.0  3.0*  24.2  0.0  0.0
$.48-$1.10  0.0  10.2  31.7  29.5  0.0  0.3*
$1.11-$4.26  20.0  8.2  50.5  12.8  5.6  3.8
> $4.26  0.0  16.3  2.0*  0.0  19.4  64.7
Total  100.0  100.0  100.0  100.0  100.0  100.0
Source:  Akin  (1984).
a. See  Table  111.9  for  exchange  rates  used  for  conversion.
*  Fewer  than  S  cases.
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According  to  these  survey  results,  subsidies  for  contraception  are  very
high  In  both  countries,  and  therefore  the  average  price  paid  for  contraception
is  lov  for  all  users. Urban  subsidies  are  slightly  higher  in  Jamaica  as
compared  to  rural  subsidies,  but  in  Thailand,  urban  subsidies  are  definitely
lower  (see  Table  III.10). Subsidies  are  most  common  for  clinical  methods
(except  for  female  sterilization  in  Thailand),  and  least  common  for  oral
contraceptives.
Price  Levels  for  Resupeply  Kethods  in Public,  NGO  and  Private  Outlets. In
the  Eastern  Caribbean  countries,  a single  currency  and  similar  history  bind  the
small  island  nations. Despite  their  cultural  and  economic  similarities,  there
are  distinct  differences  in the  prices  charged  at family  planning  associations
aad  private  pharmacies,  both  across  brands  and  across  countries  for  the  same
brands. First,  all  government  family  planning  services  are  free. Nonetheless,
a number  of public  programs  have  complained  that  they  cannot  "compete  vith  the
private  sector"  as they  are  receiving  free  commodities  from  USAID,  vhich  only
supplies  U.S.  products.  The  commercial  sector  is  dominated  by  Schering  Ag
products;  user  loyalty  is preventing  the  free  contraceptives  from  attracting
users  avay from  existing  commercial  products,  and  either  there  are  few  new
acceptors  or they  follow  user  recommendations  in  shunning  a new  product. 11
Table  III.12  compares  the  prices  of  contraceptives  for  Dominica,  Grenada,
and  St.  Lucia  for  seven  different  oral  contraceptives,  colidoms,  injections,  Neo
Sampoon,  and foam  tablets.  The  data  vere  collected  from  a local  pharmacy  in the
capital  city  of each  country;  in St.  Lucia,  three  pharmacies  vere  visited  and
all  reported  identical  prices. Data  for  all  methods  are  not  available  for  each
of the  three  countries,  hovever,  a fev  comparisons  are  possible.
11..  The  government  programs  on the  islands  are  relatively  nev  having  only  come
into  operation  in the  past fev  years.
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Table  I11.12
Prices  Charged  for  Contraceptives  at Private  Pharmacies
in  Selected  Eastern  Caribbean  Countries
(1986  U.S.  Dollars)
Method  Dominica  Grenada  St.  Lucia
Orals
Eugynon  $4.63/cycle  $3.06-4.56a/cycle
Microgyneni  2.93/cycle  $2.57/cycle  3.33/cycle
Logynon  2.46/cycle  3.70/cycle
Trinoridiol  2.78/cycle  2.41/cycle
Neogynon  2.57/cycle  3.37/cycle
Diane  8.13/cycle  8.13/cycle
Perle  1.09/cycle
Condoms  .09@  . 35@b  .04  or .12
Injection  7.22@
Neo  Sampoon  1.85  for  20
Other  Foam  Tablets  2.07  for  12
Source: Data  collected  by The  Urban  Institute.
a.  Price  range  reflects  price  of high-low  dose  pills.
b.  These  were  high  quality  Sheik  condoms,  which  explains  some  of the  price
differential.7"
The  price  of the  same  brand  contraceptive  such  as Hicrogynon,  probably  the
most  popular  pill  in  the  region,  ranges  from  $2.57  in  Grenada  to  $3.33  in  St.
Lucia,  30 percent  higher  in  St.  Lucia. Orals  are  cheapest  in  Grenada  for  all
brands,  except  Diane,  which  is the  same  price  on both  islands  that  carry  the
product,  and  is  more  than  twice  as expensive  as any  other  method. Diane  is
available  only  with  a prescription.  Perle,  at less  than  a third  the  price  of
other  orals  in St.  Lucia,  is the  social  marketing  product  distributed  through  a
USAID  funded  project.
Condom  prices  vary  widely  based  on quality  and  consumer  villingness  to  pay
It is  hard  to  compare  these  prices  since  each  country  carried  different  brands.
The  available  products  at the  time  of the  survey  vere  quite  different,  buit  no
information  vas  available  on typical  periods. 12
The  data  on injections  and  foam  tablets  are  only  available  for.a  single
country,  and  these  are  useful  in  comparing  NGO  and  private  prices  for  similar
contraceptive  products. Table  III.13  summarizes  the  prices  charged  by local
family  planning  associations  (FPA)  in  Antigua,  St.  Lucia  and  Grenada  for  the
methods  each  offers. In  St.  Lucia,  the  FPA's  industry-based  program  offers  a
vider  range  of products  and  higher  prices  than  its  family  planning  center,  thus
there  are  four  columns  in the  table.
As in  the  case  of the  for-profit  sector:,  pr-  es  of contraceptives  vary
considerably  across  islands. Ironically,  the  Grenada  FPA  has  the  highest  prices
for  oral  contraceptives,  although  its  pharmacies  had  the  lovest  commercial
prices  among  the  countries  for  vhich  data  were  available. In the  St.  Lucia
industry-based  program,  a number  of  brand  name  products  are  offered  at conces-
sionary  prices,  although  only  one  of the  three  oral  contraceptives  is priced
12.  Shopkeepers  indicated  lov  demand  for  condoms  among  local  couples.
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Table  III.13
Prices  Changed  for  Contraceptivis  at Family  Planning  Association
in  Selected  Eastern  Caribbean  Countries
(1986  U.S.  Dollars)
St.  Lucia
Method  Antigua  FP  Program  Industry  Grenada




Condoms  .12@  free  .04@  .05@
Injection  3.70  (some  charge)
Neo  Sampoon  .93  for  20  .74  for  20
other  Foam  Tablets  .46/vial  .74,/vial
Diaphragm  5.56  7.41
Jelly  1.85/tube  2.85/tube
IUD  7.41
Source: Data  collected  by  The  Urban  Institute.72
above  that  of  Grenada's  family  planning  program.  Diaphragms  are  almost  two
dollars  more  in  Grenada  than  in  Antigua,  and  Jelly  is  $1.00  mork  in  Grenada.
Condoms  are  free  in  St.  Lucia's  family  planning  program  and  is  highest  at  $.12  a
piece  in  Antigua.
Price  differentials  between  pharmacies  and  FPA  commodities  are  difficult  to
compare  because  only  two  of  the  countries  are  the  same. Comparisons  of  oral
contraceptive  prices,  however,  shows dramatic  variations,  vith  commercial
products  priced  at  5 to  10  times  as  much  as  family  planning  association
products.  Condoms  are  closer  in  price,  except  in  St.  Lucia  where  FPA  condoms
are  free. Foam  tablets  are  roughly  5  times  as  expensive  in  pharmacies  as  in  the
FPA  in  Grenada.
Comparing  FPA  and  commercial  prices  across  countries,  injections  at  the
Antigua  FPA  and  Neo  Sampoon  In  St.  Lucia'  industry-based  program  are  about  half
the  price  of  similar  pharmacy  products  in  Dominica.
These  tables  provide  some  idea  of  how  identical  products  are  priced
differently  in  a  single,  well  defined  location.  The  pricing  patterns  reflect
the  expressed  objective  of  the  pharmaceutical  companies  to  charge  what  the
market  will  bear  and  their  ability  to  adjust  prfi.s  to  consumer  income  and
willingness  to  pay  for  contraceptives.  Similarly,  as  assumed,  NGOs  price  their
products  well  below  market.  The  biggest  differential  is  in-oral  contraceptives,
but  all  FPA  products  and  methods  are  considerably  more  affordable.
Conclusion
The  private  sector  (for-profits  and  NGOs)  is  currently  serving  the  majority
of  contraceptors  in  the  developing  world  vho  rely  on  resupply  methods.  Govern-
ment  is  typically  the  most  important  supplier  of  clinical  methods,  especially  in
Asia  and  parts  of  Latin  America,  and  is  relied  upon  heavily  in  rural  areas  in
some  countries.
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The  level  of reliance  on government  sources  varies  even  more  across
countries  than  across  groups  within  countries.  The  Asian  countries  such  as
Thailand,  Bangladesh  and  Sri  Lanka  are  heavily  government  dependent,  while  in
countries  like  Lebanon  and  Egypt  government  is  a minor  player. NGOs are
particularly  active  in  a few  countries,  and in  others  play  no role  at all. In
10  of the  31 countries  in  the  sample,  20 percent  or more  of all  users  rely  on
NGO  sources  for  contraceptive  services. African  countries  rely  most  heavily  on
NGOs, and  Asian  countries  least  heavily. No systematic  pattern  of  NGO  users  is
possible  because  of the  disparate  nature  and  objectives  of the  various  NGO
groups. For  instance,  the  religious  missionaries  in  Africa  are  more  active  in
rural  areas  vhereas  a number  of the  the  family  planning  associations  (e.g.,
Colombia's  Profamilia)  are  predominantly  urban-based  programs. Thus  gen2raliza-
tions  must  be  made  on a country-specific  level.
The  reasons  for  the  discrepancies  ia  sources  across  countries  is  difficult
to  explain  with  available  data. Differences  in  public  program  quality,  invest-
meent  and  scope  obviously  will  play  a role,  as  will  the  existence  of incentives
and  disincentives  to  private  investment  in  family  planning. These  character-
istics  are  probably  as important  as income  levels  in  helping  to  explain  country
differences,  otherwise  a country  like  Bolivia  would  be reliant  on government
while  users  in  Thailand  and  Tunisia  vould  more  frequently  use  commercial
sources.
The  prices  users  pay  also  vary. The  limited  information  available  for  this
study  suggests  that  government  subsidies  reach  a large  segment  of the  user
population  in  Jamaica  and  Thailand. Given  the  income  levels  of these  tvo
countries,  it is  not  clear  that  the  degree  of  apparent  consumer  subsidy  is
required  to  keep  contraceptive  levels  up.  The  amount  and  extent  of subsidy  that
is  needed  cannot  be  determined  from  the  available  information,  but  as  household
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incomes  rise,  public  subsidies  should  become  less  necessary  and  a greater
reliance  on private  sources  should  be  warranted. In  neither  country  does this
seem  to  be  happening.
Although  the  data  allow  a focus  on Jamaica  and  Thailand,  the  issue  of  whom
to  subsidize  for  how  much is  relevant  to  most  countries  with  large  government
programs.  Public  investment  is  meant  to  reach:  (1)  those  who  cannot  afford  the
commercial  contraceptive  prices  or the  medical  attention  that  accompanies  some
forms  of contraception;  or (2)  those  who  are  deterred  from  contraception  because
of a lack  of information,  motivation  or income. The  danger  of  expansive  public
programs  is that  they  are  difficult  to  scale  back  for  political  reasons,  and
government  then  becomes  the  provider  for  anyone  choosing  to  obtain  subsidized
contraceptives  even those  who  vould  and  could  buy  from  the  commercial  sector.
The pricing  of contraceptives  varies  across  brands  for  the  same  products,
and  identical  brands  are  priced  differently  across  countries,  even  in  regions
with  strong  socioeconomic  similarities  and  geographic  proximity.  Thus there  is
evidence  that  commercial  providers  charge  vhat  the  market  vill  bear  in  any  given
context. NGO  prices  tend  to  be  significantly  lover  than  commercial prices,  and
in  many  countries  they  offer  free  services.
The  implications  of thes'  patterns  and  the  means  of enhalicing  the  role  of
the  commercial  sector  in  delivering  family  planning  is  discussed  in  Section  V.
It is  important  to  point  oit  here,  however,  that  a basic  tenet,  that  will  be
increasingly  important  to  governments  receiving  less  funding  and reduced  donor
assistance  (especially  in  contraceptives),  is that  those  vho  can  pay  for
services  should,  so that  government  can  concentrate  on reaching  those  who  need
subsidies.
The results  of this  analysis  suggest  that  the  commercial  and  NGO  sectors
are  and  can  be important  partners  in the  provision  of family  planning. Given
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the  disparity  in  reliance  on  private  sources,  there  is  additional  scope  for
private  activity  in  a number  of countries  that  currently  have  large  public
programs,  especially  among  the  for-profits.  Further  analysis  of the  data
presented  here is  crucial  to  a better  understanding  of who  uses  what  contracep-
tive  sources  and  vhy,  and thorefore  what  groups  are  being  subsidized.  Even  this
preliminary  look,  hovever,  suggests  that  promoting  greater  consumer  reliance  on
the  private  sector  could  reduce  government's  burden  vhile  continuing  to  ensure
access  to  contraception.
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Pills (per  IUD  Iper  teral.  Halo  Condom  and othecr  p-r  Radical
Country  Cycle)  insertion)  Injoetions  St.riliaation  Storilisation  (por chdoa)  intoecourser  Viita
Barbados  1.75  33.75  S.75  240.00  1S0.00  .2S  .25  10.00
seose  1.75  25.00  6.00  50.00  100.00  .30  50  10.00
Bolivia  2.08  40.00  2.2S  3.00  100.00  .26  .25  7.00
Colombia  .60  S.00  7.50  300.00  42.00  .25  2S  4.78
Costa Rica  3.40  20.00  9.00  666.00  100.00  .28  .28  15.00
Dominican  ?epuL'.:  3.00  50.00  - 66.00  6S.00  .17  .2S  3.40
Ecuador  .82  33.00  2.90  164.00  9 6 3 0 0b  37  37  7.40
tl Salvador  3.00  25.00-  - 200.00  100.00  .30  .30  6.00
Guatemala  3.00  22.00  4.00  150.00  12S.00  .2S  .25  -
Haiti  2.50  40.00  7.00  300.00  0.00  .25  .25  2.00
Londuras  2.50  30.00  5.00  175.00  100.00  .40  3.0 0d  5.00
Jamaica  2.00  25.00  4.7S  56eaO  56.00  .10  .2S  5.00
Panama  1.50  6S.00  4.7S  400.00  200.00  35  .40  10.00
Paraguay  1.30  33.00  2.25  150.00  100.00  .33  .33  6 .70e
Peru  .76  10.80  3.00  162.00  b  c  c  4.70
Siurce:  Soque  at *I.  I1966I
a.  Avorago  amount paid by a porson  in the poorer  s*gmont of society.
b.  Procedure  currently  not  available  in country.
c.  Data  not  available.  but  in past  sot at  .25.
d.  Per tube
*.  $10 with pap test.
I - Data not  availablo
M*.fp:Table  11.A-1Average  Pi-ice  of  Contraceptives  from  Private  Sector
Sources  in  Selected  Developing  Countries
Oral
contra-  Injectable
Female  ceptives  per  month's
Country  Sterilization Vasectomy  IUD  b/  (per  cycle)  Condom  supply  c/  Diaphragm  d/
Bangladesh  46.15  1.28
Brazil  1,061.25  481.25  327.5  .63  .24  1.72  69.90
Colombia  169.75  123.731  41.63  .80  .23  .72  .
Dominican
Republic  200.00  250.00  65.25  2.55  .29  2.29  27.50
Rgypt  145.50  181.50  50.39  .46  .19  . ..
El  Salvador  232.00  140.00  46.50  3.60  5.  .20  22.00
Guatemala  175.00  100.00  42.00  2.25  .33  2.83  .
Indonesia  120.00  24.30  30.70  1.38  .12  1.17
Jamaica  188.50  174.00  33.15  1.74  ..  4.00  13.40
Jordan  404.20  301.00  113.26  1.23  .35  2.86  24.00
Kenya  ..  ..  48.91  3.54  .36  3.79  33.96
South  Korea  70.88  70.88  26.62  1.02  .11  .
Iorocco  ..  ..  25.04  2.50  .17
Nigerla  ..  ..  65.04  6.98  .81  12.61  29.10
Panama  300.00  175.00  35.00  1.98  .25  6.00  ..
Philippines  ..  ..  13.60  1.21  .19  1.56
Thailand  155.00  90.00  25.00  1.25
Zaire  88.75  ..  60.41  3.55  .27  2.96
Madagascar  ..  ..  ..  2.03  .48  2.82
Mexico  ..  ..  ..  .41  .16
Nepal  ..  ..  ..  .85
a.  Average  is  estbmted as  *Adpoint  of reported  range.
b.  Includes  Insertion  and  fol  lw-up  visit.
c.  One  moanth'a  supply  is  calcuTIated  on the  basis  of  three  month's  effective  action.
d.  Includes  Initial  fitting  and follow-up  visit,  but  not  spermicide  supply.
Source:  Schearer,  1983.78
IV.  PROKOTING  TUB PRIVATE SECTOR:
ALTERNATUVE  APPROACHES
Promcting  private  sector  activity  in family  planning  has  not  been  a central
component  of public  or donor  programs  until  recently. Indeed,  historically
donor  emphasis  has  been  on public  programs,  and technical  assistance  and  funding
were  geared  a4most  exclusively  to  public  entities. International  Planned
Parenthood  Federation  (IPPF)  has  made  support  and  assistance  to  indigenous  NGOs
(family  planning  associations)  its  major  mission;  however,  for-profit  activities
have  been  ignored  for  the  most  part.
Working  vith the  private  for-profit  sector  can  mean  many things,  including
encouraging  private  companies  to  provide  family  planning  coverage  to their
employees,  or  demonstrating  the  benefits  of extending  family  planning  informa-
tion  and  services  to  employees.  Family  planning  employee  benefits  help to
foster  demand  for  family  planning,  and  typically  include  the  financing  and
delivery  of services. Where  such  programs  serve  those  previously  dependent  on
governments,  they  relieve  government  coffers. Broadening  insurance  coverage  to
include  contraceptive  services  but  relying  on other  suppliers  to  deliver  care
can  also  foster  demand  because  a third  party  pays  the  bill. Prepaid  and
cooperative  arrangements  (such  as health  maintenance  organizations)  have  an
incentive  to  promote  family  planning because  they  avoid  the  cost  of  delivery,
and  vhere  applicable,  the  cost  of  an additional  dependent's  health  care.
Prepaid  groups  can  either  provide  services  directly  or act  as a third  party
payer and  refer  patients  to  outside  sources  of contraceptive  services.
Promoting  private  investment  in family  planning  involves  a somewhat
different  set  of  activities: improving  the  efficiency  and  effectiveness  of
private  and  nonprofit  provider  services  to  assist  them  in  becoming  more
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responsive  to  family  planning  markets;  supporting  feasibility  studies  for
possible  private  investments;  supporting  demonstration  projects  vith  strong
evaluation  components;  providing  incentives  to  producers  and  distributors  that
increase  family  planning  availability  through  private  channels;  making
investment  capital  available  through  loans  (preferably)  or  grants;  and,
eliminating  the  regulatory  and  legal  impediments  to  family  planning  investments.
This  seciion  discusses  the  major  initiatives  undertaken  in  delivering
family  planning  through  the  private  sector. Although  a complete  inventory  vas
intended,  limited  and inaccessible  information  have  reduced  the  sample  to  major
activities  for  vhich  there  is  at least  minimal  documentation.  Good,  empirical
information  is  generally  lacking  for  most  ongoing  projects  in this  area. The
projects  referenced  in  publications  but  without  detailed  description  are
mentioned  in the  text.
Table  IV.1  provides  a summary  of  each  project,  indicates  the  components  of
the  effort,  and  summarizes  selected  characteristics.  The  projects  are  listed  in
chronological  order  under  three  headings: (1)  employee  benefits/industry-based
services;  (2)  social  marketing; 13 and,  (3)  promoting  private  investment  in
family  planning. The  existence  of an  evaluation  is included  as one  of the
characteristics  since  virtually  all  of these  projects  are (or  vere)  experi-
mental,  and  evaluation  is  key  to  understanding  how  vell  a program  worked,  what
worked,  and  vhat  elements  failed. Host  projects  only  count  users,  fev  undertake
a true  evaluation  of  what  vorked,  vhat  did  not  and  vhy;  nor  do many  measure  or
assess  impact,  effectiveness  or costs. A description  of most  of the  plans  in
Table  IV.1  is  provided  in  Appendix  IV.1.
13.  Only  four  of the  social  marketing  projects  are  included  here. These  recent
additions  provide  a flavor  for  the  social  marketing  approach  and  represent
never  programs. Footnote  2 in  Section  I provides  a list  of a number  of
contraceptive  social  marketing  revievs.
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Sumry  of  Experiments  in  Private  Sector  Delivery  of  Fainly  Planning
Characteristics  of  Project
Use Private  Cmpany  Contract
Country,  Funder,  Status  Dtstribution  Benefit  wlth  Private  Evaluation
Title  of  Project  of  Activtty  Project  Sumary  System  for  Employee  Providers  Training  C-Onent
Dnumu iNWn1Jm5-umi  Inwi
India:
Family  Planing  TVS-Lucas Group of  Famly  planning  lnformton  and  No  Yes  No  No  no
Programe  at  Cmpanes,  1938  services  were provided  for  16,000
TVS-Lucas  employees.  Paid  leave  and cash
Incentives  of  Pa.  260-270  were
given  to  employees/spouses  who
undeaent  sterilization.  Dise-
inetives  were  Saposed,  such  as
employment restrictions,  and
elttimtion  of  mternity,  medical
and  educationl  benefits  after
the  third  child.
Tata  Cha;ncals  Tato  Chemicals,  In  1950,  the  company introduced  Yea,  (FPA)  Yes  Yes  No  No
Nithapur  1950  fdmily  planning  iafqimaton  wth
lectures  and group  meeting,  and
contreptive.  A Rs.  25  Incen-
tive  for  sterilization  was intro-  Co
duced  nd  raised  to  Rs.  200  In  0
1965 along  with  6  days  leave.  UDJ
acceptors  received  Rs.  25  In  1967.
Free  orals  were offered  in  1969.
Tate  Industries  Tata  Industries  The company design  and  funded  a  No  Yes  No  No  Only follow  users
Ltd.  Fdmily  1950a  comprehensive  amily  planning
PlaMing  Program  project  beginning  in  the  1950,.
Jmsphedpur  Counseling  and  services  were
provided  with  Incentives  offered
for  clinical  measures.  Currently
all  Tat& plants  have  such
srvices.
Codrej  & Boyce  Godrej  & Boyce  Information,  motivation  and  Only  for  Yea  No  Yes,  for  150  No,  but  track
Manufacturing  Manufacturing  services  were  provided  to  tubectomices  otlvators  number of
Co.  Ltd.,  Bombay  Co.  Ltd.,  Bombay  employees  and  tubectonies  were  acceptors
reimbursed  at  local  hospitals.
Incentives  of  Rs.  20/sterilized
case  was provided  along  with  two
days  paid  leave.  Disincentives
Included  no maternity  benefits
after  3  chLidren,  no  housing
for  those  with  3  or  more children
unless  the  worker  was sterilized,
and  the  fourth  child  would  not  be
ad.  I to  the  ,  I  iTal  KY61 (me'd)
auracteristics  of  Frlect
use  mrvate  Contract
Cttry,  Vbmdr,  Statue  Distributien  *1loyee  witb  riwate  valettc
Title  of  Prject  of  Activity  Fijent  Sumary  Syste  SmefItt  Providers  TSnin  ea  Omet
India:
raily  Planing  lidia  Tm  Medical  offcer  wem  trald  tn  lbaM  YM  TM  To,  for  mdical  No
In  Tm  PlFta  Zatate",  WA of  ftily  pIS1  id met  estate  oftiers  to
tion  India,  lon  bopital  had csgrceptlva.  ad  mivotlos  d
lnstitute,  If5  full-tim  soi  Var  t  fr r  fly  ltfr
ftily  plauAVg  for  etivattos.
Froield  orals,  c  om,  hiD  sd
steriliation  a  of  lff8.  Inrs-
tivas  for  steuiliastios  Included
*e  5D - Se 130  to  camb  _  7-14
days  of  pa  ame.
lindutan  Uidurte  law  c_  bired  pera-profeseanal  T  lb  lb  lbt
SpimUng  Id  SpUmg  ard  staff  to  cm  the  ealtb/tmlly
Weaving kils  Waving  Kills,  plumin  cinaic  end 9 specaltite.
1962  Condome, oral,  UhV a  sterili-
ttaion  an  provided.  vostare
receve  as.  50  *  - Incentive  for
aterilimtios  _d  2 days  leave
witb  pay for  vactomies.
HSS  Spinmlg  A  No Inforntion  Two  f_ily  plaming  clinics-in  no  Too  V  YTo  lb.  bat  tn  1976
Weving  Campy  1962  the  Cmpay  Wpital  ad  worker's  38.17  of  fertile
Nospital  Famly  village-wer  set  up.  ployee  w  used
planing  were hired  as  aotivators  ad  contraceptives
Pesrch  Cotre  eaflets,  lecturee,  confereae,
aNd plays  auarae  ftmily
plaming.  Cocomo,  pills.  s
and steriliastto  were offered.
India:
Delhi  Cloth  Delhi  Cloth  4  Enloee  trained  (with  cetift-  We  Tee,  foer  NW  'a  of  NW
General  kills  Ceeral  Hills  cates)  to  act  *c  otivatora  wo  trenepots-  sutivatora
Co.  Ltd,  194  Co.  Ltd,  1964  distriuted  cotraceptives  at  the  tios  and
work site,  uis etook  a  muse-to-  refre  t
house  vsectey  c_  ip sd
compassed honholds.  Also  used
pcters,  stortes,  slogas,  md
ftim.  Volusteer  tivators  wt  r
paid  as.  30 pe  meuth.  Vasec-
tosy  iffcetives  of  PA.  70 were
provided  b  _gemnt.  1kw Delhi
WA  - ploya  Iere  _
Cowporatis,  atd  Runs  gaW  3
days  of  paid  lea.  (Iote:  otbhr
c  _  E  plats  had  sitghtly  pr'-
vide  pills,  ce_dom,  n.  Ios
steritisttit.Table  IV-  (cont'd)
dhracteristics  of  Projt
Urs Privete  Contract
Country,  rwder,  Status  Distributio  employ  witb  Private  Evaluation
Titlo  of  Projet  of  Activity  Project  Summry  Syste  Benfit  roidsrs  Training 
mAim  WIT/imNin!-Win  inviin  (cot'd)
Indiss
Qajeret  efifery  India  Oil  Distrktitam  of  tfaUy  pluming  Tom  lb  ,lb  lb
(miuim  Oil  Corporation,  literture,  letue  by experts
Corporation.  laroda,  1A  ad  aIdbitions  and film.  Con-
Deroda)  treceptive  ers tre.  In  1965,
striliwztions  _d  mUI  wr
offered  aid  add  to  pills,
coedom,  jelly  ad  foam table.
Vaact  Incentive  of  as.  200
(raised  to  am. 500 In  1975).
Aleebic  Croup  Al'mbc  Ccoup of  Famly  plumin  informetion,  lb  Too  lb  Tea,  for  lb  bit  trcke
of  Industris,  Industrila,  1966  servic  d ectivatwe  were  motivators  users  en
30y  provded  fer  the  4.500  wokers.  ritratlom
A copamy  1ec  wwrk  tracked  ad  eurvsp
tboe  'in  sed'  of  famly
pluming.  Sterilisatiop
acceptors  mr  traind  as  mti-
vators  ad  sotivator  rcewivd
icentlve  peyments.  Hastin
were held  with  nonecceptore 
regularly.  Steriliastion
acceptors  rweivd  tln  off
end  PA. 15-45 d  10ag  on
circumstauces.
-Philspi:
Family  Lte  &  Hr_lan-  A copny  prgram  fudd  pertly  lb  Te,  for  lb  Yes,  for  Yes,  costs  of
Frmily Plaming  Philippine  Co.,  by  the  governant  offere  info:-  tramport_-  eotivatorr  progrm  aid
In Hlalian-  1970  stion,  eduation,  Ed  motiva-  tion  Ed  net  savlis
fhilippine  Co.  ticn  witb  hoe  (follow-up)  refreshments
visits.  Paid  leave  to  attend
family  plumtin  lectures,  paid
sick  leve  after  a  vasectomy,
ai  echolarhipe  for  the
chtldr  of  fally  plaming
ecceptore.  Pills.,  condin,  nm,
uteriligation,  Ed  other  wthoda
were Offred.Table IV-1 (zont'd)
Curacteristics  of  Projct
Use Private  Contrat
Country.  Funder,  Status  Distribution  Employee  with  Privat*  Evaluation
Title  of  Project  of  Activity  Project  Smmary  System  eefit  providera  Training  CoM
0'wm  WIT/Dln  irSm-  smvis  (cnt'd)
Kore:
Kaus Ho Tire  Kau  Ho Tire  Co pny  Mngemmnt  ad  the  union  No  yes  No  ND  lb
Industrial  Industrial  aopted  nd pro  oted  f_ily
Compny  Cony.  1972  plAnnn  and mle  It  part  of  the
persomAl  magemennt  policy.
Compay oriented  new employees
d  educated  existing  employees
in  the  benefits  mid specifics  of
fmily  pluming.  Incentives  are
in  the  fom  of  priorities  for
house  sd  loas,  pd  holiday
after  a  vasctomy.  DLtacentives
include  covered  obstetric  care
through  the  third  child.  proso-
tioa  restriction  for  employee
with  large  famlies  and those
with  sor  tha  4  children  sat
leave  the  firm.  Condoems  pills.
nd sterllsation  offered.
Sri  Lanka:
Industrial  Family Plannin  UfO  semasra  witb  FPASL  urging  No  YI"  Yes. gover-  Ye,  for  No
Sector  Programs  Asswlatloo  of  convinced  labor  unlons  Lo  press  ment fnAWd  motivators
Sri  Loam,  1972  for  family  plaraing  as  a  bone  FFASL
fit.  Thirty  popalation  educators  provided
va  trained  with  paying  salaries  ervlces
for  the  30 days.  Eacb motivator
was given  4 days/mth  to  educate
thelr  fellO  employee.  Instituk
tional  qestlomalrea  and follor-
up  otivtlon,al  activities  for
employees are  provided.  Sterili-
at'lon  was offered  with  Rs.  50 
3 (vas-.:toay)  or  10 (tubectomy)
days  paid  leave  as  an  incentive
whether  the  employee or  spouse
werE,  scerilIJ.?-.Table IV-1  (coat'd)
Characteriatics  of  Project
Use Prlvate  Contract
Country,  runier,  Statue  Distributioan  ER  )y-  with  Private  Evaluation
Title  of  Project  of  Activity  Projet  Sumary  System  Om  it  Providera  Trainin  Cqtonn
rUMB  mLT  nUIi-Ui  SnWIMS (cot'd)
Indonesia:
Fadily  Planing  P.T.  lebritam  Faily  plamng  is  Integrated  No  Ya  Yea,  3tfalm  No  s
at  P.T.  Inritea  and 31U,  1974  with  the  campuy  baltb  facili-  for  fre  con-
tsl  at  tbie  cany  of  1.S73  traceptiem
worer.  _h  itei  b,  py  t-
cLa  m  tstiff  iudeeatke
mativailm  octivities  tbroug
film,  Ieter,  _  brochs.
ImIp,  PAUs,  e_s  am  steril-
isatL  anprov-  d  Tde e  _m  -
reqairse  regiaratiam  With tdo
fiwy  plinie  clinc  a  _
ad_nftU  uLWcom  Itf
they  fail  to  nugister.  F_lly
slhines  an  oly  provided  to
thl  chiMes..
kf  r_iae  ag  Pth_flader  5_  Fmily  pimir.  clini  s  ND  e  No  U  11
Servi  f  1,77-INS  eateblAd  at  tuD pleuat.  Eight
Industrial  fild  waars  at  e_c  be
1okr  eapected  tagts  am  receved
referral  ft  for  Me  A sign-
latim.  Clinics  provide
cornelie  ad  sece.
Impact of  UC,19Sl  Tmeffectivmesof  )mltb  lb  yes  No  Yo,  of  Yes, of  cd_
Trained  rmla  edueator,  tradm  (volunter)  otivatorc  i  contracep-
Labor Unlon Shop  'ahop  stowardeae  already  tives
Stewardese"  on  employed by the  fig,  end a
nOtivators  in  control  group  war  compred  as
Family  Planing  td  tbhlr  impat  on  contraceptive
Services  use  acros  educstlon  program;
no  aigificant  differences  were
noted  across  typs  of  or  lack  of
a  ottvator.
Tenta  Induatricl  PathfLnder  Fugd  Family  planing  lnformaton.  Yes,  for  Yes  No  Yea  of  edLcal  IA?  & CPS at
Famly  Planning  1983  educatien.  counellng  and  sterilisation  and  administra-  project  end
Project  wthods  (bhrtier  methods,  tion  staff
pills  lUlh)  prowided  to  4,0CC
factory  workers  at  a  clinic
on-site  during  working  hours.
Health  and  sterlzeation  needa
will  be  referred.  KAP & CPS
be  theCharacteristics  of  Project
Use Private  Coatract
Country,  Wusder, Status  Distribution  Pply  witb  Private  Evaluation
Title  of  Project  of  Activity  Project  Summary  System  Rfelit  Providera  Tanit.  m
m  M  UU/SMY-SMD  S  iin  (cmnt'4,
St.  LiaW1:
Contraceptive  WAID Population  lthi  ms  a  dec_med  eqeriat  Yes,  to  obtain  Po  No  Yes.  for  YTe
Distribution  In  Council  Opera-  comparing  factory  otivation  ad  contraceptives  .otivator/
Factories  In  tional  Reseac  sale  of  oetaceplve  (orals,  for  "It  l  t  sles  staff
St.  rucia  Project,  1986  condams  d  ftC)  by factory  factories
workers  witb  a  *m  as back-p.
vran  vi1idtiwn  m  provider.
Employe  did  sinficantly
better.
Medco:
F_tly  Pl1i:g  OSAID  Popalation  Althougb  a  local  grup  prowie  Tea  lb  no  Ye,  for  N  aslac
Delivery  Strat_-  Cucil  Opera.  servies  already  to  plans  In  sotvatore
cle  in  an  tional  eserch  C.J.,  th  facilities  that
ldustrial  Project.  1987  ser  10,00  _ployees  are  to
Setting  Include  a  promoter program  udure
(Cuidad Juarez)  employee  are  selected,  traind,
mupervised,  ad  mplied  by  the
locl  group,  NWAC.
Philigpplws  r  Poputloai  Canter  Ia-plant  volunteer  (Ilv)  we"  Yea  Tea  Yes  Yes of  ItV  G  Oaly tracked
Industry-besad  Founmmation,  trained  to  prmote  famil_y plannig  project  ain-  mw acptore
Pa  'ly  Plamain  1965-1987  use.  UIs  referr-d  fellow  otratton  staff
Project  mployees  to  cmpay  1seiars,
company  rars,  ad  outside  clinics
as  appropriate.  The total  -mber
of  acceptors  roe  In 90  of  the
firm.
Peru:
Electro  Ums  WSAD  TIPnS  After  quick  overview of  d  nad,  N/A  Yer  tPrepid  con-  No  No
and HILO  Project,  Qngoig  undlettook a  cost/benefit  of  add-  tract  vith
Family PluMing  Ing  family  p?lis  to  caleu  local  FPA
health  benfit  packges (15,000
employees  ad  dependents  at the
two firms).  Arranged  for
contract  with  loal  PVO  to  buy
family  pluaing  ervices.
Turkey
Proviston  of  Pathfinder  Fund,  Services  will  be provided  to  No  Yea,  but  door  No  Yes,  for  nurse  NO
Famly  Planntng  1986  20,000  workers  to  15 factories.  paying  for  It  and midwives
Inforstion  A  Grantee  will  psy  to  equip
ServIck9  In  15  existing  health  cinice  and
Workplaces  personnel,  train  a full-time
nursemdwife  per  site  sad  MD
oversite*  ad  provide  educatton
and  otivation  for  employees  and
their  spouses.Table IV-1  (cont'd)
OCaracteristics  of  Project
Use Private  Ctract
Country.  Funder,  Statucs  mltribution  Employe  with  Private  Eval  tion
Title  of  Project  of  Activity  Proect  SiM  qry  System  leefit  Protiders  Trainwin  Cpnt
D  81iNNW  ITD11USIT-USCD  SO  (cont'd)
Bolivia
Fmily  Planning  Pathfinder  Fwid,  Famly  pluin  lnforuation  NO  No  TeYe  of  Mu  am  lb
and Health  Popalation  CQM-  sevicee  will  be  provided  to  F;ly  Pl
Services  for  cil  and USID  20,000 minig  famUil  In  thre  clinic  physicians,
Organized  Operatlonal  towns.  Service.  lclude  piU,  auxilary  urve,
Workers  Aeserch  Project  IUD, fam  and condoms. Training  field  eductorrs,  6
for  mdlcal  staff  md  promoters  volunteer  promoters
In  inlouded.  Ka  physicins  Will
received  nan-mnetary  incetves
foT  f-aIY  plaming  eevicee-
Fmily  Plar  ing  USUD  EAterpriss  Integrated  progras  of  reserchb  I/A  TYe  No  lb  ria  to  seem  _
Program through  Centro  de lnveetl-  education,  counseling  ed  direct  fit.  m  eving  of
Employers  gaiones  Social.  family  plaming  aerviceg  a*d  famly  plumin  to
(IS)  Prom  at workin  I  . .. :  es  with  150-  mloyers  surveys
Proposal  170  mloym  to  be approached.
Indonesia:
P.?.  Cremsy  USAID  Enterpris  P..  COmy Dajej  is  a  fitr  with  No  Yee  No  TM  lb 
Ojaja  Family  Progrm  Proposal  1.30  employes0. The firm  wl  lk
Planying  Progrm  renovate  &  Enterprise  will  cover
all  expene.  for  a deily  famly
plannin  clinic  for  2 year.
Mexico
Fmily  Plamig  USAID  Enterprlse  uSA  propo  to  provide  fadly  No  Yes  Tee.  for  con-  Tee  for  Mm  Te,  through  DI
Services  at  Progrm  Propov  l  plannin  srvice  to  Its  9,000  traceptive  end mdlcal  monitorin 
Induatrial  Unides  employes  In cany  ElUlrce.  peremel.  eva lntian  of
S.A.S.E.P.  FEIDU  (PV  supplies  contracep-  Also  trainn/  progrm  by 2AfI
Quintero  tives  under a  subcontract).  orientation  _  tasssemm
Industril  Objectlve  li  to  reduc  birth  for  _layeWe  of  net  benfits
Camplex  rate  amd  teranty  leave.  tAP  12 times  a year  at  proect  clne
pro  and post  progra  planned.
Nigeria
LEN  Employee  USAID  Enterprise  Lover Drothers  Nigerli  Ltd.  wnt  No  Yes  Unclear.  but  Te,  of  NO
Clinic  Family  Program Proposal  to  eat  up a  fadly  planning  pro-  love  plan  to  _dIcal  suff,
Plannang Child  gram  na  exlsting  covny  cilnics  obtain  con-  personnel  and
Spacing Program  servino  white-collar  employees.  trsceptlve.  voluntetr
All  methods will  be provided  and  w  sle  tivatora
referrals  mad  for  sterilization,  presumbly
Will  determ  desand  through  after  the
focus  Sroups,  tAP surveys  and  project  end.
TIPPS project  analyses.  Sterilization
referralsTable  IV-l  ,
Characteriltics  of  Project
Use Privete  Contract
Country.  Funder,  Status  Distribution  Employe  with  Private  Evaluation
Title  of  Project  of  Activity  Project  Summary  S7te.  Benefit  Providers  Training  Coqamnt
FlOIU  inWwrjDzUSm!SAr  VIES (cont'd)
Thailanid  USAID Enterprise  Projet  WIU  extend  ad  improve  Ys  Yes  No.  PVO  Yes,  of  Assessat
Factory-Based  Progra  Propoal  Necha's  existing  factory-based  Implementing  volunteer  of  progre
Family  Plaing  family  planning  servicce.  KIS  projet  motivatora
Services  for  operation  and  evaluation  to
cut  costs.  IUP  survey  to  deter-
m  d_mnd.  Foods  will  also
reorientation  nMd Ltrelamling
of  existin  pror  d  expur-
dion  to  maw sites.
iimuri  mv*u  not=in  M FMini  RAMn
Indonaesi
feasibility  of  USAID  Enterprise  Moe  project  will  assess  attitudes  N/A  MIA  N/A  N/A  Project  Is
Commercial  Progra  mPrposal  of  likely  candidate  couples  and  am aseesaomet
Clinics  Providing  tbeir  wi1ligmes  to  pay;  the  of  udat  might
Steriliztation  in  lIiklhood  of  MS raeferal;  and  be possible
Jakarta  the  coat  of  outfitting  and
The  WK  USAID  Entrprise  MWO  clinics  (of  11)  ~i,ich  are  Tes  NO  NO  No  N
Entrepreneurial  Progra  Proposal  underperforming.  Enterprise  wll
Dmvlojast  wourk  witb  TIM  to  improve their
pricing  and msanement  and
raise  overall  utilization.
Thailand:
Family Planning  USAID  Enterprise  PopAultion & commity  Devlopmt  N/i  */A  N/A  N/A  Kmuasman and
Nawkat Survy  Program Proposal  Association,  (PDA)  wll  support  a  buoineaa  planning
and  arketatio  PDA--Coopers  and Lybrand study  of
Capability  the  c'uudoe market  in  Thailand  and
Evaluation  the  developmmut  of  a  basinea  plan
for  IDA.  The latter  will  Include
pricing  poliles,.  distribution
strategies.  promotional  efforts.
and gmneial  strategise  a  finan-
cia  eassesments.
Brazil:
Aaaeasing  Coats  USAID  Population  Cost-burnlt itanlysis  of  adding  yes  yes  N/A  N/A  yes
VAd  Benefits  of  Council  Opera-  family  planning  to  NM benefits.
incorporating  tional  Resarch  Analysis  estimated  that  beneitse
Family Planning  Project  would he esaer  and mmoreffective
Into  H16)  contraceptive  me.,  fewer  births,
(by 63),  57.52  reduction  in  abor-
tion  complications.  Costs  would
he increased  In  DID and inpatient
services  for  family  plaming.Table  IV-1 (cont'd)
CharacutListics  of  Project
Use Private  Contract
Country,  Funder,  Status  Dlstribution  Employee  with  Private  Evalust!on
Title  of  Project  of  Activity  Project  Su_ary  System  Benefit  Providers  Training  Component
0DPIO IVFA3U  DNV  .IrW  Di FAMILr  PLNIM  (cont'd)
Mexico:
Medical Service  USAID  Enterprise  Project  will  build  on an IPPF  Yes  N/A  yes  On fifatcial
Micro-enterprlses  Program Proposa  actfvity,  nd cat  up 20 sall  - vability  of
in  Metropolitan  heltb  service centere  WiLh  the  enterprise
Areas  special  inphais  on  family
plmnnag.  Physician.  nd
prioters  wiU  be trained,  the
letter  will  also reetive  fl  mt-
clal  Incentives  to  lncreas  the
rmber  of  users.  We will  be
guaranted  the  value of  a minl-
_.amber  of  F_mly  Planing
vielte  at  the  onset  which are
phased  out  over  two years.
Self-Financting  UStID Enterprins  Provide  Social  Security  & pri-  Private  1M  For  Social  No  lOe in  IUD  Measu  coats
Family Planning  Program  Proposial  vat*  M)D  with  lUb  ad  training.  Offices  Security  insertions
Plaing  Set  up now PVO  to  backstop.  participants
Peru:
Micro-business  USAID  (ADIN)  ADIM  us  clnic  as referral  Yes  Yes,  as part  No  Yes  yes
IJkn  Operational  and supplies  cooditles  to  of  ADIN




Sterling  Products  FPLA  Ongoig  (I)  Sterling  Products  will  ue  Yes  Yea  Yes  Yes,  I.  and  No
Private  Sector  3 Year Project  Its  drug distribution  network  nurses  at  can-
Family Planning  to  diatribute  pille,  foaming  psny health
Project  tables  and condom  to  3,500  services In
outlets.  famlly  planning
(2)  Add family  planning  to
health  aervices  of  companies.
Ghans:
Social  Marketing  USAID  SOMAtRC  An established  phrmceutical  Yes  Yes  No  Of pharnaiste  No
Project,  Ongoing  distributor  (DANAFa))  is  die-  nd chmical
as of  1984  tributing  contraceptives  to  800  sellers  in
pharmacies and 3,500  chatical  contraceptive
sellers.  Training  and certifi-  methods sd
cation  of  comercial  sellers  screenin,.
Included.Table  IV-I  (cnt'd)
OCracteristics  of  Project
Use Private  Contract
Country.  Fuder,  Statu  Distribution  Eployee  with  Private  Evaluation
Title  of  Project  of  Activity  Projet  S9mry  Systeo  Imtfit  Providers  Training  Cmpomant
IL  1  (cont'd)
Nligriat
IlbAen  Nhrat  US&ID  Operationl  Projtct  Is  expudn  retailin  Yes,  (for  a3T,  U/A  N/A  Tee  Witb  Of ealem.  prces,
Project  Researchb  Colmuia  of  Costracertf!1*  (orls,  cn-  malaria  trat-  certificate  am  costs
UnivrsityAftivmr-  das,  _d  fotamng tablets)  from  _mt  d  first  i  eompetion
sty  of  Ibadm  only  chmiate  sbops  to  murt  aid  too)
owl"  trad_.  Approch  bd  on  an
sY  of  taes  SW foca
poq  of  ptmtlia  c  .
lomialas  _laic
Coatrecative  LIM  NUw  Project  Vil  a  b_ad-mm  m  1  "  No  am  Ushrin  lb  TM.  M1  amps
Social  NeetiWm  Project  advwen  ad  lea  pried  Corporation  ioact  a  ai
ora  otratePtiVO  (Scherim
prect)  ts  smaxht  ad  wala.
mren  a£ceptablety  at  _m-
irasaptives.  A eaomd Phase may
Istrui  -ce  Adh  pAU  _  f_1.
Q1il  Cho.  of  1  TI  Afte  _Ak  efmui  d  ofp  tl  lb  lb  U 
iser,  Ltd.  U  r*jct  iS  ao  fo  asavem,  amidsritab  a
_oebaf  it  ma"  of 
family  p-asir  io  mpeps  bin-
fits.  ihe anmplopme  ,  y
mi1  a  memt  fima_i  bmflts
fre  aing  faiRy  plamAg_  to
am-site  halth  aeic.
c  rial  WA  UD  Tins  Project  to  estimtiu  th  cost  Tes  "me  lb.  alas  Fosably  lb  lb
Industrial  Ongoi  and bmnefita  of  addig  fmily  Implmentid  heilth  is
Vadlcl  Aid  pleaing  to  helth  imuamce  aon  by
Society  conpmi"'  rerlaborud  bafsiits.  CDWS  ma
eloWYs. hame-
fit  progrm
a.  btcludes  compy  distribution  mtwrwb.
b.  Contract  arragmat  with outside  ntity,  for  er_pU,  a  famly  plumig  aseeiation,  private  compay,  to  prvide  services  for  cohon  being  *erved by  the  projet.
c.  Excludes  process  evaluatiam.90
Pa ily  Planning  as  En  Employee  Benefit
Company  Programs.  Large  companies  have  led  the  effort  toward  making  family
planning  services  and  contraceptives  available  to  workers  and  their  families.
The  rationale  for  the  involvement  is that  large  families  have  added  to  employee
stress  and  demands  on their  time,  vhicb  affects  productivity  and therefore
raises  company  costs  (Tata,  1979;  Hurthy,  1983). Maternity  leave,  child  care
needs,  and  childhood  illness  are  added  costs  vith  a large  number  of female
employees  because  vomen  are  more  likely  to  miss  vork.  to  care  for  children  and,
unlike  men,  require  both  some  maternity  leave  and  medical  costs  for  delivery.
Some  companies  provide  benefits  to  the  dependents  of  employees  and  vhere  this  is
the  case,  medical  care  costs  to  employees  is  directly  related  to family  size.
Large  families  are  also  more  time  consuming  and  distracting  for  employees  than
are  small  families,  and the  quality  of life  is  substandard  for  households  vith
large  families,  and  likely  to  remain  so (Tata,  1979;  Murthy,  1983). In  addition
to  potential  savings  from  smaller  employee  families,  some  firms  set  up family
programs  from  a sense  of social-responsibility.  These  reasons  are  not  mutually
exclusive,  so  many  of these  can  play  a role  in  a firm's  decisions  to  offer  or
promote  family  planning.
The first  employee  family  planning  programs  vere  initiated  by private
Indian  companies  as far  back  as the  1930s. Most  of the  industrial  workers  in
these  nev  industries  were  hired  from  rural  areas  where  large  families  and  child
labor  were  the  norm. Company  provision  of family  planning  was  partly  an effort
to  socialize  these  new  urbanites  and  to  assist  them  in  adjusting  to  a nev
environment  (Tata,  1979).
In 1938  TYS-Lucas  began  a family  planning  program;  followed  by  Tata  Iron
and  Steel  Company  in 1950;  Alembic  Chemicals  in  1956;  and,  Hindustan  Spinning
and  Veaving  Mills,  Gujarat  Refinery,  and  Godrej  & Boyce,  and the  Tea  Plantations
al.tp:Fwaly Plarning  Pvapr  (whole)91
in  the  early-1960s.  In the  Philippines,  the  Havaiian-Phillppine  Company  began  a
family  planning  effort  in 1970. These  firms  sensitized  their  work  force  about
family  planning;  set  up various  motivational  activities;  usually  covered  all
costs  of contraceptives  and family  planning  services;  and,  elentually  set  up
monetary  incentives  for  acceptance  of clinic  methods,  especially  sterili:ation,
and  developed  disincentives  for  large  families.
Incentives  in these  company  programs  included  payment  for  undergoing  steri-
lization  (all  six  firms);  paid  leave  for  a sterilization  acceptor  of between  2
and  10 days;  life  insurance  policy  for  employees  whose  vife  underwent  steriliza-
tion  vith  policy  values  decreasing  as the  number  of living  children  increased
(Tata);  and,  a one  time  payment  for  an IUD  insertion  (Tata). Alemr'v  Chemicals,
Godrej  & Boyce,  Gujarat  Refinery,  and  Tata  all  provided  free  mediL  re to
sterilized  men  and  their  families,  and  Tata  gave  preference  to  steril-zed
couples  in loan  allocations  (Murthy,  1983).
Disincentives  for  large  families  at Indian  plants  were  much  more  diverse
than  the  incentives.  For  example,  those  at  TVS-Lucas  consisted  of elimination
of  school  and  medical  benefits  for  the  fourth  and  all  subsequent  children.  At
Godrej  & Boyce,  maternity  leave  for  women  employees  was  only  extended  up to
three  children,  only  three  children  could  be  admitted  to the  catpany  school,  and
company  hcusing  vas  only  open  to families  with  two  children. TVS-Lucas,  with
full  union  concurrence,  adopted  hiring  practices  that  involved  only  hiring  men
with  three  or more  children  if  they  agreed  to  a sterilization  (Murthy,  1983).
In  Korea,  employees  with  more than  four  children  were  fired  (Vhang,  1979).
In  addition  to industrial  plant  programs,  a  number  of agricultural  estates
and  cooperative  organizations  have  adopted  rural  programs  to  encourage  family
planning  use. Three  Indian  Tea  estates  that  employed  large  numbers  of  women  and
provided  living  accommodations  on the  estates  began  a "no  birth  bonus  scheme,"
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contributing  5 rupees  a month  into  a retirement  account  each  month  the  voman  vas
not  pregnant  (Ridker,  1980). Three  major  Indian  sugar  factories,  Jamaican  sugar
and  bauxite  companies,  Colombian  coffee  grovers,  P.T.  Imbritex  textile  factory
in  East  Java,  Indonesia,  and  Pertamina  Oil  Enterprises  all  have  established  some
form  of motivation  or contraceptive  service  availability  at their  facilities
(Draper  Fund,  1986).14
Labor  unions  have  also  been  involved  in  promoting  family  planning  as an
employee  benefit. In  India,  unions  were  either  in tacit  agreement  vith
management's  policies  or vere  vorking  in tandem  vith  them  in the  1950s. In
Turkey,  family  planning  has  become  a top  priority  for  the  union  organization  as
the  vorking  aged  population  increases  and  economic  opportunities  decline  (Draper
Fund,  1986). In Sri  Lanka,  unions  have  become  major  promoters  of family
planning  benefits  for  employees.
International  Assistance.  In addition  to  industry  and  labor  union
initiatives,  international  organizations,  bilateral  donors  and  NGOs  have  become
involved  in family  planning  as  an employee  benefit. Indeed,  many  of the  union
promoted  efforts  vere  stimulated  by the  International  Labor  Office  (ILO)  and in
some  cases  international  NGOs. This  generally  means  expanding  employee  benefit
packages  to include  on-site  services  (i.e.,  delivery)  or financial  coverage  for
family  planning  (i.e.,  financirng),  and  typically  involves  training  medical  and
administrative  personnel,  and training  and  deploying  (volunteer)  motivators  vho
inform  fellov  employees  about  the  benefits  and  sources  of-family  planning. The
cost  of the  programs  are  almost  alvays  borne  by the  company  and/or  donors,  and
only  infrequently  do users  pay  something  for  services. In  Sri  Lanka,  the  Family
14. Ueerakoon  (1986)  also  cites  two  USAID  operational  research  projects  in
Guatemalan  coffee  and  cotton  plantations.  Both  experiments  failed
miserably  with the  former  gaining  no  acceptors  and the  latter  only  one.
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Planning  Association  (FPASL)  spearheaded  an industry-based  program  where  costs
were  shared  by the  FPA,  government,  and  industry--both  management  and  unions.
The  International  Labor  Office,  a  U.N.  organization,  has  a long  standing
program  to  address  access  to  private  sources  of family  planning.  Their  efforts
have  focused  on lobbying  for  expanded  employee  benefit  packages  to  include
family  planning,  and  has  included  country  studies,  conferences  and  seminars,  and
documentation 1of successful  experiences  (ILO,  1979,  1985;  ILO  Regional  Office
for  Asia  and the  Pacific,  1974;  Murthy,  1983). Much  of  ILO's  work  has  been
undertaken  in  collaboration  with  or with  funding  from  the  U.N.  Fund  for
Population  Activities  (UNFPA).  Among  nongovernmental  organizations  (NGOs),
Pathfinder  Fund,  International  Planned  Parenthood  Federation  (IPPF),  Family
Planning  International  Assistance  (FPIA)  and the  Population  Council  have
initiated  employee-based  schemes  in  a fey  countries.  Virtually  all  projects
subsidize  contraceptives  and  most  have  covered  the  costs  of  establishing  and
training  personnel.
Although  not  a  major  player  in this  area  historically,  USAID  has  recently
launched  two  large  family  planning  projects  vhose  mandates  are to  promote  the
private  sector  in  family  planning. The  subprojects  of USAID's  Technical
Information  on Population  for  the  Private  Sector  (TIPPS)  begun  in  1984  and the
Enterprise  Program  begun  in  1985  are  a mixture  of innovative  and  new  approaches,
as  well  as expansion  of existing  employee  benefit  models. Both  of these
programs  will  be  described  in  more  detail  and  some  specific  examples  will  be
given  to innovative  projects  that  have  been  undertaken.  Another  USAID'project,
OPTIONS,  is  attempting  to  address  the  legal  and  other  policy-related  impediments
to  greater  private  sector  activity  in family  planning. Tovether,  these  programs
constitute  the  most  significant  concerted  efforts  in the  area  of private  sector
and  family  planning,  and  have  quickly  dominated  the  field.
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Social  Karketing  of  Contraceptives
Social  marketing  applies  a model  of using  private  distributors  to  market
subsidized,  nonclinical  contraceptives  (pills,  condoms,  injectables  or vaginal
methods),  thus  using  market  inceat es to  distribute  and  retali  the  contracep-
tives  at belov  market  prices. Subsidized  products  are  proviaed  a nev  brand
name,  slogan  end  packaging  and  are  sold  alongside  traditional  private  sector
products. Typically  the  nev  contraceptive  brand  is  developed  and  marketed
intensively  through  an aggressive  and  broad  advertising  campaign. Market
research  accompanies  the  product  choice,  packaging  and  the  advertising  campaign
so  as to  ensure  community  acceptance.  It is  assumed  that  the  product  vill  be  of
greater  interest  to  lover  income  couples  than  the  commercially  priced  commodi-
ties  that  are  beyond  their  means. USAID's  long  standing  Social  Marketing  of
Contraceptives  (SOMARC)  project  has  pioneered  this  effort  to  use  the  incentives
and  methods  of private  marketing  to  encourage  pr4vate  vholesaling  and  retailing
of family  planning,  thereby  greatly  expanding  access  points  (Sherris  et  al.,
1985).15
SOMARC  is  adjusting  its  traditional  approaches  to take  greater  advantage  of
its  relationship  with  the  private  sector. In  Ghana,  SOMARC  is  training
traditional  chemists  and  pharmacists  to  assist  potential  users  in  selecting  an
appropriate  contraceptive  product  and  identifying  complications.  The  premise  is
that  an informed  seller  can  and  will  promote  a product  vith  a sufficient  profit
margin. Since  there  are  more  chemist  shops  than  pharmacies,  the  approach  vould
reach  a broader  audience  than  relying  on trained  pharmacists  alone. A similar
15.  Social  marketing  campaigns  often  promote  different  facets  of private  sector
involvement.  Local  market  research,  survey  and  advertising  firms  are  used
for  product  development  and  product  launch  as vell  as for  monitoring
program  progress,  local  packaging  operations  are  often  used  to  do the  over-
packing  of the  socially  marketed  products.
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USAID  supported  pro!ect  In  Nigeria  is  attempting  to  market  a  number  of  products
through  existing  retail  outlets  and  is  also  providing  family  planning  sexvice
provision  training  to  traditional  and  modern  providers.  In  the  Dominican
Republic,  a  brand-specific  effort  by  SOMARC  is  piggybacking  on  the  distribution
network  of  the  selected  brand's  manufacturer.  Brand-specific  advertising  is
planned  during  the  second  phase  of  the  project,  which  is  likely  to  give  the
manufacturer,  Schering  Ag,  a  major  boost  in  terms  of  market  share. 16
Traditionally,  SOKARC  developed  a  new  social  marketing  product  with  its  own
brand  and  slogans.  The  Dominican  Republic  is  the  first  effort  to  introduce  a
subsidized,  known  brand  (and  price)  through  an  established  manufacturer  and
distributor.
Promoting  Private  Sector  Activity  in  Family  Planning
While  companies  have  established  family  planning  programs  and  NGOs  and
donors  have  assisted  companies  and  distributors  to  design,  finance  and  deliver
services,  it  is  only  recently  that  incentives  for  greater  private  sector
investments  in  family  planning  have  been  tried.  Virtually  all  of  these  efforts
are  products  of  two  of  the  nev  USAID  projects  mentioned  above,  the  TIPPS  Project
and  Enterprise  Program.
These  two  nev  projects  are  currently  in  the  proposal  or  initial  stage  and
take  fresh  approaches  to  promoting  the  private  sector.  USAID's  TIPPS  project  is
undertaking  a  "business  analysis"  (cost  benefit  analysis)-to  demonstrate  the
savings  that  firms  could  realize  from  introducing  family  planning  to  their
employees.  TIPPS  disseminates  the  findings  widely  to  e  o  rage  other  firms  to
consider  offering  family  planning,  and  currently  has  p"  to  work  in  Brazil,
Nigeria,  Zaire,  Zimbabve,  India,  and  Indonesia.
16. This  issue  vwas  discussed  at  length  in  Section  II  above.
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Another  innovative  approach  is  being  tested  under  USAID's  TIPPS  project  in
Zimbabve. A business  analysis  is  being  undertaken  vith.  CIMAS,  the  country's
largest  health  Insurance  company  vith  135,000  clients  and  2,100  member
companies.  The  company  anticipates  that  it  vill  be able  to  reimburse  for  family
planning  with little  or no increase  in  premiums  based  on  a preliminary
assessment.
Tvo  different  projects  in  Nexico  involve  innovative  approaches  to  increase
the  number  and types  of outlets  that  offer  family  planning  products. The
Enterprise  Program's  Micro-enterprises  Project.  is assisting  private  physicians
to  set  up family  planning  clinics,  and  Enterprise  is  absorbing  all  of the
investment  risk  in the  first  fev  monthr  by  guaranteeing  the  physicians'  salary;
however,  the  project's  risk  is  systematically  reduced  over  12  months  after  vhich
donor  support  is totally  withdrawn  and the  clinics  must  operate  on their  own
without  a subsidy. This type  of project  should  be carefully  assessed  and  vill
be discussed  further  in  Section  V.
Enterprise's  Self-Financing  Project  in  Mexico  is training  private  and
social  security  physicians  in IUD  insertion  and  selling  contraceptives  to them
at cost  to  ensure  that  the  lov  income  populations  they  serve  can  afford  and  will
pay  for  the  contraceptive.  No other  subsidy  is  contemplated.  Uhile  the  latter
raises  the  issue  of  vhen  or if the  contraceptive  subsidy  can  be  vithdravn,  the
incentive  structure  of the  project  is to  encourage  the  private  sector  to  operate
in  response  to  market  forces.
Tvo  Enterprise  projects,  one  in  Thailand  (Family  Planning  Products  Market
Survey  and  Marketing  Capability  Evaluation),  the  other  in  Indonesia  (the  YKB
Entr2preneurial  Development  Project)  propose  to  assist  local  NGOs  in improving
their  management,  financial  viability,  and  effectiveness  in  distributing  family
planning. Both  efforts  are  aimed  at  making  these  enterprises  more  competitive
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and  attractive  to  users.  Since  public  sector  ability  to  corntinue  to  provide  free
contraceptives  Is  questionable  over  the  longer  term,  these  NGOs  may  vell  be  the
major  alternative  source  for  current  users  who  cannot  offer  unsubsidized
commercial  prices  and  who  must  rely  on  public  or  quasi-public  service  programs.
Thus,  reducing  overall  costs  of  family  planning  provision  even  for  NGOs  is  In
the  long  term  interests  of  family  planning  availability.
Enterprile  Program's  Feasibility  Study  of  Commercial  Clinics  Providing
Sterilization  in  Jakarta  is  also  an  interesting  method  of  encouraging  priv.-.
sector  act'uity  in  an  area  that  has  an  uncertain  demand,  and  therefore  ma.
constitute  i  risky  investment.  Gathering  and  analyzing  information  on  the
nature  and  extent  of  the  family  planning  market  is  an  appropriate  nd useful  use
of  public  funds,  especially  vhere  the  social  benefits  are  high  and  individual
risks  are  high.
These  experiments  are  altering  the  definition  of  private  sector  activities.
They  are  not  only  persuading  firms  to  shoulder  the  cost  of  family  planning
provision,  but  they  do  not  alvays  provide  financing  for  services.  These  nev
initiatives  offer  services  that  can  help  initiate  or  enhance  a family  planning
service  delivery  operation,  provide  seed  money  for  family  planning  investments
and  feasibility  studies,  or  demonstrate  the  financial  benefits  of  such
investments.  It  is  a  different  and  much  more  market  oriented  approach  than
those  applied  in  the  past  and  it  bodes  vell  for  sustained  service  availability
vithout  long-term  donor  involvement.
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Privatization  and  Government  Inc.;atives  to  the  Private  Sector
Although  not  vell  documented,  there  are  developing  country  examples  of the
privatizing  of family  planning  delivery. Public  family  planning  programs  in
Korea  and  Taiwan  have  contracted  with  private  physicians  to  perform  steriliza-
tions  and,  in  Taiwan,  IUD  insertions  as  well. The  government  reimburses  private
providers  for  the  services  provided  to  eligible  low-income  couples. Seventy-
five  percent  of IUD  insertions  and  80 percent  of all  sterilizations  financed  by
the  Taivan  government  are  performed  on  a reimbursement  basis. Nearly  all
sterilizations  in  Korea  are  obtained  from  private  providers  both  on  a fee  for
service  basis  or reimbursement  basis,  depending  on the  income  group  of the
recipient  (Draper  Fund,  1986). In  Nigeria,  a private  pharmaceutical  firm
handles  the  distribution  of contraceptives  to  government  health  centers.
Government  incentives  to  encourage  private  provision  of family  planning  is
not  an  area  with  much  information.  Korea,  however,  allovs  companies  a tax
exemption  if they  have  over  500  employees  and  provide  subsidized  contraceptives
for  employees  (Whang,  1979). In  1976,  Malaysia  legislated  that  women  with  3  or
more  surviving  children  need  not  be allocated  the  legally  mandated  maternity
benefits  (Perumal,  1979).
Information  on tax  incentives  (or  elimination  of  disincentives)  in
developing  countries,  and incentives  to  expand  insurance  coverage  and  include
family  planning  in that  coverage  is lacking. 17 The  TIPPS  effort  in  Zimbabwe  is
attempting  to  encourage  a private  insurance  company  to  add  family  planning,  but
this  is  a donor  rather  than  a government  generated  effort. Nonetheless,  this
kind  of program  represents  an important  means  for  achieving  increased  demand  for
private  family  planning  services.
17.  USAID's  OPTIONS  project  is  initiating  an activity  with  the  government  of
Morocco  to  assess  the  consequences  of  altering  the  tax  structure  on local
(Footnote  17  Continued  on  Next  Page
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S'lient  Characteristics  of Private  Sector  Proje:ts
A number  of the  never  projects  are taking  into  account  consumer  demand--an
element  frequtently  overlooked  in  previous  efforts  in  both  the  public  and  private
sectors. In order  to  ensure  that  provision  and  subsidization  of family  planning
vill  have  any  ef'ect  on use  and  is  a  sound  investment,  some  idea  of the  extent
of  demand  for,services  is  essentiai.  Otherwise  services  may  go unused,  and
investments  are  wasted.
Cost-benefit  studies  in  family  planning  often  assume  that  all  births  are
unvanted. Analyses  such  as that  of Nortman  et  al.  (1986),  which  assume  that
family  planning  interventions  vill  result  in  averting  all  births,  are
unrealistic  and  only  are  useful  as theoretical  exercises. In practical  terms,
investments  in  services  should  be based  on a perception  of the  value  of the
service  to  the  employer  and  the  potential  demand  among  employees. For  example,
Mexico's  Industrias  Unidas  project,  Egypt's  Tanta  project,  the  Dominican
Republic's  social  marketing  project,  Zimbabwe's  business  analysis,  and  Bolivia's
Family  Planning  Program  determined  demand  through  surveys  and focus  groups.
However  crude,  at least  these  programs  are  making  an attempt  to  assess  potential
use.
A  number  of projects  are  tracking  utilization,  often  by  method,  as was  done
in  UHO's  Turkey  project;  however,  most  fail  to  account  for  substitutions  from
other  sources  which  inflates  the  impact  and  value  of the  program. Less  common
are financial  assessments  or measurement  of net  project  benefits. Table  IV.2
summarizes  the  financial  characteristics  of each  of the  projects  in  Table  IV.1.
The included  factors  indicate  whether  contraceptives  have  been  donated  and  by
(Footnote  17  Continued  from  Previous  Page)
production  of contraceptives.  The results  might  indicate  how  minor  tax
changes  could  alter  private  invbztment  behavior.
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Finncial  Characteristice  of  Private  Family  Planntig  Delivery  Experiteate
Subsidization
Title  of  Project,  COntraceptive  Donor Subsidy  Policy  and  astimates  of
Country  Donated  Company Subsidy  for  Services  Client  Pays  Free  Costl/Rvenaues  or  Budget
India:
Fam ly  Planin  Uso  Tes  no  me  No Informtto,
Programm,  TVS
LUC"
Tata  Cbemlcals,  No  Tr  so  so  no mfor_ti"o
mithpur
Tata  Idumtries  we  Yee  no  TS  (Cr4iiamally  is  lmfeatiom
Ltd.  family  highe  I
Plasning  ProSrm  employs"  paid
fee)
Oodrej  & Boye.  *.  Ys  MD  No  Ubs  itfo.tia
Hanufacturieg
Co.  Ltd.,  Sobay
F*mily  Planning  s".  by  "A  of  Tes  Us  Us  so  informatio 
Is  Te  Rotates  Iadia
misiuca  Uo  s  es,  full  subsidy  No  as.  I.SO/cycle  Rs.  2,375  per  motb
Spinning  and  for  all  but  oral  orals  for  physlcian  fees
Weaving  Hills  contraceptlive






Delhi  Cloth  I  Yes,  by  FPA  Yes  No  No  No  Informatlon
General  Mills
Co.,  Ltd.
Gajarat  Refinery  No  Yes  No  No  No  lnformation
(Indian  Oil  Corp..
BarodaTitle  of  Project,  Contraceptives  Donor Subsidy  Policy  and Cetimates  of
Country  Donated  Company  Subaidy  for  Services  Client  Pays Fees  Costs/Revenuem or  Oudget
OWLOM iNVITA/DUSTRJ  -ASED  - SmV  (comttd)
India:
Alebic  Group  No  Yes  No  No  Company  spent an average
of  Industries,  of  about Ra.  15.000  per
Sombay  year  on  literature,
Incentives  and other
lncdentals.  Personnel
and *oe  operating  costs
were not  Included.
Philippines
Family  Plenalng  Yes,  by governmet  Yes.  for  No  No  Total  program cost  to  the
In  Havailmn-  personnel  and  cmpany  - 117,820  (com-
Philippinv  CO.  medical  expenses  traceptives  educational
aterial,  and  training
provided  free  by the
government).  Staff
costs - 35000Iyear
(U  Sl  '  *pesos)
torea:
Kaus  Ro Tire  No  Teo  No  Ho  1972 - mid-1978 costs 
Industrial  Co.  57,330,000  won  almost
702 of  It  for  Incentives
Sri  Lanka,
Industrial  Sector  Yee,  by FPASL  Yes,  for  incentive  No  No  No information
Program  payments  and  moti-
lvator  activities
Indonesia:
P.T.  Imbritex  Te, by B10uH  Teo  No  No  No Information
Bangladesh
Family  Planning  Yee,  by Ministry  No Inforomtion  Yes  No information  Project  costs:
Services  for  of  Health  and  1972-78  - $30,426
Industrial  Population  Control  1983-84 - 23,437
Workers  1987-88  - 26,696
Turkey
Impact  of  Trained  No Information  Yea,  for  clinic  No  No Information  Project  coet  - $28S10
Female  Labor Union  space
Shop Stewardesses




Tanta  Industrial  No information  Yee  Yes,  for  LOP  No Information  Project  cost  - $19,659
Family  Planning  from  Pathfinder
ProjectTable  IV.2  (cont'd)
Subsidiaat  ion
Title  of  Project.  Contraceptive  Donor  Subsidy  Policy  and  Cetimat-e  of
Country  Donated  Company  Subsidy  for  Services  Client  Pays  F*e  Coats/ehveaues  or  Budget
YWL!U O  TIS  SUi-NAiS  SIiin  (co.t'd)
St.  Lucia:
Contraceptive  so  No  so  Tea,  well  below  Project  cost  - $25,000




Assessing  Costs  U/A  U/A  No  Teo,  at  lo et  Project  cost  - $26,000
and Benefits  of  througb  prepay-  (plus  undetermined




Fad  iy  Planning





Industry-based  No,  but  starter  No  No  Yes.  at  commer-  No information
Family  Planning  packs  for  the  clal  outlet;  no
Project  first  visit  were  infornmtion  on





Electro  Lime  A  No  Yes  No  No  Cost  for  4  years  $23,000-
HILPO  Family  $50,300  for  Electro  Lime
Planning  (Li"-)  and  $3S.400  for  HILPO
Provision  of  Tee.  by Patb-  No  Yes  No  Costs  10/86,C  9/86  -
Family  Planning  finder  Fund  $196,1883
Informatton  and
Services  In 15
Workplaces
Bolivia:
Family  Planning  T  Tee  No  Yes  Yes.  but  heavily  Project  costs
Health  Servtces  subsidized  Pathfinder  fund  - $105,192
for  Organized  coIutm  $35.212
Workers  USAID  - $56,792
Yes  NHo  e.  a  I  Tee  but estimate  Pro  lect  cost:  $105,112
on -'LV.4
Subsidization
Title  of Project,  Contraceptlves  Donor  Subsidy  Policy  and  Etimatese  of
Country  Donated  Company  Subsidy  for  Services  Client  Pays  Fees  Costs/Revenues  or  budget
XPLomW  ITNR/F  0DUSTI-3ASED  SEVIcES (contd)
Indonesia:
P.T.  CGasy  Djaja  Yes, by OKXEN  in  Yes  Yes,  for  two  years  No  information  Project  cost  - $25,180
Family  Planning  year  one and by
Program  3111  snd  gnter-
prie  in year  two.
mexico:
Famlly  Planning  No, obtained  Yes, for space  Yes,  through  Unclear,  but no  Project  coat  - $83,000
Industries  at  through  sub-  equipmnt. May  EXFAM: training  sention  is  made
IUSA ZPq Indus-  contract  vith  also cover  long  materials,  dona-  of  this
trial  Complex  WO  term  operation  ttons  s  services
NiZeria:
LBN Emplroyee  Yes,  and company  Yes  Yes  Not  yet  Project  cost  - $114,070,
Clinic  Family  will  obtain  sme  determtned  ith  435,000  from  Enter-
Planning  Child  contraceptive.  at  prite  Program.  The  costs
Spacing  Program  wholesale  prices  of  contraceptives  are  not
included.
Thailand:
Factory-based  Yes  No  Yes  Yes  Project  coat  - $260,255  0
Family  Planning
Services  Project
OWTlCNG MIAuT  IUMTU  IN FAMILY  FNAIN
Niseria:
Gulf  Oil  No  Yes  No  No  No  inforuatton  predomi-
nately  technical  assistance
Zimbabwe:





Feasibility  of  N/A  N/A  N/A  N/A  Project  coat  - $24,000
Comercial  Clinics
Providing  Sterili-
zation  in  Jakarta
The  YKB Entrepre-  Yes,  by  BKKBN  N/A  Yes,  from  PVO  Yes  Project  cost  - $10,552
'neurial  Develop-
ment  ProjectTable  IV.2  (cont'd)
Subsadlzation
Title  of  Project.  Contraceptives  Donor  Subsidy  Pollcy  *nd  Estimates  of
Country  Donated  Company  Subsidy  for  Serviceg  Client  Pays  Fees  Coats/Revenues  or BWget
uNOTlrC PfITAhX  INYEXlS  IN  DAN*  L? PL*L  IN  (cont-d)
Thaillnd:
Family  Planning  N/A  N/A  N/A  N/A  Project  cost  - $59.038




Nedical  Service  In first  year  N/A  Only  for  first  Yeo  Project  cost  - $150,039
NicGenterprises  only  M.D
In  metropolitan
Areas
Self-Financing  Sold  to  NDs at  Social  Security  so  eas  but  below  Over 3130,096/year
Family  Planning  cost  and donated  services  only  market  price  for
Project  to  Social  IUD because  of
Security  na  subsidy.  Consul-




Sterling  Products  Tea  to  both  dis-  Tea.  for  provider  Teo  Clients  pay  for  Sales  from  distribution
Private  Sector  tributlon  projects  time  at health  pharmacy  & chemSet  project  grossed  $700,000
Family  Planning  clinic  shop  products  for  In  first  four  months.
Project  benefits  project  Total  project  cost  -
Chan&
Social  Marketing  Tea  N/A  N/A  YeT,  but  below  $1,000,000  over  four  years
Program  maiket  price
Nigeria:
lbedan  Market  Teo  N/A  NIA  Tes  Three  quarters  of  revenue
Project  goes beck  to  project,  one-
fourth  to  traders
Dominican  Republic
Contraceptive  No  No  No  only  paying  Yea,  but  less  than  Not yet  determined
Social  Marketing  for  advertising  *rket  price105
whom,  whether  the  firm,  donor,  or  user  pays  for  the  services,  and  the  reported
costs  (usually  anticipated  expenditures)  of  the  program.
The  TIPPS  project,  USAID's  operational  research  project  (Columbia
University)  in  Nigeria,  Mexico's  Industrias  Unidas  project  and  Enterprise
Program's  Medical  Service  Micro-enterprises  in  Mexico  are  attempting  to  measure
net  costs  both  ex-ante  (all  TIPPS  projects)  and  ex-post  (both  Mexico  projects).
Even  where  the  cost  of  the  project  is  recorded,  in-kind  donations  are
frequently  ignored  even  where  the  donation  consists  of  all  contraceptives,  vhich
constitute  t  e  bulk  of  program  recurrent  costs  in  developing  countries.  Only
one  company  hus  measured  the  net  financial  benefits  of  a  company  family  planning
program,  the  Havaiian  Philippine  Company.
The  company's  annual  costs  for  the  family  planning  program  were  $
(P$35,000.00),  which  covered  salaries  of  clinic  staff  and  motivator,s  as  vell  as
contingencies.  The  clinics  were  already  furnished,  the  vasectomy  operating  room
had  been  donated  to  the  company,  and  contraceptives  vere  donated  by  the
government.  The  company's  costs  vere  modest.  Their  savings  came  from  not
having  to  pay  the  following  maternity  and  birth  costs  per  voman:  pre-natal
consultations  and  medications  (U.S.  $37.00),  the  full  cost  of  delivery  (U.S.
$40.50),  maternity  leave  benefits  (U.s. $102.15  for  42  days),  and  post  natal
care  (U.S.  $10.10),  vhich  amounted  to  $189.85  in  current  U.S.  dollars  (P$1,405)
per  averted  birth. 18 In  addition,  the  company  saved  on  social  services  for
dependents,  particularly  savings  for  health  care  and  education.  The  company
estimates  that  between  1972  and  1976,  they  saved  a  net  total  of  $59,190  (PS
438,007).  Thus  significant  savings  can  accrue  from  the  establishment  of  family
planning.  Hovever,  the  true  cost  of  the  service  should  take  into  account  the
18. Exchange  rate  for  1975  vas  1$  *  7.4  *  U.S.  S
1.00.
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cost  of the  contraceptives  and  the  depreciation  of the  family  planning's  share
of the  clinic  facilities.  This  vould  have  reduced  the  net  savings.
The  extent  of financial  and  human  risources  required  to  operate  a project
are  almost  never  known,  and  the  "cost/budget"  estimates  reported  in the  table
virtually  alvays  exclude  technical  assistance  personnel  regardless  of the
funder. Technical  assistance  is frequently  a  costly  if  valuable  project  element
and therefore  all  the  cost  figures  are  gross  underestimates.
Assessing  the  impact  of company  or  donor  investments  is  infrequent.  A
number  of the  early  Indian  company  programs  compared  employee  birth  rates  and
contraceptive  use  vith  national  averages. In the  Indonesian  P.T.  Irnbritex
company,  the  company  indicated  that  the  employee  birth  rate  vas  8 per  thousand
as compared  to  34-36  per thousand  in the  "general  community"  (Suma'mur,  1979).
In  all  cases,  however,  employees  had  lower  birth  rates  and  higher  prevalence
rates  than  the  community  at large. What to  attribute  these  differentials  to  is
impossible.  The  employee  cohort  was  better  off  than  the  average  Indian,  there
vere  convenient,  subsidized  services,  motivational  activities  and,  in  some
cases,  strong  disincentives  to  large  families  at each  of the  industrial  sites.
All  of these  have  the  potential  for  affecting  family  size  decisions,  but the
relative  importance  of any  one  activity  has  not  been  assessed.
Thus  the  evaluation  component  of these  projects  is  limited,  and  even those
that  have  attempted  to  measure  some  aspects  of the  projects  have  fallen  short  of
the  ideal.
Vho  pays  for  Contraceptives?
Charging  users  for  services  or commodities  is  uncommon  in both  public  and
private  programs. There  are  exceptions,  of course. Where  there  is  an  attempt
to  promote  private  networks  and  expand  availability  of family  planning,  such  as
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the  SOMARC  efforts,  or where  private,  for-profit  suppliers  are  the  exclusive
focus  of an intervention,  family  planning  services  have  fees  attached. Some  of
the  nevly  designed  projects  of the  Enterprise  Program  are  introducing  nominal
fees  that  are  well  below  those  markets,  and  a fev  of these  (e.g.,  the  Self-
Financing  Project  in  Mexico)  are  planning  to  phase-in  a self-supporting  fee-for-
service  arrangement.  TIPPS,  vhile  its  main  objective  is  demonstrating  the
financial  benefits  of family  planning  provision  to  employers,  has  also  begun  to
served  as  a broker  to  Peruvian  firms  that  vish  to introduce  family  planning  into
employee  health  services. Donors  are  not  paying  for  contraceptives  or services
under  TIPPS  assistance;  either  management  or,  less  often,  users  vill  cover  all
opersting  and recurrent  commodity  costs. All  of these  innovations  are  nev  and
none  has  received  any form  of evaluation.  As a result  no firm  conclusions  can
be reached  on their  effectiveness,  but  their  design  are  vorth  tracking  as a
source  for  future  guidance.
At the  other  extreme  of subsidies  and  user  payments  are  a number  of
companies  in  Asia,  notably  in  India,  and  Korea,  that  in the  1960s  established
incentive  payments  for  employees  to  select  sterilization  and,  in  some  cases,  the
IUD;  the  companies  absorbed  the  costs  not  only  of services  and  commodities  but
of recipient  payments  as  well. These  two  countries  as  well  as companies  in  Sri
Lanka  and  Indonesia  also  set  up  disincentives  to large  families  and  many
pregnancies,  as already  mentioned.  All  of these  programs  were  managed,
designed,  and funded  with  minimal  if  any  outside  assistance,  suggesting  that
managers  recognize  the  benefits  of  smaller  employee  families.
Where  companies  and  donors  bear  the  entire  cost  of bringing  family  planning
information  and  services  to  workers,  programs  do not  promote  private  providers
or the  private  sector  unless  companies  contract  out for  services. Employee
benefit  programs  inform  individuals  about  family  planning  through  trusted
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sources,  make  services  more  convenient  and,  as mentioned,  usually  cover  the  cost
of service  delivery  and  commodities.  The  effects  of nev  employee  benefits  for
family  planning  include: shifting  the  source  of service  from  other  public  or
private  sources;  shifting  users  from  traditional  or less  effective  methods  to
more  effective  contraceptive  methods;  or,  increasing  the  level  of  overall
acceptance  from  improved  information  and  access. Which  of these  is  most  common
is  unclear,  although  some  programs  have  assessed  method  shifting,  increases  in
knowledge,  and  nev  users  at the  site  (ignoring  the  possibility  of a shift  from
outside  sources).
Vhereas  firms  that  elect  to  supplement  employees  salaries  through  family
planning  services  are  providing  an additional  benefit,  donors  that  are  serving
the  factory  population  through  subsidized  services  are  aiming  their  subsidies  at
iqiddle  income  earners,  even  if that  means  lover  middle  income. It is  unclear
vhy  those  services  need  to  be  subsidized  by  donors  or  hov  long  the  donor  vill  be
able  to  bear the  cost  of the  program. Thus  there  is  an issue  of  whether  there
should  even  be  a commodity  subsidy  on  an ongoing  basis,  and  how  long  such  an
arrangement  should  or can  go on.  Social  marketing  programs,  on the  other  hand,
are  aimed  at lower  middle  or upper  lover  income  households  under  the  assumption
that  the  poorest  couples  will  seek  free  public  services. However,  there  is
equal  access  for  all  users  and  since  no  assessment  of social  marketing  users  has
ever  been  undertaken,  no evidence  exists  on who  uses  the  products. The SOHARC
project  in the  Dominican  Republic,  hovever,  is  planning  to  undertake  such  a
study.
The  other  issue,  vhich  none  of the  projects  consider,  is  how  much  of a
subsidy  is  required  to  reach  the  target  population.  Some  of these  projects  have
modest  budgets,  mainly  because  contraceptives  are  not  purchased  for  the  clinic.
What  has  not  been  assessed  is the  relative  effectiveness  of modest  technical
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assistance  and  seed-money  programs  and  those  with  generous  budgets  that  pay  for
most  program  elements  Including  contraceptive  commodities.
The  potential  drawback  of  benefit  programs  vhere  donors  are  involved  and
have  promoted  the  program  to  management  through  offers  to  cover  (some)  costs,
especially  for  contraceptive  commodities,  is  vhen  the  subsidization  can  be
terminated.  Where  management  and  employees  come  to  expect  the  provision  of free
contraceptives,  changing  the  rules  i.s  difficult.  The  constant  extension  of
FPIA's  Nigeria  project  may  be  due  to their  inability  to  withdrav  since  it is  a
popular  and  vorking  program,  and  has  received  a number  of extensions  since  its
inception.
The  question  is,  should  donors  subsidize  private  services? Should  they
finance  the  recurrent  costs  of  programs  of for-profit  entities? Providing  free
contraceptives  to  employee  benefit  programs  essentially  subsidizes  recurrent
costs  of for-profit  activities.  The  TIPPS  Project  does  not  subsidize  contracep-
tive  commodities  (except  in  Africa  where  contraceptives  can  only  be  obtained
through  donor  programs),  although  many  "private  sector  projects"  do so. Where
contraceptives  are totally  subsidized,  employees  have  no incentive  to  use  the
private  market  and  rely  instead  on the  largesse  of their  companies.  When
companies  extend  services,  management  decides  who  benefits  and  what to  buy  for
employees,  rather  than  letting  employees  make  the  decision.
Conclusion
There  are  a  number  of established  projects  in  promoting  family  planning
through  private  means,  and  a number  of  nev  and  innovative  projects  are  in their
infancy. The  latter  are  going  beyond  the  traditional,  employee  benefit
programs  vith frequent  donor  subsidies  for  services  and  contraceptives,  to try
nev  approaches  that  both  foster  demand  and  encourage  private  investment  in
L.tp:atly  Plann4ng  Paper  (whole110
family  planning. Noreover,  projects  that  rely  on  employers  are trying  nev
approaches.  The  gap  in these  experiences  are  evaluation  and issues  of long  term
sustainability.
This  rich  set  of experiences  is testing  numerous  different  approaches  and
assessment  of these  could  be the  source  of future  guidance  in  designing  alterna-
tive  delivery  and  financing  modes  that  do  not rely  on public  funds.
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V.  BOV  TO PRONOTI  PRIVATE  ACTIVITY
As  discussed,  promoting  family  planning  use  in  developing  countries  has
historically  implied  government  and  donor  collaboration  in  making  contraceptives
videly  available  at concessionary  prices. The  vast  majority  of those  services
vere  meant  to  be delivered  through  public  sector  outlets,  usually  at zero  price.
The  means  of  designing  successful  programs,  reaching  all  population  groups,  and
retaining  users  have  been  studied,  tested,  and  perfected  so that  in  some
countries  at least  government  programs  are  reaching  the  bulk  of  users  vith
effective  means  of contraception.
The role  of  nongovernmental  entities  has  been  afforded  considerably  less
attention. Indeed,  little  is  really  known  about  what  kinds  of NGO family
planning  programs  work  best,  hov  much they  cost,  or vho  they  serve. On the  for-
profit  side,  little  hard  analysis  exists  to  guide  governments  in  hov  best  to
promote  and  regulate  commercial  endeavors.
The  foregoing  sections  of the  paper  attempted  to  set  out  what is  known
regarding:  (1)  private  production,  distribution,  and  delivery  of contraceptive
services;  the  incentives,  disincentives,  and  impediments  faced  by private
companies  and  Investors;  (2)  the  distribution  nf users  across  sources,  with  some
attempt  to  explain  the  correlates  between  user  characteristics  and  source;  and
(3)  the  private  sector  delivery  initiatives  that  have  already  been  identified  or
tested.
This  background  sets  the  stage  for  the  topics  discussed  here,  vhich  focus
on the  possible  options  for  public  sector  (and  by  extension,  donor)  intervention
to  expand  the  use  and improve  the  operation  of the  private  family  planning
market,  as  an alternative  to  direct  public  intervention.  The folloving  provides
options  and  a guide  to the  most  appropriate  role  for  government  in  nurturing  the
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private  market. While  not  all  of these  options  will  be  appropriate  in  every
setting,  they  provide  a panoply  of possible  actions  for  governments  and  donors
to  consider.
Role  of Government  Policy  and  Action  in the  Private  Health  Sector
Government  policies  set  the  parameters  under  vhich  private  entrepreneurs
function. Fupdamentally,  the  governmental  role  should  not  be to  subsidize
either  consumers  or producers/distributors  of  contraceptives  where  otherwise  the
market  would  lead  to the  same  outcome. The  public  sector  can  set  obstacles  or
enhance  the  climate  for  the  private  sector. For  instance,  vhen tariffs  are  set
to  discourage  imr..'-ts  due to  balance  of payments  difficulties,  they  will  affect
private  investors'  dttempts  to  modernize  a family  planning  clinic--if  most
equipment  must  be imported--and  vill  force  private  providers  co  raise  the  price
they  charge  for  imported  contraceptives.  Overregulation  can  cramp  the  expansion
of  private  insurance  and  offer  disincentives  for  innovations  such  as adding
family  planning  to  employee  benefit  packages;  restrictions  on new  health  care
delivery  mechanisms  can  limit  the  development  of pre-paid  group  practices  such
as health  maintenance  organizations  (HMOs),  a particularly  valuable  outlet  for
family  planning  vith  HMO  emphasis  on  preventive  care;  licensing,  price  controls,
and taxation  can  make  family  planning  investments  urprofitable  and  unattractive;
and  restrictive  earnings  repatriation  policies  can  discourage  new  entrants  and
competition,  thus  leading  to  higher  prices. These  kinds  of restrictions,  while
perhaps  legitimate  to  achieve  other  policy  objectives,  can  create  disincentives
for  entrepreneurial  activities  in  health  and family  planning.
Government  can  promote  greater  private  sector  activity  through  modifica-
tions  in policy;  introducing  legislation,  or establishing  new  or revised  laws
that  encourage  and facilitate  private  investment;  and through  direct  technical
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and financial  assistance.  This  can  mean  either  assisting  the  private  sector
expand  the  supply  of family  planning  service  delivery  through  assistance  and
removal  of impediments,  or through  efforts  to  raise  the  demand  for  private  care.
The former  implies  access  to  technical  assistance  and  capital  for  family
planning-related  investments.  The  latter  suggests  encouraging  alternative
financers  of health  care,  that  is,  promoting  insurance  coverage,  the  development
of HMOs,  and  other  third-party  payers  through  tax  incentives  or other  regulatory
means.
Private  Sector  Options  and  Their  Applicability  Across  Countries
A number  of  different  kinds  of interventions  can  be undertaken  to -romote
private  sector  activity. Table  V.1  summarize  these  options,  explaining  the
possible  initiatives  that  can  affect  the  demand  for  private  sources  or the
supply  of private  contraceptive  services,  and  the  necessary  steps  for  initiating
each.
Because  of the  complexity  of the  effects  of the  multiple  objectives  to  be
achieved  by specific  interventions,  the  folloving  discussion  is  organized  around
major  options. 1 9 The  major  kinds  of interventions  that  government  can  make  to
foster  greater  private  sector  activity  cover  a broad  range. Not  all  of these
are  applicable  in  all  cases,  and in  some  countries  all  of these  can  be  difficult
to implement.  The  degree  to  vhich  public  and  private  entities  coexist,  the
19.  For  example,  establishing  a reimbursement  system  to  replace  or complement
direct  public  provision  of family  planning  relies  on private  providers  to
deliver  care  vhile  the  public  sector  pays  for  it. This  kind  of system
obviously  expands  the  demand  for  private  family  planning  services,
stimulates  private  investment  in  family  planning,  and reduces  the  role  of
public  entity;  hovever,  it  can  be a  complex  and  involved  proposition  vhen
it is  part  of an overall  shift  in  government's  financing  of  health  and
family  planning.
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Table  V.1
Summary  of Options  for  Promoting  Increased  Demand  for  and  Supply  of
Private  Family  Planning  Services
Means  to  Foster  Private  Steps  Needed  to
Family  Planning  Services  Accomplish  Effort
Foster  Demand  for  Private  Sector
Partially  subsidize  private  sector  Social  marketing  (type)  programs;
serv'ces  reestablish  eligibility  for  subsidies,
vhich  forces  those  able to  pay to  seek
o  Social  marketing  initiatives  private  sources  of contraception
o  Means  testing  for  public  services
Promote  private  insurance  coverage,  HMO  Legislation,  tax  breaks  and  other  legal
and  other  third-party  payers,  including  and financial  incentives  requiring
family  planning  vith  existing  nev  broad  public  sector  endorsement
Insurance  and  employee  benefit  packages
Adjust  public  payment  reimbursement,  Legislative  and  bureaucratic  changes
voucher  or  capitation  system  for
patients  treated  by  private  providers
instead  of  direct  provision
Promote  Private  Supoly  of  Family
Planning
Technical  Assistance
o  assistance  to  improve  the  o  supporting  experts  to  assist
management  and  efficiency  of  private  organizations  and  firms
private  operationsa
o  upgrading  and  assistance  to  o  new  or  modified  programs
management
o  information  on private  sector  o  information  gathering  and  studies
status  and impediments  to its
expansion
o  research  and  evaluation  to  assess  o  nev  programs/evaluation  of
cost  effectiveness  of  alternative  existing  programs
arrangements
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Table  V.1 (cont'd)
Page  2
Means  to  Foster  Private  Steps  Needed  to
Family  Planning  Services  Accomplish  Effort
Financing
Provide  access  to  loan  capital  (vith  Establish  laan  fund  and  effective
donors/government  taking  foreign  method  of operation.  Absorbing  risk
exchange  risks)  may involve  higher  level  concurrence
o  loans  to  encourage  private
investment
o  tax  relief  to  providers
o  reduction  in impediments,  (see
belov)
Incentives  to  private  providers,  Can involve  simple  nonenforcement;
based  on an understanding  of private  adjustments  to  existing  regulation,  or
sector  impediments  and  vhat  legislative  changes,  depending  on
constitutes  attractive  returns. For  constraint  and  necessary  action
example,  reducing  tariffs  on
contraceptives,  or  easing  price
controls
Privatization  of Public  Delivery
Contracting  out  to  make  greater  use  Entails  adding  a provider  under
of the  private  sector  in the  delivery  government  contract.
of  services
Reimbursement,  voucher  or capitation  Involves  legislative  and  bureaucratic
system  for  family  planning  to  rely  on  changes,  but  can  help to  narrov
private  rather  than  public  providers  eligibility  and  lover  costs
Shift  existing  programs  and  resources  Difficulties  vith  shifting
to  private  providers/managers  to  resources/firing  government  employees
provide  or  operate  facilities.  For  may  require  high  level  approval
example,  paying  NGOs  to  deliver
services
Social  marketing-type  collaboration  Develop  joint  activities  with the
between  public  and  private  entities  private  sector  vith incentives  to
to  address  equity  concerns  as  vell  as  attract  private  entities
operational  efficiency
a.  Such  assistance,  hovever,  is  inappropriate  for  profitable  multinationals  or
parastatals  vhere  the  companies  have  access  to  and  can  afford  appropriate
expertise.
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existing  level  of private  activity,  and  consumer  perceptions  of the  accessi-
bility,  quality  and  reliability  of private  suppliers  will  all  play  a role  in
determining  what  course  is  most  appropriate.
Inforuatiotr/Technical  Assistance.  Promotion  of private  activity  involves
understanding  the  legal,  financial,  and  economic  climate  in  which  (potential)
family  planning  investors  operate. First,  it is  important  to identify  the
incentives  and  disincentives  investors  face  in  establishing  or expanding  health
care  programs.
Secondly,  the  constraints  that  impede  investments,  need  to  be understood
and  addressed. Government  and  donor  actions  can  serve  to  identify  and  redress
the  disincentives  and  constraints,  bolster  existing  incentives,  and  design
initiatives  that  complement  existing  incentives  and  promote  new  activities.  For
example,  if  a fledgling  insurance  industry  is concentrating  on life  insurance,
encouraging  companies  through  tax  breaks  to  provide  health  and  family  planning
coverage  to their  employees  can  spur  the  demand  for  private  family  planning
commodities  and  services. In turn,  the  rise  in  demand  offers  an incentive  to
companies  to  add  family  planning  to  existing  policies  or  develop  health
insurance  programs  that  include  contraceptive  services.
Every  country  can  benefit  from  a better  understanding  of the  role  and
importance  of the  private  sector,  gaining  a more  informed  basis  upon  which  to
proceed. In many  instances,  the  private  sector  is  dismissed  by government  as
ineffective  and too  small  to  be considered  before  any  kina  of assessment  has
been  attempted. Promoting  for-profit  or even  NGO  activities  depends  on knoving
the  impediments  these  investors  face,  and  such  a study  can  be  undertaken
anywhere. Similarly,  almost  any  country  can  develop  a social  marketing  program
that  piggybacks  on  existing  distribution  networks. These  activities  are
virtually  universally  applicable  and  potentially  useful  to  governments
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interested  in  harnessing  the  private  sector  in  meeting  fertility  reduction
goals.
Access  to  capital  is  a  very  real  constraint  in  many  countries  due  to
underdeveloped  capital  markets  and  the  modest  profits  of small  scale  health
investments.  Providing  access  to  loans,  including  foreign  exchange,  can
critically  affect  vhether  indigenous  companies  can  invest  in  family  planning.
Giving  potential  investors  access  to  capital  may  be a  key  element  in  promoting
greater  private  sector  activity. For  instance,  if  establishment  of  a private
family  planning  clinic  is  constrained  by insufficient  capital  and  a shortage  of
foreign  exchange  to  import  medical  equipment,  then  loans  in both  local  currency
and  foreign  exchange  are  a means  of promoting  the  finalization  of the
investment.  Moreover,  this  tends  to  be a problem  in the  International
Development  Association  (IDA)  countries  as  well  as the  nevly  industrialized
countries.(NICs),  and it  is  an adaptable  activity  across  the  spectrum  of
recipient  countries.
Financing  Assistance.  Donor  assistance  in  private  activity  can  be critical
in  making  consultants  available  to the  government,  in  developing  and  financing
the  process  of establishing  and  carrying  out these  initiatives,  and,  most
importantly,  in  evaluating  their  contribution  to reducing  facilities'  costs
and/or  raising  quality  vhile  ensuring  continued  access  to  family  planning  of the
indigent. Foreign  e-change  loans  may  only  be obtainable  through  a donor
financial  loan  scheme. Moreover,  some  concessions  on repayment  arrangements
(e.g.,  repayment  in  local  currency  may  be  necessary  since  health  and  family
planning  services  do not  generate  foreign  exchange)  may  be best  handled  through
foreign  assistance.
Public-Private  Collaboration.  Expanded  public  ^ooperation  with  the
commercial  sector  (i.e.,  private  pharmaceutical  companies  and  distributors)  to
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accomplish  greater  user  reliance  on private  providers  vith  a minimal  subsidy
from  the  government  is  varranted,  especially  given  the  successful  collaboration
that  has  occurred  in  social  marketing  endeavors.  Based  on observations  across
countries,  it  seems  that  private  firms  are  not  induced  by  current  market
conditions  to  dramatically  lover  the  price  of orals  and  achieve  a higher  volume
of  sales  through  pharmacies.  This  suggests  that  the  profit  maximizing  position
entails  high  prices  and  low  volume. This  does  not  mean  that  acceptable  profits
could  not  be gained  from  higher  volumes  and  lover  prices. Schering  Ag's
experience  in the  Dominican  Republic  provides  some  indication  that  positive
profits  can  be  generated  from  such  a strategy,  provided  there  is  adequate
advertising  and  promotion  for  the  product. The issues  are  how  do profits  differ
across  the  two  pricing  strategies,  and  vhat  kinds  of incentives  are  needed  to
encourage  the  high  volume  lover  price  option.
Social  marketing-type  approaches  where  public  and  private  groups  collabo-.
rate  at  vhat  each  is  best  at can  be an important  avenue  to pursue  for  possible
reductions  in  cost  or improvements  in  delivery  efficiency.  For  example,  were
the  government  to  subsidize  generic  advertisement  and  promotion  for  orals  and
emphasize  that  they  are  nov  more  affordable  and  that  pharmacies  are  a possible,
convenient  place  for  purchase,  and,-in  return,  private  firms  (or  a subset)
agreed  to  lower  the  price  on at least  one  of their  marketed  orals,  prevalence
might  be raised  with  minimal  government  investment  and  subsidy. Whether  privat
firms  would  benefit  enough  to  participate  is  an empirical-matter.  Also,  the
degree  to  which  this  approach  gains  nev  users  is  also  an open  question.
Nonetheless,  enhanced  public-private  collaboration  is  warranted  in the  long  run
interests  of  keeping  supplies  available  to  potential  and  current  users.
Privatization.  Privatization,  where  the  government  can  hire  private
specialists  or groups  to  undertake  certain  tasks  for  the  government,  is  a key
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method  to increase  the  demand  for  private  health  care  and  stimulate  potential
suppliers. Privatization  options,  hovever,  are  more  complicated  and involve
investments  of  greater  political  capital  than  many  of the  other  options
discussed  here. For  example,  privatization  is  only  possible  vhere  there  is  a
political  will to  change  the  manner  in  which  services  are  delivered.  This  can
mean  firing  government  employees  if  contracted  private  services  are  being
substituted  for  public  services,  vhich  requires  endorsement  and  support  from  the
highest  levels  of  government.
Privatization  may  also  help  to  improve  the  efficiency  of family  planning
delivery  as well  as reduce  the  public  sector's  subsidy  burden. The  Jamaican
government  with  USAID  assistance  has  just  completed  the  transfer  of laundry  and
housekeeping  services  to  a private  contractor  in four  major  public  hospitals.
Government  employee  unions  posed  an obstacle  to  the  reforms  since  the
contracting  implied  firing  government  employees  currently  carrying  out those
tasks;  hovever,  since  privatization  the  cost  of these  same  services  has  been
halved  while  performance  has  been  enhanced.
Economic  Policy  Changes. Changing  the  incentive  structure  for  private
entities  investing  in family  planning  may  vell  involve  changes  blessed  at the
same  high  levels  as privatization  initiatives.  Granting  tariff  adjustments  or
exceptions,  relaxing  price  controls,  or offering  tax  breaks  cannot  be
accomplished  by  ministries  of  health,  the  government  body  typically  responsible
for  family  planning. These  decisions  require  the  concurrence  of other
ministries,  the  legislature,  where  relevant,  and  perhaps  the  head  of state.
Thus  a consensus  and  strong  political  backing  are  required  to implement  some  of
the  key  changes  in  incentives  that  affect  private  family  planning  providers.
Promoting  Private  Activity. Building  on  existing  strengths  and  exploiting
veaknesses  to  advantage  vithin  the  market  can  also  bolster  efforts  in private
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family  planning  activity. For  instance,  an  over  supply  of physicians  is
reducing  vages  in some  countries  and  leading  to  unemployment  among  doctors.
Creating  incentives  to  encourage  their  participation  in family  planning
delivery  (as  is  occurring  already  in  Mexico  under  the  USAID  Enterprise  Program
project)  can  be  a means  of obtaining  services  at a reasonable  charge  for  the
government's  target  population.  Greater  reliance  on the  for-profit  private
sector  for  the  provision  of family  planning  services  in the  developing  vorld  is
possible  vhere  the  private  sector  resources  already exist,  are  dormant,  or can
be mobilized  through  proper  use  of incentives.  The  potential  seems  greatest  in
Latin  America  and  the  Middle  East  where  physician  unemployment  is  a rising
problem. Hany  of the  NICs  in  Asia  already  have  large  private  sectors  and  these
can  also  be encouraged  to  expand  and  modify  short  term  objectives  (e.g.,
profits).
In  Africa,  where  the  monetized  economy  is  smaller  and  public  programs  tend
to  be weak,  however,  contraceptive  prevalence  is  low  even  among  urban  couples
employed  in the  monetary  economy. Therefore,  getting  private  firms  to  add
family  planning  benefits  to their  health  benefits  may  be  a very  fruitful
approach  to  raising  contraceptive  prevalence.
The  degree  of subsidy  necessary  to  attain  high  cont.raceptive  prevalence  is
going  to  depend  on the  ability  of people  to  pay  for  contraception  and  on their
desire  to  contracept.  The  ability  and  willingness  to  pay  for  contraception
often  move together. In  Africa,  the  commercial  prospects  for  increasing
contraception  seem  poor  because  the  profit-maximizing  prices  are  beyond  the
reach  of most  (potential)  users. However,  the  public  sector  is  also  underdevel-
oped  and typically  lacks  the  administrative  capacity  and  resources  to  expand
family  planning  services  that  the  Thailand  and  Indonesian  governments  have.
Therefore,  donor  and  government  resources  should  be  directed  at using  the
fl.tp:Fasly  Planninq  Paper Eutho1e)121
private  sector  as  much  as possible  as SOHARC  is trying  in  Zimbabwe,  or as a  new
USAID  project  is  attempting  to.do  in  Nigeria.
Alternative  Financing  Options  for  Family  Planning. Insurance  is  probably
the  most  important  means  of fostering  demand  for  private  sector  (especially  for-
profit)  services,  although  the  focus  of insurance  has  historically  been  on
curative  care. It is  a most  relevant  approach  in  the  NICs  where  an established
insurance  industry  exists,  although  this  option  may  offer  the  opportunity  to
foster  a nascent  industry. Insurance  is  a complex  service  that  is  often  beyond
the  capacity  of countries  with  minimal  managerial  and  technical  talent,  hovever
(Wasow  and  Hill,  1986),  so this  option  needs  to  be  pursued  with  caution.
A federal  reimbursement  system  vhere  government  reimburses  private
providers  for  services  to the  eligible  population  is in theory  applicable  in
many  settings,  but  it too  is  complex. In most  cases,  adopting  a medical
reimbursement  system  implies  a total  revamping  of the  financing  and  delivery  of
Wealth  care,  although  it  may  be  an initiative  that  could  be tested  or applied  on
a limited  basis  for  some  services  such  as family  planning. In tandem  with  such
a switch,  some  assistance  must  be  given  to the  private  sector  both  to  gain
access  to the  resources  it  needs  to  develop  services,  and  to  promote  insurance
or other  coverage  (e.g.,  HMOs)  for  the  population  not  covered  by the
reimbursement  system. Hence,  the  proposition  has  a number  of different  facets
that  need  to  be considered  as a package  if the  political,  medical  and  economic
issues  are to  be  addressed.
Portugal  has  recently  established  a  diagnostic  related  groups  (DRG)  system
in  its  hospitals  thereby  adopting  the  U.S.  model,  so nev  reimbursement  systems
can  be  adopted,  but  't  is an involved  and  lengthy  process. A reimbursement
system  requires  that  the  government  has the  ability  to  oversee  and  manage  a
great  many tasks  from  defining  eligibility,  to  setting  acceptable  charges,  to
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managing  and  administering  a complex  set  of billings,  payments  as vell  as
service  access. It  may  be  overly  complicated  and involved  for  some  governments.
However,  reimbursement  arrangements  have  worked  vell  in  Korea  and  Taivan.
Government  Regulations
The  other  role  for  government  that  has  not  yet  been  discussed,  but  becomes
important  as privatization  occurs  and  the  private  sector  takes  on  greater
responsibility  for  delivering  care,  is that  of oversight. Whether  the
initiative  is  a contract  to  a private  entity  or greater  latitude  for  private
actors,  the  government  needs  to track  progress  and  performance,  and  regulate
activity  for  the  social  good.
In contracting  out,  for  example,  it is  essential  that  the  terms  of agree-
ment  are  met  and that  the  government  has  some  recourse  to remove  the  contractor.
This  obviously  requires  human  and  financial  resources.  Contracting  out  has  some
hidden  costs  to the  government  that  are  not  readily  apparent. Additionally,  if
the  government  decides  to  let  multiple  contracts  for  a number  of  small,  discrete
tasks,  the  oversight  responsibilities  become  major  undertakings.  Fever
contracts  encompassing  a number  of  different  tasks  may  be preferable  and  less
time  consuming  because  there  is  only  one  firm  with  which  to  negotiate.
Regardless  of the  size  of  oversight  the  issue  is  a very  real  one for  thinly
(professionally)  staffed  ;istries  of health.
Regulation  of the  private  sector  to  prevent  abuses,  ensure  quality,  help
mitigate  waste  and  control  costs  are  common  throughout  the  developed  vorld,
including  the  U.S.  For  example,  the  acquisition  of costly  high  technology  in
the  health  field  in the  U.S.  is typically  regulated  to  prevent  overcapacity,
which  unregulated  would  raise  the  cost  of care  so that  all  owners  could  cover
the  cost  of their  underutilized  equipment.  Reimbursements  for  family  planning
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and  health  services  to indigents  are  priced  by the  government  based  on a package
of  minimal  services  to  control  costs. Another  implicit  tool  used  by  govern-
ments,  especially  the  U.S.,  is  competition,  which  helps  to  control  costs. The
advent  of  HMOs in  the  U.S.,  for  example,  has  promoted  competition  and  helped  to
contain  costs.
Thus  where  private  providers  are  active  in introducing  or expanding
existing  services  to  encompass  family  planning,  government  can  help  to improve
affordability  and  mitigate  limitations  of  alternative  private  financing
mechanisms  through  regulations.  Moreover,  government's  oversight  rather  than
direct  delivery  may  be  a more  efficient  way to  provide  family  planning.
Conclusion
Thus  donors  and  governments  can  work  jointly  to:  (1)  promote  the  private
health  and  family  planning  sector  through  tax  incentives,  improved  private
access  to (loan)  capital,  expanded  technical  assistance,  relax  existing  legal
and  political  obstacles,  and  provide  better  aceess  to  information;  (2)
redesigning  public  financing  of health  care  to  reimburse  private  providers  for
delivering  care  rather  than  relying  exclusively  on direct  provision  through
government-operated  facilities;  and,  (3)  hire  private  contractors  to take  on
functions  for  the  government  such  as:  management  of family  planning  clinics,
leasing  out  clinic  management  and  service  delivery,  or  outright  selling  of
public  health  and family  planning  facilities.
Although  there  are  a number  of options,  their  applicability  must  be
assessed  on  a country-by-country  basis. Each  option  involves  a  set  of primary
actions  and  may require  secondary,  supporting  actions  on the  part  of the
government.  Since  many  of the  proposed  options  involve  tradeoffs  (economic  and
political),  governments  and  donors  will  need  better  analyses  on the  costs  and
al.fp:Family  Planning  Papet  (whole)124
benefits  of the  options. Evidence  on the  costs  (in  terms  of lover  contraceptive
prevalence  or  depressed  sales,  for  example)  associated  with  particular
impediments  like  price  ceilings,  taxes,  or tariffs  would  provide  governments
vith the  information  needed  to  gauge  whether  policies  shoulo  he changed.
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VI.  CONCLUSIONS  AND  RECOMMENDATIONS
This  paper  has revieved  existing  evidence  on the  private  sector,  vhat  it
is,  where  and  how it  operates,  the  kinds  of impediments  it  faces,  and  the
options  for  structuring  closer  public-private  collaborative  arrangements.  This
section  provides  a summary  of the  key  findings  vith  regard  to  who the  private
sector  is serving,  hov  commercial  ventures  have  fared,  and the  appropriate  role
for  private  sector  groups,  and then  outlines  outstanding  issues  and  areas
deserving  further  attention.
The  private  sector  is  made  up  of both  for-profit  entities  that  operate
exclusively  on earnings,  and  nongovernmental  organizations  that  function  under
subsidies  from  government,  charity,  and  sometimes  earnings  from  users,  but  are
privately  run.
The  commercial  sector  serves  a  wide  range  of contraceptive  users  in
developing  countries.  It is the  major  source  of  nonclinical  methods  in  almost
every  country,  and  in  some  countries  the  key  source  of clinical  services. For
example,  in  Thailand  the  commercial  sector  provides  the  bulk  of female  (but  not
male)  sterilizations.  Younger  women  tend  to rely  on commercial  sources  for
contraception  as do urban  relative  to  rural  vomen. And  as expected,  more
education  and  higher  incomes  are  associated  with  a  greater  likelihood  that
commercial  sources  rather  than  subsidized  services  will  be  used.
Despite  these  patterns,  there  are  dramatic  differentials  in  reliance  on
commercial  sources  across  countries  of relatively  similar  socioeconomic  status.
In  Thailand,  only  33 percent  of  married  women  with  more  than  a secondary
education  use  commercial  sources,  whereas  66 percent  of Egyptian  women  with  no
education  rely  on commercial  sources. Contraceptive  prevalence,  hovever,  is
twice  as high  in  Thailand  (65X)  as it  is in  Egypt  (30X). Thus  the  expected
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relationships  within  each  society  are  borne  out in  most  cases,  but the
differentials  across  countries  are  far  more  significant  and  call  for  a
reexamination  of the  determinants  of use  of commercial  sources  of contraception.
Private  producers  and  distributors  of contraceptive  services  have  continued
to  invest  in  countries  where  the  climate  is  poor  (i.e.,  low  returns),  in  the
hopes  of  gaining  a foothold  for  future  profits. Impediments  such  as price
controls,  tariffs,  restrictions  on repatriation  of  earnings,  and  general
bureaucratic  difficulties  have  raised  the  price  of commercial  products  and
reduced  profits  in  many  countries.  Most  importantly,  government  programs  have
cut  into  commercial  companies'  market  shares  and  profits. Indeed  competition
from  government  programs  has  forced  private-public  collaboration  to  allow
private  companies  to  survive  locally. In  effect,  strong  public  programs  have
crowded  out  private  activity,  especially  that  of the  for-profits.
Private  providers  offer  an alternative  to  government  programs,  are
typically  more  convenient  and  reportedly  offer  higher  quality  products  and
services. Commercial  providers,  however,  can  only  serve  those  who  can  pay,  and
the  pattern  of operation  in  developing  countries  suggests  that  high  volume  and
modest  prices  are  'Less  profitable  than  high  prices  and  low  volume;  although  no
firm  evidence  exists  on the  existence  of such  a str.tegy. The  current  pattern,
however,  effectively  closes  out  commercial  sources  to  some  segment(s)  of the
population.  Lowering  prices  to  capture  a larger  market  share  does  not  appear  to
be common,  although  there  are  a few  nev  efforts  such  as the  SOHARC-Schering  Ag
collaboration  in the  Dominican  Republic  to  deliver  a  mid-priced  product
commercially.  But  a firm  may  be reluctant  to  lower  its  price  without  having  the
ability  to  attract  nev  users  to the  product--they  are  prevented  from  advertising
their  product  in  most  countries.
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NGOs  appear  to  flourish  vhere  the  government  has  had  difficulty  building
strong  health  or family  planning  infrastructures,  as in  Africa,  but  their  role
is  mixed  in  other  regions. NGOs  can  also  play  key  roles  where  governments
cannot--by  taking  the  lead  and  supporting  contraceptive  services--like
sterilization  that  are  perceived  as too  controversial  to  be  a part  of the
official  government  program. How  much  NGOs  compete  with for-profits  is  not
known. The for-profits  are  more  efficient  than  government  while  NGOs  are  in
some  undefined  place  in  between. Lack  of information  prevents  any
generalizations  about  NGO  performance  and  efficienLy.
Although  options  for  promoting  private  activity  have  been  discussed  (see
Table  V.1  for  a summary  of the  suggested  options),  none  has  been  tried  and
documented,  so these  have  emerged  from  theory,  discussions  with the  affected
parties,  and  a reviev  of the  literature  on somewhat  similar  actions. The
planned  and  ongoing  efforts  in this  area  deserve  greater  attention  and
evaluation  and the  next  subsection  addresses  these  gaps.
Unansvered  Questions  and  Areas  for  Future  Activity
Despite  the  volume  of  activity  in the  area,  the  many  surveys  that  have
addressed  some  aspects  of the  private  sector,  and the  modest  attempts  to
understand  the  mechanism,  efficiency  and  effectiveness  of family  pianning
programs  in the  private  sector,  a great  deal  of pertinent  data  and  analysis  are
lacking. Indeed,  fev  firm  conclusions  can  be  made  regarding  the  experience  with
private  sector  approaches,  partly  because  so many  are  in the  formative  stages,
but  also  because  the  level  of evalua on  has  been  so poor. Similarly,  conclu-
sions  regarding  potential  users  of  commercial  products  are  inadequate  both  in
terms  of  appropriate  data  and  analysis. Data  on costs  and  efficiency  are
exceedingly  poor. Cost  data,  where  they  exist,  are  incomplete,  and  comparative
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costs  across  programs  are  hampered  by incomparability  of the  services  and
service  components  costed  out. No definitive  conclusions  can  be made  on costs
of  programs  or delivery  modes.
This  subsection  points  out  the  weaknesses  of the  existing  literature  and
highlights  areas  for  further  work. It is  divided  into  three  separate  sections:
evaluation,  determinants  of private  sector  use,  and  costs  and  cost
effectiveness.
Evaluation.  Despite  the  progress  in  evaluation,  most  of the  private  sector
projects  summarized  in  Section  IV  do or  are  planning  an inadequate  assessment  of
the  costs  and  benefits  of the  investment.  The  evaluation  criterion  most  often
used  is  the  increase  in  the  number  of contraceptive  users  occurring  after  the
introduction  of the  project. Rarely  is  cost  per  user  calculated.  Counting  new
users  by  method  is  quite  useful,  but  it is  equally  important  to  measure  the
costs  and  benefits  of the  program  to  decide  if  there  are  better  and  cheaper
means  of financing  and  delivering  family  planning  services.
In particular,  evaluations  need  to  focus  on the  family  planning  behavior  of
the  target  group  to  gain  a better  understanding  of the  following:  importance  of
motivators  versus  printed  matter  in  advertising  the  availability  of services;
the  importance  of on-site  services  as opposed  to  vouchers  or reimbursement
arrangements  through  commercial  outlets;  the  shifts  in  sources  that  take  place
with  the  introduction  of benefits,  that  is,  the  permanence  of the  increase,  the
number  of  acceptors,  the  effectiveness  of the  methods,  and  the  profile of the
(potential)  user  who  benefits  most  from  on-site  services;  vhat is the  most
appropriate  and  effective  roles  for  donors;  and,  whether  donating  contraceptives
enhance  or inhibit  the  establishment  of  a self-sustaining  family  planning
program?
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The impact  of  alternative  means  of promoting  private  delivery  of family
planning  should  be assessed  in  both  absolute  and  relative  terms. These  evalua-
tions  generally  are  not  anticipated  for  the  ongoing  projects  described  earlier.
For  example,  does it  pay  to  provide  grants  or loans  to  physicians  to  set  up
clinics? Do firms  improve  their  operation  and  efficiency  through  a management
reviev? Does  including  family  planning  in  an insurance  or HMO  benefit  plan
raise  the  demand  for  family  planning? This  is  particularly  relevant  vhere  vage
earners  make  up the  middle  class,  many  of vhom  may  already  practice
contraception.  What  are the  tradeoffs  betveen  convenience  of on-site
contraceptive  services  and  reimbursing  referrals  in terms  of costs  and
continuing  users? Despite  the  ex  ante  cost  benefit  analysis,  do firms  actually
save  money  over  time  either  on a  gross  or  net  basis  by  introducing  family
planning  to  their  employees?  What  kinds  of firms  are  more  likely  to  experience
net  savings? For  vhat  kinds  of target  groups  (i.e.,  different  prevalence,
income  or fertility  levels)  will  the  impact  and  cost  savings  be  greatest? These
kinds  of questions  address  the  gaps that  currently  make  project  design
difficult.  Guidance  on what  elements  to  stress  and  how  to  structure  private
sector  programs  in the  future  can  only  be  obtained  through  careful  evaluation  of
planned  or  ongoing  projects.
Capital  markets  in  most  develop.ng  countries  are  not  well  developed.  Small
operators  and  businessmen  often  cannot  raise  the  necessary  investment  capital  to
set  up a family  planning  (or  health  and family  planning)-facility  even  if
profitability  vere  assured. Thus,  consideration  of loan  funds  to  make  capital
available,  including  foreign  exchange,  couid  contribute  to  ameliorating  the
critical  deficiency  in  investor  incentives  in  developing  countries. Indeed,
experimenting  with  different  loan  arrangements  would  be ideal  to  reach  different
investors  and  maximize  investment.
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The  question  of  how to  price  contraceptives  is  an important  issue  too,  if
the  premise  is that  the  private  sector  vill  eventually  take  over  and  continue
programs. Vhere  management  has  decided  to  provide  family  planning  as an
employee  benefit  free  of charge,  the  issue  is  decided,  but  where  free-standing
projects  are  planned  or  NGOs  are  assessing  how to  become  more  efficient  and
solvent,  how  to  price  services  to  both  earn  revenues  and  yet  retain  users  are
important  questions.  There  is  some  evidence  that  the  price  elasticity  of demand
varies  across  contraceptives  and therefore  cross  subsidization  may  be  possible.
Host  of the  projects  reviewed  in  section  IV  assume  an inability  to  pay  or  an
ability  and  willingness  to  pay  only  nominal  amounts. Some  experimentation  and
documentation  is  varranted  in  measuring  the  elasticity  of  demand  for
contraceptives  with  respect  to  price,  and  to  establish  how  much  of  a trade  off
there  is between  convenience  and  price. Although  this  is really  an  adjunct
issue,  it is  nonetheless  key to  the  continuation  of private  sector  projects  and
will  be important  in future  endeavors.  The  sustainability  of many  of these
projects  over  the  long  term  depends  on recovering  some  share  of costs.
Determinants  of  Private  Sector  Use. The  available  data  on source  of
contraceptives  was  reviewed  in  Section  III. The  analysis  provided  an overview
of the  topic  and  indicated  regionai  patterns  and  disparities.  Hovever,  the  CPS
and  DOS  data  are  somevhat  limiting  in  not  being  complete  enough  to  *apture  some
of the  issues  of interest,  such  as the  difference  in  reliance  on  NGO,  social
marketing  and  commercial  sources  of contraception.  Horeover,  better  information
on  supply  would  help  interpretation  of the  source  information,  and  vould  allow
demand  analyses  to  control  for  supply  characteristics.
Host  important,  however,  is the  need  to  analyze  these  data  in  greater
depth,  controlling  for  the  many  factors  that  affect  consumers'  decisions.
Comparative  multivariate  analysis  is  key  to  a better  understanding  of the
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Information  presented  here. The  CPS  and  DHS  data  are  available,  accessible  and
of reasonably  high  quality. They  deserve  to  be further  analyzed  along  the  above
dimensions.
Thus,  both  an  effort  to  exploit  existing  information  and  to  collect  broader
and  more  focused  information  on  consumer  behavior  in  family  planning  decisions
are  warranted. Moreover,  a more  rigorous  approach  is  called  for  given  the
emphasis  to  date  on  anecdotes  and the  dearth  of data. Both  data  and  analysis  of
existing  (and  nev)  data  could  contribute  importantly  to  a better  understanding
of the  role  and  contribution  of the  private  for-profit  and  NGO  sectors.
Costs  and  Cost  Effectiveness.  As  part  of the  reviev  of  what is  known
concerning  the  private  for-profit  sector  and  how it  compares  vith  other
providers,  the  cost  and  cost-effectiveness  of  alternative  providers  vas
explored. Little  good  evidence  exists  on the  costs  of  government  programs,
commercial  providers  consider  costs  proprietary  information,  and  social
marketing  programs  have  never  been  costed  out. The  NGOs have  probably  the  most
available  cost  data,  although  it is  virtually  always  incomplete  and  only
available  for  some  endeavors.  The  majority  of this  evidence  is  compiled  in
Levis  (1985).
The lack  of cost  information  prevents  comparisons  of the  cost  effectiveness
of alternative  financing  and  delivery  arrangements.  No guidance  is  available  on
the  most  efficient  means  of delivering  family  planning  to  different  income,
location,  education,  and  age  groups. Even the  industry-based  programs  have  by
and  large  ignored  the  (full)  cost  of their  programs. For  example,  there  are  no
plans  to  compare  costs  and  effectiveness  across  projects  to  determine  the  best
approaches  to  fostering  demand  for  family  planning  or promoting  activities  by
the  private  sector. Cross-project  evaluations  are  neither  mandated  by  any
project  nor  anticipated  by  any  entity. Assessing  the  costs,  effectiveness,  and
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savings  (e.g.,  to firms)  across  experigents  vould  assist  the  next  generation  of
projects  avoid  pitfalls  and  focus  on the  most  valuable  project  designs  of the
projects  revieved  in this  study. Only  the  Philippines'  Philippine-Hawaiian
program  measured  company  costs  and  savings  of the  family  planning  effort,  but
even there,  no contraceptive-costs  are  included,  since  commodities  were  donated
Some  new  projects  plan to  do impact  evaluations,  but  none  has  even  begun. The
lack  of  analysis  will inhibit  their  ability  to  measure  the  savings  from  family
planning  service  delivery,  and  prevent  comparisons  across  alternative  delivery
arrangements.
Thus,  collection  of cost  information  and  assessments  of relative  efficiency
and  effectiveness  is  key to  helping  donors  and  policymakers  make  sound  decision
regarding  resource  allocations  and  program  design. Currently,  little
information  is  available  to  assist  that  process  in family  planning.
The  private  sector  is  a  major  actor  in family  planning--and  its  actual  and
potential  role  should  be  much  better  understood.  The  future  agenda  should
address  the  gaps  in information  regarding  consumer  behavior  and  consumer  demand
for  private  services;  introduce  greater  rigor  in  analysis  of existing  data
(e.g.,  CPS  and  DHS  data);  collect  specific  data that  can  address  the  topics  suc
as cost  and  cost  effectiveness  of  alternative  providers;  introduce  sound
evaluations  into  planned  or initiated  efforts  aimed  at promoting  the  private
sector;  experiment  with  and  document  alternative  means  for  establishing
effective  incentives  to  promote  private  activity;  experiment  with  and  assess
privatization  of public  services;  and,  introduce  greater  cost  recovery  in  NGO
programs.
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Sumary  of  Key  Private  Sector  Approaches  in  Family  Planning
AFRICA
Ghana:  Social  Marketing  Program,  Ghana
Funding  From: USAID SONARC  Project
Source:  SOMARC  Reports
The  Contraceptive  Social  Narketing  (CSM)  program  in  Ghana  is implemented
by  a Ghanian  commercial  firm  (DANAFCO)  that  sells  oral  contraceptives  without
prescriptions  at pharmacles  and  chemist  shops  wnere  personnel  have  received
special  family  planning  training.  DANAFCO  will  subcontract  advertising  and
promotion  to  Lintas  Ghana,  a local  ad agency. Pharmahealth  Ltd.  will  train
pharmacists  and  chemical  sellers  to  sell  oral  contraceptives  and  other  family
planning  products  provided  by  AID. Three  products  will  be  marketed  initially:
an  oral  contraceptive,  a foaming  tablet  and  a  condom. Because  of the  low  rate
of contraceptive  prevalence,  (12.4  percert  of  married  women  of reproductive
age  are  currently  using),  the  potential  CSM  market  is  estimated  to  be  quite
large.  SOHARC  thus  intends  to  increase  oral  contraceptive  prevalence  in
urban  areas,  from  7 percent  to  10  percent.  The total  number  of  urban  women  of
reproductive-age  is  842,000.  Total  urban  men  over  age  15  is  937,000. A
retail  audit  will  be  used  to  develop  a pricing  strategy. Estimated  prices  are
C 10 for  a package  of four  condoms,  C 30 for  three  cycles  of pills  and  C 20
for  one  package  of foaming  tablets.  Estimated  budget  for  the  program  is
$1,000,000  spend  over  4 years  ($250,000  for  the  first  year,  $310,000  for  the
second,  $295,000  for  the  third  and  $170,000  for  the  fourth).
Market  researc..  conducted  prior  to  product  launch  will  include  a consumer
intercept  interview  of  600  contraceptive  users,  name  testing,  focus  groups,
package  testing.  Contraceptive  sales  and  usage  vill  be closely  monitored
through  periodic  retail  audits,  in-pack  coupons  to  identify  nev  buyers  and
provide  a crude  measure  of  side  effects  and  a longitudinal  study  of  CSM
customers.  A monitoring  program  vill  evaluate  the  results  of the
demonstration.
Training  for  pharmacists  and  retail  sellers  began  in  March  1986,  vith
virtually  100  percent  participation  for  pharmacists  and  41 percent
participation  for  chemical  sellers.  The  project  will  examine  how  well
phrmacists  and  chemical  sellers  screen  women,  especially  first  time  oral
contraceptive  users. Ghana  currently  has  a prescription  requirement  on oral
contraceptives  and  it  is  hoped  that  the  trained  chemical  sellers  and
pharmacists  will  effectively  convey  to  potential  users  the  likely  side  effects
and  advise  vomen  for  vhom  strong  contraindications  are  present  that  they
should  see  a physician  before  issuing  the  orals..A-2
Nigeti;  LBN  Employee  Clinic  Family  Planning/Child  Spacing  Program
Funding  From: USAID  Enterprise  Program
Source:  Proposal  Prepared  by Lever  Brothers  Nigeria,  Ltd.
Lever  Brothers  Nigeria  Ltd.  is  a manufacturer  and  marketer  of  soaps,
detergents,  edible  products  and  personal  products.  It is  requesting  $35,500
from  the  Enterprise  Program  (out  of  a total  budget  of $114,070)  for  a family
planning  program  at its  existing  clinics  In  Apapa,  Agbara  and  Aba  vhich  serve
3,000  employees.  Its  program  vill  also  be  used  in three  clinics  serving  1,600
employees  at United  Africa  Company  (UAC),  LBN's  sister  company. LBN  projects
800  nev  acceptors  out  of the  target  population  of  4,600  employees  currently
served  by the  clinics. It  vill  also  train  its  clinic  staff  in family  planning
motivation,  contraceptive  distribution  and  program  management,  and  develop  a
system  to  evaluate  and  monitor  the  program.
LBN  vill  serve  employees'  families  through  outreach  and take-home
components.  LBN  vill  tailor  the  program  to  employee  needs  by  using  results  of
focus-group  intervievs,  user  surveys  (KAP)  and  marketing  studies  (TIPPS)  of
the  workers'  attitudes  and  preferences  regarding  family  planning. Nursing
staff  and  medical  directors  will  receive  training  in  all  contraceptive
methods:  pill,  IUD,  condom,  vaginal  foam,  diaphragm,  injectible,  natural
family  planning  and  sterilization.  The  estimated  number  of potential  female
acceptors  is  721.
LBNI  clinic  nurses  and  motivators  vill  be trained  by Planned  Parenthood
Federation  of  Nigeria  (PPFN),  the  Lagos  University  Teaching  Hospital  (LUTH)
and  Sterling  Products  Ltd. LBN's  medical  director  has  already  seen  other
family  planniag  programs.  Tvo  staff  nurses  and  one  nursing  sister  have
already  been  certified  in  IUD  insertion.  Personnel  managers  have  attended  a
seminar  on the  importance  of family  planning.  The  program  vill  also  be
supported  by field  vorkers:  in-plant  motivators  and  educators  selected  from
among  the  medical  units'  "first-aiders"  and  the  workforce  at large. LBN  will
obtain  pills,  condoms  and  foaming  tablets  from  Sterling  Products  Ltd.  at
vholesale  prices: 60  kobo  for  one  cycle  of pills,  32  kobo  for  foulr  foaming
tablets  and  32 kobo  for  four  condoms.  The  contraceptives  will  be  sold  either
at cost,  less-than-market  mark-up  or .reely  distributed,  depending  on  LBN's
management  decision. USAID/Lagos  or the  Enterprise  Program  will  supply  other
commodities:  1040  cycles  of pills,  11,520  condoms  (plus  10,000  for  community
sales),  240  injections,  320  IUDs,  2880  foaming  tablets  and  eight  medical  kits
for  sterilization.  This  supply  is  based  on six  months  for  760  new  acceptors.
(Since  the  program  is  new,  even  previous  users  will  be considered  nev
acceptors.)  The  nursing  sister/program  coordinator  vill  distribute
commodities.  The projected  product  mix  based  on the  KAP  study  will  be  2n
percent  pi!.ls,  40  percent  IUds,  10  percent  Depo-Prevora,  25  percent  barrier
methods,  ! percent  natural  family  planning. Patients  will  be referred
elsewhere  for  services  such  as voluntary  sterilization.  Emphasis  vill  be
placed  on  male  acceptance  of family  planning.A-3
Nigerias  Sterling  Products  (Nigeria)  Private  Sector
Family  Planning  Project
Funding  From: Family  Planning  International  Assistance
Source:  Private  Sector  Family  Planning  Project,
Project  Description  and  Budget,  FPIA
The  project  aims  to  increase  the  distribution  of  contraceptive  products
and  services  through  two  distinct  channels.  First,  Sterling  Products  Nigeria,
a  pharmaceutical  firm  vith  production  facilities  in  Nigeria  and  an  established
network  that  distributes  its  full  line  of  pharmaceutical  products  through
Nigeria,  has  decided  to  add  contraceptive  products  to  the  products  it  sells  to
its  vide-reaching  retail  outlet  netvork.  Its  115  distributors  in  the  19
states  of  southern  Nigeria  added  pills,  foaming  tablets,  and  condoms  to  the
products  sold  to  the  several  thousand  retailers.  Sterling  is  already  well
positioned  in  the  family  planning  arena  as  it  handles  the  distribution  of
contraceptive  products  in  the  public  sector.  In  the  first  four  months  of
project  activity,  an  average  of  1.25  million  condoms  and  125,000  pill  cycles
had  been  distributed  per  month  in  19  rather  than  just  11  states.  The  sales
from  contraceptives  had  generated  NB  700,000  in  the  period  with  20  percent  of
the  revenue  meet  operating  costs  and  the  vent  into  other  family  planning
projects.  An  estimated  30  percent  of  Nigeria's  chemist  shops  and  pharmacies
had  received  and  sold  contraceptives  as  part  of  the  project.
The  second  effort  aimed  at  increasing  family  planning  acceptance  is  to
convince  private  companies  in  Lagos  to  add  family  services  to  their  already
existing  health  services.  The  training  of  company  educators  and  nurses  is
paid  for  by  the  project  vhile  the  private  companies  pay  for  enlarging  the
scope  of  health  care  provision.  The  middle-income  employees  and  their  spouses
are  the  projected  target  group.  Seminars  on  the  productivity-enhancing
aspects  of  offering  family  planning  services  to  employees  were  given  to
personnel  managers.  Nurses  and  doctors  from  36  organizations  vere  trained  in
family  planning  services  and  24  companies  added  these  services  to  their  health
services.  In  the  long  term,  the  project  aims  to  train  more  than  1,000  nurses
and  educators  and  30  doctors.  Contraceptives  vere  provided  free  at  the
factory  clinics.  Factories  covered  some  of  the  costs  of  the  family  planning
services.
The  success  of  the  privately  distributed  products  vas  partly  undermined
by  the  free  pills  from  pubic  health  facilities  that  found  their  way  to  the
commercial  outlets,  offering  competition  vith  the  Sterling  pills.  Addi-
tionally,  because  the  foaming  tablets  vere  in  limited  supply,  they  vere  not
Incorporated  in  the  distribution  effort.  It  is  maintained  tIat  thle prngraw
had  almost  become  self-supporting  by  the  end  of  its  first  funding  period,  and
It  vas  anticipated  that  a  surplus  vould  be  produced  that  could  be  used  tc
finance  other  family  planning  projects.  Hovever,  given  that  the  commodities
are  donated,  It  is  not  clear  whether  revenues  from  the  project  cover  all
costs,  or  if  only  operating  costs  are  covered.
The  existence  of  a  vell-developed  and  functioning  distribution  system
that  reaches  chemist  shops  and  pharmacies  that  are  dispersed  throughout  the
country  seems  key  to  the  usefulness  of  this  model  for  application  to  otherA-4
countries.  Given  such  a  system,  more  Information  would  be needed  on the
commercial  profitability  of the  effort,-cost  of  distribution  and  mark  up  at
each  stage  of the  distribution  chain  and  the  mark  up taken  by  each  agent  to
assess  its  long  term  sustainability  vithout  subsidy  or  at least  determine  what
kind  of  subsidy  vould  be  necessary.
This  vas  anticipated  as  a five  year  project,  with  a committed  three  year
funding  period: June  of 1985  to  October  30,  1986. It vas  extended  to
November  1,  1986  then  to  February  29,  1988
ASIA
Bangladesht  Family  Planning  Services  for  Industrial  Workers
Funding  From: Pathfinder  Fund
Source:  Pathfinder  Proposal
Two  family  planning  clinics  were  planned,  one  at Adamjee  Jute  Hills  and
one  at the  Labor  Velfare  Center  in  Srimangal.  Eight  field  vorkers  provide
outreach  services  at each  cite. Each  field  vorker  vill  be  responsible  for
referring  at least  12  clients  per  month  to  the  clinics  (four  for  steriliza-
tion,  five  for  IUDs,  three  for  injectibles  and three  for  condom/foam).  Field
workers  will  receive  Tk 200  per  month  plus  referral  fees  for  sterilization  and
TUDs. Clinics  will  be  opened  for  six  days  a  veek,  from  8:30  am to  3:30  p.m.
Each  clinic  vill  have  a female  counselor,  a  clinic  coordinator  and  a technical
committee  which  will  meet  every  three  months.
Funding  from  Pathfinder  was  $30,426  in 1977-78,  $23,437  in 1983-84,  and
$26,696  vas  requested  for  1987-88. Funding  from  Pathfinder  was  requested  in
1987  to  continue  the  clinic  services  in  Admajee  and  Srimangal.  From  March  to
October  1986,  the  clinics  performed  598  sterilizations,  278  IUD  insertions  and
distributed  288  injectibles,  2640  cycles  of  pills  and  38,206  condoms. During
1987-88,  1,100  sterilizations  are  expected. Immunization  will  also  be
provided  to  women  and  children  under  two. Contraceptives  are  provided  by the
Ministry  of Health  and  Population  Control. Evaluation  vill  be  based  on
progress  reports,  quarterly  financial  reports  and  summaries  of technical
committee  findings. An  Evaluation  Reviev  Committee  in  Boston  will  evaluate
the  project  at  midpoint.
No mention  is  made  of costs  to  individuals.
Indonesia:  Feasibility  Research  into  a  Commercial  Cliniic
Providing  Sterilization  Services  in  Jakarta
Funding  from: USAID  Enterprise  Program
Source:  Project  Proposal
The  Enterprise  Project  is  supporting  three  different  projects  in
Indonesia  that  attempt  to  increase  the  role  of the  private  sector  in  meetingA-5
the  family  planning  needs  of  Indonesians.  The  original  impetus  for  the
project  came  from  the  recognition  by the  Indonesian  government  that  the  family
planning  needs  of Indonesians  could  not  be  met  through  exclusive  reliance  on
the  public  sector. In 1983,  the  public  sector  supplied  94 percent  of the
contraceptive  services. Vhile  the  government  hopes  that  contraceptive
acceptance  vill  double  betveen  1980  and  the  year  2000,  it  is facing  budget
constraints  that  limit  the  expansion  of  government  services. Curiously,  rural
contraceptive  prevalence  rates  exceed  urban  rates. Complaints  about  the
public  health  system  in  urban  areas  center  around  the  inconvenient  and  short
hours,  the  long  vaiting  times,  the  shortage  of  contraceptive  products  and  the
suspicions  about  the  quality  of the  free  products  at the  public  clinics. Each
one  of the  three  projects  aims  to  tap  the  resources  of the  private  sector  and
to  exploit  the  villingness  to  pay  for  health  services  that  exists  among  the
middle  income  class  in  Indonesia.
The first  project  involves  assessing  the  viability  of  a self-sustaining
commercial  elinic  for  sterilizations  in  Jakarta. The  project  will  gather
evidence  on--fist,  the  attitudes  of likely  candidate  couples  (married  couples,
already  practicing  contraception  in their  late  thirties)  tovard  villingness  to
pay  for  sterilization;  second,  the  likelihood  of physicians  referring  patients
for  sterilizations  and  third,  the  costs  of  outfitting  and  maintaining  a
clinic. The  outcome  of this  analysis  is  an assessment  of the  viability  of a
comercial sterilization  clinic. The  budget  is  $24,000.
Indonesia:  The  P.T.  Gamay  Djaja  Family  Planning  Program
Funding  from:  USAID  Enterprise  Program
Source:  Project  Proposal
The  second  project  is  intended  to  be  a model  example  of  ;ov  employees  and
employers  alike  benefit  from  family  planning  services  provided  on site. P.T.
Gamay  Djaja,  a firm  vith  1,300  employees  has  agreed  to  provide  daily  family
planning  service  on the  premises.  The firm  will  absorb  the  costs  for
renovating  rooms  for  the  service  provision  and  vill  provide  the  necessary
furniture.  The  Enterprise  project  vill  provide  technical  assistance,  equip-
ment  and  supplies,  and  a full-time  nurse  midvife  and  part-time  physician  for
the  first  two  years  after  which  responsibility  vill  be  assumed  by  P.T.  Gamay
Djaja. The  BKKBN  (the  Indonesian  family  planning  board)  will  provide  the
contraceptive  products  free  of charge  the  first  year  and  The  Enterprise
project  together  with  the  BKKBN  vill  provide  the  contraceptives  free  of charge
In the  second  year. Success  of the  project  vill  be  measured  in terms  of new
acceptors  and  continuation  rates. No mention  is  made  of employee  contribtu-
tions  or of  estimating  the  net  cost  to  the  firm  of continuinig  to  piovJdIe  tIte
services. The  estimated  budget  is  $25,180.A-6
Indonesia:  The  YRK  Entrepreneurial  Development  Project
Funding  from: USAID  Enterprise  Program
Sources  Project  Proposal
The  third  project  involves  determining  both  the  best  location  in  Jakarta
and  the  optimal  operating  and  service  structure  of  a family  planning  clinic
offering  gynecological,  maternal  and  child  health  service  to  an  upper  middle
income  clientele  so that  the  clinic  vould  generate  a profit. the  Enterprise
Project  is  collaborating  vith  the  Yayasan  Kusma  Buana  (YKB),  an  Indonesian
Private  Voluntary  Organization  that  has  run  8 family  planning  clinics  in
Jakarta  for  the  last  several  years  to  drav  up the  plans  for  the  nev  clinic  and
to  make  the  other  clinics  more  self-sufficient.  Of the  8  clinics,  only  one  is
self  supporting,  and  overall,  only  50 percent  of  costs  are  met  through
revenues.  Through  intervievs  with  actual,  past  and  potential  clients  and
staff,  attempts  vill  be  made  to  understand  the  lov  utilization  and  revenue
levels  of some  of the  clinics. It is  felt  that  full  cost  recovery  may  not  be
possible  because  some  of the  clinics  are  located  in lower  middle  income  areas.
Ultimately,  it is  hoped  that  cross-subsidization  across  clinics  can  lead  to
overall  self-sufficiency.  It is  not  clear  vhether  their  definition  of self-
sufficiency  encompasses  clients  paying  for  the  contraceptive  products  because
it  appears  that  the  BKKBN  donates  commodities.  The  Budget  is $10,552.
Philippines: Industry-based  Family  Planning  Project  (Manila)
Funding  from: Population  Center  Foundation
Source:  Final  Technical  Report
In an 18-month  project  begun  in  1985,  30 industrial  establishments  in
metro  Manila  used  a program  developed  by the  Population  Center  Foundation  to
use  in-plant  volunteers  (IPVs)  to  generate  demand  for  family  planning  informa-
tion  and  services. IPVs  vere  trained  vith  lectures  seminars,  audiovisual
presentations  and  other  materials.  FP  services  vere  made  available  to
employees  either  in  company  clinics  or through  outside  FP  service  clinics.
Outside  clinics  either  brought  services  to the  company,  or provided  services
through  referrals.
Family  Planning  Organizatien  of the  Philippines  (FPOP)  sent  a surgery
unit  to  firms  to  perform  vasectomies.  Contraceptive  starter  packs  (pills  or
condoms)  vere  donated  by  manufacturers  for  users'  first  visit. Acceptors
subsequently  purchased  contraceptives  from  drug  stores.
IPVs  vere  recruited  from  among  employees  vho  were  using  family  planning,
and  received  a 10  hour  orientation.  Refresher  courses  were  offered  monthly.
IPVs  approached  vorkers  to  discuss  family  planning,  then  referred  them  to the
company  clinic  nurse. Group  activities,  such  as  lectures  and  seminars,  vere
held for  interested  employees  at least  once  a month. Most  activities  were
held  during  breaks  from  vork. The  project  staff--five  project  officers  and  a
project  coordinator--vere  trained  to  act  as resources  on FP  and  to  provide
support  and  guidance  to  IPVs. Their  course  lasted  for  12  days;  three
refresher  courses  vere  offered.A-7
A  mid-assessment  of  the  study  included  intervievs  with  a  random  sample  of
HWiAs  from  30  companies,  and  10-16  IPVS  from  each  company.  The  end  of  project
status  was  compared  to  baseline  data. Results  indicated  that  family  planning
Increased  In  all  but  three  of  the  companies.  Total  acceptors  enrolled  in  the
project  vere  2,844,  out  of  a total  combined  vorkforce  of  22,000.
Thailands  Pactory-Based  Family  Planning  Services  Project
Source:  Proposal  Prepared  by  The  Population  and
Community  Development  Association
Funding  fro-st  USAID  Enterprise  Program
The  Population  and  Community  Development  Association  (PDA)  has  been
offering  family  planning  services  since  1974.  Through  its  sales  of  non-
clinical  birth  control  in  drug  stores,  clinics  and  factory  health  centers,  it
generates  funds  to  pay  for  rural  family  planning  programs  and  other  social
services  in  Thailand.  PDA  is  requesting  34,953,000  ($190,500)  to  supplement
its  own  expenditure  of  B1,816,237  ($69,855)  for  a two  year  project  to  expand
and  improve  its  existing  factory-based  family  planning  services.  The  improve-
ments  vill  include  developing  a  Management  Information  System  to  increase
efficiency  and  aid  in  evaluation.  PDA's  existing  factory  program  involves
both  on-site  clinics  and  mobile  clinics.  In  the  on-site  clinics,  a factory
employee  is  trained  by  PDA  to  distribute  pills,  condoms  and  foaming  tablets.
The  mobile  clinics  will  also  distribute  clinical  methods  to  factories  with  on-
site  clinics  and  the  full  complement  of  services  to  those  without.
PDA  proposes  to  improve  its  services  in  three  ways. First,  it  will
streamline  and  focus  delivery  by  conducting  a  KAP-like  survey  to  determine
actual  need  for  services.  Records  will  be  established  of  the  sex  and  age  of
continuing  and  new  acceptors.  PDA  expects  to  be  able  to  market  its  service
more  effectively,  increasing  its  sales  of  contraceptives  to  factory  employees
and  serving  15  percent  more  acceptors  in  the  first  year. Its  second  goal  is
to  add  200  new  factories  to  the  219  it  already  serves  (180  more  in  Bangkok,  10
each  in  Chiang  Mai  and  Nakhon  Ratchsima).  A  survey  of  factories  will  identify
more  than  300  potential  factories  and  their  family  planning  needs  to  target
those  that  could  best  use  PDA's  services.
The  Management  Information  System  (MIS)  will  enable  PDA  to  provide  more
detailed  data  on  the  costs  of  products  and  services  which  will  help  to
identify  cost  savings  opportunities  in  production,  set  prices  and  develop
marketing  strategies,  and  identify  an  appropriate  portfolio  of  products  and
services.  Expanding  and  refining  its  management  information  and  financial
management  systems  will  identify  cost  saviigs  atil  detet  mine  a  more pl tiltnli
package  of  services.  A  management  information  team will  assess  PDA's manage-
ment  information  needs  by  interviewing  managers  and  technicians.  Two  training,
sessions  will  be  held:  one  for  technicians,  and  one  for  managers.  Consultant
services  vill  be  hired  to  aid  in  system  design  and  evaluate  the  system  after
implementation.
PDA  intends  to  provide  IUDs,  injectibles  and  vasectomies  through  mobile
clinics.  On-site  clinics  will  distribute  brochures  explaining  the  PDA  mobile
unit. Volunteer  distributors  will  coordinate  mobile  clinic  visits,  andA-8
register  employees  for  services. Employee  organizations  and  trade  unions  will
be recruited  to  facilitate  promotion  of-the  project.  PDA  will  have  a project
staff  vhich  vill  recruit  factories  and  volunteer  distributors  (motivators)--
training  distributors  in  groups  of  40.  Training  materials  for  the
distributors  will  be  based  on needs  determined  by the  initial  surveys  of
factory  employees  and  distributors  coordinator.  Training  vill  emphasize
motivating  acceptors,  distributing  non-clinical  birth  control  and  promoting
mobile  services. Project  staff  vill  keep  records  on  usage  in  all  factories
and  review  the  project  at the  end  of the  first  year. Volunteer  coordinators
will  resupply  distributors  vith  non-clinicaL  birth  control.
PDA  expects  that  most  of the  users  vill  be  vhite  collar  male  workers.
The  goal  of its  model  program  is to  provide  more  services  at a lower  cost  to  a
larger  number  of people.  In order  to  implement  the  project,  PDA  is requesting
638,950  cycles  of birth  control  pills,  7,675  dozen  condoms,  500  packs  of
foaming  tablets  and  7,800  IUDs. PDA  provides  no  estimates  of fees  charged  to
users.
Thailand:  Family  Planning  Products  Market  Survey  and
Marketing  Capability  Evaluation
Funding  from: USAID  Enterprise  Program
Source:  Proposal  Prepared  by  Population  and
Community  Development  Association,  Thailand
The  Population  and  Community  Development  Association  (PDA)  has
distributed  birth  control  devices  in  Thailand  for  12  years. Mechai  Viravaidya
founded  PDA  as the  Community-Based  Family  Planning  Service  (CBFPS)  in  1974  to
address  the  unmet  need  for  contraception  in  Thailand. PDA  sells  family
planning  products  through  drug  stores  and  clinics,  and  uses  the  revenues  to
finance  some  of its  family  planning  and  other  community  programs. PDA
recruits  residents  of communities  to  distribute  contraceptives  and  provides
family  planning  services  in  clinics  and  family  planning  centers,  school  health
programs,  counseling  services,  institutional  programs  and  a mobile  vasectomy
service.
PDA's  condom  marketing  program  generates  income  to  support  the  rural
family  planning  programs.  Condoms  are  distributed  in towns  and  cities  through
drug  stores  and  clinics;  pills  are  distributed  in  rural  areas  through  PDA's
family  planning  volunteers.  (The  government  family  planning  program  supplies
rural  areas  with  condoms.) In urban  areas,  PDA's  price  to  merchants  is  almost
tvice  that  of other  distributors,  who  must  then  raise  the  price  charged
customers.  Of the  three  types  of  PDA  condoms  available  to  customers  from
retailers,  the  cheapest  is  given  to  PDA  free  of charge  from  IPPF,  re-packaged
and  sold  over  the  counter  at three  for  35 ($US  $.19).
PDA  wishes  to  improve  the  efficiency  and  effectiveness  of its  family
planning  products  marketing  programs  and  proposes  to  evaluate  its  own
marketing  capability  and  conduct  market  research  with  assistance  from  a
subcontractor  (Coopers  and  Lybrand).  The  project  vill  also  study  the  family
planning  products  market  in  Thailand  to  assess  the  demand  for  and  distribution
of  family  planning  products  and  explore  consumer  behavior  towards  family
planning  products.  Objectives  of  the  project  include  collection  of  informa-A-9
tion  about  the  market,  vhich  vill  be-used  to  develop  a strategy  for  husiness
development  and  marketing--including  the  market  for  contraceptive  methods
other  than  the  condom  and  the  pill. The  long-term  objective  is  to  lover  the
cost  and  increase  the  availability  of non-clinical  family  planning  methods.
Information  on distribution  will  be  gathered  from  existing  research  as  vell  as
through  interviews  vith  contraceptive  distributors.  Information  about
consumer  behavior  and  attitudes  vill  come  from  a survey  of  households  in
selected  cities  in  the  Northern,  Northeastern,  Central  and  Southern  regions  of
the  country.
PDA's  own  marketing  program  will  be  evaluated  to  reduce  costs  and  re-
orient  the  program  as a commercial  activity. PDA  hopes  to  increase  usage  of
contraceptives  by improving  its  marketing  of condoms,  pills  and  spermicides
and  by  serving  new  markets. Coopers  and  Lybrand  and  PDA's  Research  and
Evaluation  Division  (RED)  vill  consolidate  findings  and  present  a recommended
business  plan,  which  will  include  specific  pricing  policies,  distribution
strategies,  promotional  efforts,  managerial  strategies  and financial
assessments.
From  its  market  survey,  PDA  will  determine  vhat  contraceptive  products  it
will  sell. The  total  budget  for  PDA's  market  studies  is  $59,038,  $55,000  of
which  is  requested  from  the  Enterprise  program.
LATIN  AKERICA  AND  CARIBBEAN
Bolivia:  Family  Planning  and  Health  Services
fo-r  Organized  Workers
Funding  from: Pathfinder  Fund
Source:  Proposal  Prepared  by  Consultora  Boliviana
de  Reproduccion  Humana  (COBREH)
Family  planning  services  will  be provided  to families  of organized  mine
workers  in  the  Altiplano  region  of  Bolivia:  La  Paz,  Oruro  and  Potasi.
Information  and  services  will  be provided  to  20,000  families  that  currently
have  no access  to  family  planning,  and  about  5,000  new  acceptors  are  expected
in the  first  year.  Three  clinics  will  be  established  and  27  MOH  physicians
vill  be trained.  The  project  has  been  undertaken  at the  request  of the  labor
systems  in Latin  America,  which  is  primarily  composed  of  members  of the
Miners'  Labor  Unions.
Awareness  of  the  service  will  be prnmoted  through  T.&C and cnmmutnity
activities:  volunteer  promoters,  trained  clinic  staff  and  pamphlets.  MOH
physicians  will  be trained  to  provide  family  planning  services  (pills,  IUDs,
foams  and  condoms),  and  equipment  and  educational  materials  will  be  purchased
for  the  project. Three  auxiliary  nurses  and  three  field  workers  will  be
trained  in family  planning  education  and  in  record-keeping  skills. The  nurses
vill  provide  family  planning  services,  field  educators  will  train  volunteer
promoters.  Four  community  workers  will  be trained  to  provide  family  planning
counselling  (including  home  visits)  to  210  volunteer  promoters,  who  will  be
selected  from  members  of local'mothers'  clubs. All  clinics  will  provide  free
services  and  subsidized  contraceptives.A-10
Prices  for  the  contraceptives  vill  be  BS 1.00  (IIS  $.54)  using  1986
exchange  rate  US $1  - BS 1.86)  for  one-cycle  of pills  or 20 condoms  or  one  can
of foam,  and  BS 5.00  (US  $2.68)  for  one  IUD. The  OH physicians  vill  provide
services  in  MOH  hospitals  and  maternity  clinics,  and  are  supposed  to  receive
unspecified  non-monetary  incentives.  Voluntary  promoters  vill  talk  to  people
in their  neighborhoods  and  refer  them  to  informational  talks  given  by field
educators.  Community  workers  vill  follov-up  with  clients  who  have  not
continued  with  services.  The  La  Paz  clinic  staff  and  facility  will  be  used  to
train  physicians,  nurses,  community  workers  and  field  educators.  Three  clinic
physicians  vill  be trained  in  family  planning  services  and  IUD  insertion,  as
will  the  27  MOB  physicians.  Field  educators  will  train  volunteer  promoters  in
techniques  to  promote  the  benefits  of family  planning.
Evaluation  vill  be  based  on the  amount  of  educational  materials
developed,  the  number  of trained  vorkers,  the  number  of referrals  to  clinics
and  the  amount  of contraceptives  distributed.  Monthly  reports  and  user  feed-
back  vill  form  the  basis  for  the  evaluation.  The  estimated  budget  BS 195,658
(US  $105,192)  from  Pathfinder  Fund  and  BS 65,464  ($35,212)  from  COBREH.
Boliviat  Family  Planning  Program  Through  Employers
Funding  from: USAID  Enterprise  Program
Source:  Centro  de  Investigaciones  Sociales,  La Paz,  Bolivia
The "Centro  de  Investigaciones  Sociales"  (CIS)  or Social  Research  Center
in  La  Paz  proposes  a project  to  promote  family  planning  for  working  vomen  in
the  four  largest  cities  in  Bolivia. It consists  of  an integrated  program  of
research,  education,  counseling,  and  direct  family  planning  services  to  be
implemented  through  the  industrial  and  commercial  sector.
CIS  has  chosen  working  vomen  because  of the  family  difficulties  that  this
group  frequently  encounters.  It  vill  contact  150-170  employers  and  plans  to
work  closely  vith  them  in the  planning,  education,  and  direct  implementation
of the  project. Through  concurrent  research,  CIS  hopes  to  demonstrate  the
indirect  benefits  to  employers  of these  family  planning  services  and  thus  to
encourage  industrial,  commercial,  and  banking  enterprises  eventually  to
establish  similar  projects.
The  project  vill  be implemented  by  an  education/promotional  team  in  each
of the  four  cities,  overseen  by  a central  coordinating  team  in  La  Paz  that
vill  ensure  consistency  and  quality. All  tasks  vill  be  implemented  in
conjunction  vith  a local  advisory  board  of industrial,  commercial,  and  hanlring
institutions.
The  research  component  of the  project  will  include  several  studies: pre-
and  post-tests  of family  planning  knowledge,  attitudes,  and  practices  will  be
administered  to  women  in participating  enterprises;  and  studies  on the  costs
of pregnancy  and  maternity  to  firms  and  the  social  security  system  will  be
undertaken  in the  hopes  of showing  the  savings  to  be  obtained  through  a family
planning  program.A-1l
The  latter  study  vill  be  based  on  a  number  of variables,  including  the
direct  costs  associated  with  payments  to  social  security  for  pregnancy  and
maternity,  the  indirect  costs  to  the  firm  of  absenteeism  and  replacement
vages,  and the  costs  to  the  family  or individual.  Another  planned  study  is  a
process  evaluation  of the  project's  components.
The information  and  education  component  will  sponsor  a series  of seminars
for  employees  on family  planning  and  general  welfare  and  vill  produce  promo-
tional  educational  materials.  CIS  expects  to  hold  close  to  200  seminars  for  a
targeted  group  of  6200  participants.  Seminars  will  be  mostly  for  vomen,  but
on  occasion  will  Include  men  and  with their  vives. The  seminars  will  be  held
in the  workplace.
As part  of the  project's  research,  pre-tests  will  be distributed  to  vomen
in the  various  participating  firms. Six  months  after  the  seminars,  question-
naires  will  be  given  to the  same  respondents  in  order  to  measure  attitude
change  and  the  educational  impact  of the  seminars.
Private  counseling  on family  problems,  especially  on reproductive
conflicts  and  family  planning,  vill  be  offered  in three  ways: 1) immediately
after  the  seminars;  2)  consultation  hours  in the  workplace;  3)  appointments  at
other  times  in  another  location.
The fourth  component  of the  project  will  be  direct  family  services  for
women  vho  vant  them. Services  vill  be  given  in  conjunction  vith  the  seminars
and  counseling.  CIS  projects  attracting  1560  nev  users. In  addition  to
these,  because  the  project  is  increasing  the  social  acceptability  of these
issues  and  is  promoting  changes  in  attitude  toward  family  planning,  CIS
predicts  a multiplier  effect  in the  communities  at large,  which  should
increase  contraceptive  services  to  3000  nev  recipients  vithin  a year.
Cost  of services  is  not  spelled  out  in  great  detail,  but  CIS lists  the
price  for  minilaparotomies  (tubal  litigation)  at US $60  (including  clinic,
lab,  and  medical  fees,  and  care  for  1 to  2  days)  and  "reversible  methods"  at
$5.  The  project  hopes  that  women  should  be  able  to  pay  some  portion  of the
cost  --  perhaps  only  3 to  5 percent  --  of the  contraception  and  medical
attention.  CIS  hopes  to  see  the  employers  continue  the  project  by
incorporating  these  services  into  their  medical  offices,  with  the  project
providing  these  contraceptives  for  an  undefined  period. Alternatively,  the
employers  could  contract  with  CIS  to  provide  these  services.
Brazil:  Assessing  Costs  and  Benefits  of Incorporating
Family  Planning  Service  Delivery  into  HM0
Funding  from: USAID  Operational  Research  Project  Implemented  by
Population  Council  and  Assistenia  Medica
a  Industria  e  Comercio  Ltda.  (AMICO)
Source:  Final  Report
Brazilian  HKOs  do not  generally  offer  family  planning  services.
Introducing  family  planning  into  the  HM0  netvork  would  make  these  familyA-12
planning  available  to  an  estimated  2  million  potential  users,  up to  90  percent
of whom,  should  they  be current  family  -lanning  users,  have  little  or  no
access  to  medical  back-up.  The  study  was  carried  out  in the  city  of  Belo
Horizonte,  capital  of the  state  of Hinas  Gerais.
Need  for  family  planning.  The  analyses  revealed  a clearly  perceived  need
for  adding  family  planning,  both  on the  part  of the  beneficiary  population
(women  ages  20-44),  and  on the  part  of the  services  providers  (physicians  with
whom  these  vomen  come  into  contact).  Fifty-two  percent  of the  women  not
currently  pregnant  have  already  met  or exceeded  their  desired  family  size,  and
another  26 percent  wish  to  delay  further  childbearing  for  two  years  or more.
Nevertheless,  only  55 percent  of the  non-pregnant  population  use  an  effective
contraceptive  method.
Although  the  beneficiary  population  have  already  achieved  low  fertility
levels,  through  high  contraceptive  practice  the  health  risks  incurred  in the
pursuit  of this  fertility  control  are  considerable.  Chief  among  them  are  high
rates  of induced,  illegal  abortion;  high  rates  of caesarian  delivery  to
accomplish  a simultaneous  tubal  ligation;  and  high  rates  of  pill  use  with
medical contraindications  for lack of access  to  other effective temporary
methods. In  addition,  42 percent  of  all  women  of moderate  to  high  obstetric
risk  are  not  adequately  protected  against  a future  pregnancy,  despite  the  fact
that  a majority  of them  also  do  not  want to  become  pregnant.
Feasibility  of offering  family  planning. Ninety-two  percent  of the  women
not  currently  pregnant  report  that  they  would  use  some  contraceptive  method  if
family  planning  vere  offered  by the  health  care  program. While  this  figure  is
unrealistically  high,  it  does  reflect  a strong  interest  among  the  beneficiary
population  in  receiving  these  services.-
More  conservative  projections  indicate  that  incorporation  of family
planning  services  would  both  increase  total  contraceptive  prevalence  and
improve  the  method  mix  of contraceptives  used  (i.e.,  substitute  more  effective
methods  for  less  effective  methods  and  safer  for  less  safe  methods).
Furthermore,  the  extra  demand  generated  by the  family  planning  services  could
be  handled  within  the  existing  institutional  capacity  in  Belo  Horizonte,
without  requiring  either  additional  staff  or additional  facilities.
The  physicians  surveyed  shoved  positive  attitudes  towards  incorporating
family  planning  services  delivery. Many  already  provide  these  services  on an
ai-hoc  basis,  and  even  more  would  participate  if  family  planning  were  formally
recognized  by the  health  plan.
Costs  and  benefits  of  offering  family  planning. Projections  indicate
that  incorporation  of family  planning  services  delivery  would  reduce  the
number  of births  covered  by the  health  plan  by  6 percent.  the  number  of
abortion  complications  treated  by  57 percent,  and  the  rate  of caesarian
section  delivery by 10  percent. Outpatient  service  utilization  in  gynecology
would  increase  by  6 percent,  and  utilization  of hospital  surgical  facilities
would  increase  by 7  percent.
Quantification  of the  benefits  to  cost  ratio  depends  on the  methodology
employed--marginal  costs  versus  opportunity  costs. Marginal  costs  were
adopted  because  at the  present  time  the  Belo  Horizonte  region  shows  unusedA-13
capacity  of 19  percent  in terms  of  physician  (ob/gyn)  time  and  35 percent  in
terms  of the  physical  plant. Estimation  of benefits  Is based  on contraceptive
user  targets  and  Is  uninfluenced  by  prevailing  market  conditions.  Estimation
of costs  is  based  on the  number  of acceptors  needed  to  achieve  these  user
targets  and is  sensitive  to  changes  in  market  conditions  (client  turn-over,
whether  or not  other  health  plans  also  adopt  family  planning).  However,  under
both  the  worst-possible  case  conditions  (high  client  turn-over  and  no other
HaOs  offering  family  planning)  and  under  best  possible  case  conditions  (low
client  turnover  and/or  family  planning  offered  by  all  health  plans)  a positive
benefits  to  cost  ratio  would  be  achieved  in the  third  year  of program
operations,  according  to these  projections.
Dominican  Republic:  Contraceptive  Social  Marketing
Funding  from:  USAID  SOMARC  Project
Source:  Contract  Prepared  by  SOMARC
SOMARC  and  La  Asosiacion  Dominicana  Pro  Bienstar  de la Familia
(Profamilia)  have  developed  a contraceptive  social  marketing  (CSM)  program  in
the  Dominican  Republic  (D.R.). The  project  will  be implemented  in two  phases.
The first,  which  is  already  undervay,  involves  marketing  of  a low  cost  oral
contraceptive  (Microgynon,  a Schering  brand  of orals)  procured  by Profamilia
and  sold  at just  over  US $1.00  (10/87  exchange  rate  for  DR $3.7  - U.S.
$1.00)--half  the  price  of  currently  available  contraceptive  pills. The  second
phase  would  introduce  a  new  product  line  of  AID  supplied  birth  control,  as
well  as brand-specific  advertising.  Phase  II  is  contingent  upon  receiving
exemption  from  the  country's  ad valorem  tax  on all  imported  goods  (including
contraceptives).  The  goals  of the  CSM  project  are to  increase  availability
and the  correct  use  of contraceptives,  and  to  document  such  increases.
The  CSM  market  in  D.R.  is  estimated  at  48,840  women. About  83 percent  of
users  are  expected  to  select  oral  contraceptives,  and  17  percent  to  use  either
condoms  or  vaginal  foaming  tablets.  The  current  market  for  condoms  is
estimated  at  4,000  men. Phase  one  concentrates  on marketing  low-cost  pills,
using  non-brand  specific  advertising  to  increase  awareness  of the  availability
and  acceptability  of  contraceptives.
SOMARC  originally  estimated  selling  250,000  condoms  to  2,500  men in the
first  year  of phase  two,  and  introducing  a second  type  of pill  as  well  as
foaming  tablets.  During  Phase  one,  SOMARC  determined  that  it  would  not  be
cost-effective  to  introduce  a second  pill. The  decision  to  sell  condoms  will
he based  on a demonstrated  market  need  for  them,  taking  into  consideration
tlint  tile  [ane  thar  condnms  leave  not  been  advertised  leftire  Iii  ghe  D.R.,  as
well  as the  fact  that  condoms  may  reach  young  adults  and  lower  socioeconomic
classes.
SOHARC  will  contract  with  Interprocon  to  conduct  a KAP  survey  of
respondents  following  on  a 1984  baseline  survey  of 1504  men  and  women.  Of
these  1504,  it  expects  to receive  responses  from  700. The  survey  will  be used.
to  determine  the  change  in  behavior  of  CSM  users  and  estimate  the  net impact
of  CSM  on contraceptive  prevalence.  SOMARC  also  intends  to  do a time  series
study  to  determine  the  substitution  effects  of a  CSM  oral  contraceptive.  OMSAA-14
has  been  selected  to  conduct  initial  market  research  evaluating  the  promo-
tional  campaign  for  Microgynon  (the  Phise  one  pill)  and  determining  the  extent
of  usage  of temporary  methods  for  child  spacing. In  addition,  market  research
will  be used  to  determine  if  Microgynon  is  reaching  the  lover  socio-economic
classes.
The  cost  of the  project  has  not  been  determined.
Nexicot  Family  Planning  Delivery  Strategles
ln  an Industrial  Setting  (Ciudad  Juarez)
Funding  frce:  USAID  Operation  Research  Project
Sources  Population  Council  Summary  and  PI Description
The  Materno-Infantil  y Plainificacion  Familiar  de  Ciudad  Juarez,
Chihuahua  (MIPFAC),  currently  provides  family  planning  services  towvorkers  in
maquiladora  (in-bond)  plants  on the  Mexican  Border  by training  and  supplying
plant-paid  nurses  working  In the  maquiladora  plant  clinics. The  plants  employ
10,000  yorkers,  60 percent  of  whom  are  women. Although  the  system  works
fairly  well,  the  grovth  of  MIPFAC's  current  service  delivery  strategy  has  been
hampered  by  several  problems. Included  among  these  are  that  often  plants  have
no clinics  or  medical  personnel,  many  plant  managers  do  not  accept  the
services  for  fear  it  might  interfere  vith  production.  Moreover,  medical
personnel  either  are  not  alloved  much  time  to  provide  the  services  or they
refuse  to  cooperate.
KIPFAc  proposed  to  implement  an  alternative  service  delivery  strategy
program,  employing  plant  vorkers  as promoters  to  be trained,  supervised  and
supplied  by MIPFAC. Its  previous  experience  suggests  this  was  a feasible
strategy. The implementation  of this  strategy  has  the  advantage  of  giving
MIPFAC's  current  program  much  greater  strength  and  flexibility  as both
strategies  can  be used  alone  or combined,  depending  on the  particular  service
delivery  problems  of  each  plant. A brief  contraceptive  use  prevalence  survey
will  be  conduced  in  8 of the  plants  (4 from  each  service  model)  in  order  to
establish  baseline  prevalence  of  service  delivery.  Another  brief  prevalence
survey  will  be  conducted  to  assess  program  effects  of  each  strategy.
Mexico:  Family  Planning  Services  at  IUSA's
Ernesto  Peralta  Quintero  (EPQ)  Industrial  Complex
Source:  Proposal  Prepared  by Industrias  Unidas,  S.A.
Funding  from:  USAID  Enterprisi  Pzogram
Industrial  Unidas,  S.A.  (IUSA)  is  an industrial  firm  with  9,000  employees
in  two  locations.  It produces  plastic  materials.  Alejo  Peralto,  owner  and
operator,  proposes  to  provide  family  planning  services  in  his  company  clinics.
The  first  service  will  be  provided  in  Queretero,  Mexico,  in  the  Ernesto
Peralta  Quintero  (EPQ)  complex.  The  program  will  be implemented  by  providing
family  planning  training  to  the  doctors  and  nurses  already  in the  company's
clinics. FEMAP,  a Mexican  Family  Planning  PVO,  would  supply  contraceptives
under  a subcontract.  IUSA  is  requesting  $83,000  for  start  up  costs.A-15
Mexican  Social  Security  Institute  services  are  located  too  far  from
IUSA's  factories  to  be convenient  to  lFs  vorkers.  The  program  has three
objectives.  The  first  is  reduce  the  birth  rate  at the  EPQ  complex  from  10.2
percent  to  5 percent  vithin  two  years. The  second  is to  cut  in half  the  vork
hours  lost  due  to  maternity  leave. The  final  objective  is to  provide  a  model
for  other  companies  to  follow. To achieve  these  goals,  IUSA  intends  to
refurbish  and  expand  its  medical  facilities  and  provide  education  in family
planning. A  month-long  family  planning  course  vill  be  offered  12 times  per
year for  industrial  workers  at  EPQ's  pre-training  school. (All  nev  hires
attend  the  pre-training  school.)  Three  six-veek  courses  vill  be offered  to
professionals  and  semi-professionals  in  groups  of 30 to  40.  Two  12-veek
courses  vill  be  offered  at the  technical  high  school  to  35  students,  most  of
vhom  vill  later  be  employed  by  IUSA. All  courses  vill  be  offered  to  mixed
groups  (men  and  vomen). Personal  counseling  vill  be  provided  as needed.
Although  IUSA  states  that  the  program  vill  train  doctors  and  nurses
already  in its  clinics,  it  appears  that  it  vill  hire  nev  staff  for  its  clir.ic
at  EPO. The  Project  Operations  Director  vill  be  an  obstetrician-gynecologist
vith family  planning  experience,  and  will  be  assisted  by  an assistant  nurse.
A social  vorker  vill  implement  educational  and  informational  activities  and
act  as liaison  between  education  and  social  services  as  vell  as assist  in
evaluation.  The  social  worker  and  the  physician  vill  conduct  classes  after
vorking  hours. An  anesthesiologist  vill  be  contracted  for  microsurgery.
Actual  services  vill  include  education  and  provision  of  family  planning
services,  including  an IE&C  program. MEXFAM  vill  train  the  physician,  nurse
assistant  and  social  vorker  in family  planning  and  evaluate  their  capabilities
aftervard.  The  program  will  be  evaluated  periodically  as to  benefits  to
employees  and  profitability  to  the  company. MWEXFA  vill  conduct  a KAP  study
of 150  IUSA  employees  and  develop  a monitoring  system  for  data  collection.  It
will  conduct  five  monitoring/evaluation  visits  during  the  project. Materials
for  courses  vill  be  obtained  free  of  charge  from  MEXFAM. After  revieving
results  of the  KAP  study,  the  social  vorker  and  projects  operations  director
will  determine  the  content  and  duration  of training  programs  for  nev
employees,  assisted  by  MEXFAH. The  KAP  survey  vill  also  be  used  to  determine
the  services  to  be  provided  by  the  clinic. A  monitoring  system  will  be
developed  by IUSA  and  MEXFAM  to  collect  data  on  costs  and  benefits. A second
KAP  survey  will  be  conducted  at  6 months  prior  to  the  end  of the  project  to
determine  changes  in  knovledge,  contraceptive  prevalence  and  pregnancy  rates.
It is  not  clear  vhat  contraceptives  vill  be  offered,  although  condoms,
IUDs  and  sterilization  are  mentioned.  No  mention  is  made  of  costs  to  users
for  the  contraceptives  or  counseling.A-16
Mexicos  Medical  Service  Microenterprises  in the  Metropolitan  Areas
of  Fast_Groving  Cities  (Mexlco  City,  Guadalajara,  Hont-errey,
ReMa,  oatzacoalcos,  Torreon,  Morelia,  Hasatlan,  and
UuMacan)
Funding  from: USAID  Enterprise  Program
Source:  Fundacion  Mexicana  para  la  Planeacion  Familiar  Proposal
This  project  hopes  to  generate  a network  of twenty  small  medical  enter-
prises  that  offer  health  services,  vith  special  focus  on family  planning  in  9
cities. The  network  should  be  self-financing  by the  end  of the  project. The
Fundacion  Mexicana  para  la Planeacion  Familiar  (MEXFAM)  vill  be  responsible
for  the  execution,  follov-up,  evaluation,  and  administration  of the  project.
The  Enterprise  Program  is  expected  to  participate  in  project  evaluation.
HEXFAM  has  selected  these  cities  because  their  populations  through
fertility  or migration  are  groving  at  a much  faster  rate  than  the  national
grovth  rate. In addition,  there  are  an estimated  60,000  unemployed  doctors  in
the  country  vhile  about  25 million  Mexicans  are  receiving  no health  care. The
goal  Is to  attain  20,000  family  planning  acceptors  in the  first  part  of the
project.
Tventy  sites  will  be selected,  based  on the  areas  vith  the  highest
poverty  and  population  grovth  levels,  and  the  fevest  medical  services. One
doctor  and  ten  family  planning  promotion  assistants  vill  be  chosen  for  each
site. In  addition,  each  promotion  assistant  vill  be  assigned  two  sites,  and
receive  financial  incentives  to  increase  the  number  of users  of  contraception.
In  addition,  a Health  Committee  (comprised  of the  community's  "moral
authorities")  vill  be formed  at each  site  to  act  as the  community's  liaison
with  the  project,  and  vill  eventually  take  over  the  basic  infrastructure  at
the  end  of the  project.
The  doctors  vill  be trained  in the  anatomy,  physiology,  and  methods  of
tamily  planning,  and  vill  also  receive  training  in  administration,  community
promotion  of family  planning,  and  the  operating  systems  of  HEXFAM.
Doctors  vill  set  up  convenient  consultation  hours  (no  further  details
available).  The  project  vill  procure  the  necessary  equipment  for  the  project,
but  will  pay  those  costs  for  the  first  year  only. MEXFA vill  pay  the  doctor
for  all  first-time  family  planning  visits,  and  in  addition,  vill  guarantee  a
minimum  of paid  visits,  decreasing  over  time  (from  120  visits  the  first  month,
to  5 In  month  24). The  doctor  vill  charge  patients  for  all  general  consulta-
tion  and  subsequent  family  planning  consultations.  It is  expected  that  by the
terminatlon  of this  project,  the  doctor  will  have  a regular  cliecitele.
Fees  have  been  set  for  specific  services  (ranging  from  a  family  planning
consultation  to  cycles  of birth  control  pills  or IUD  insertions),  vith
slightly  lover  fees  for  poorer,  marginal  areas. In  addition,  physicians  are
authorized  to  make  exceptions  in the  case  of  people  vho  cannot  pay  the  set
costs.
Some  of the  evaluation  criteria  to  be  applied  include:  number  of users
vho  continue  to  participate  in the  project,  the  time  that  it  takes  eachA-17
micro-enterprise  to  reach  financial  self-sufficiency,  and  hov  administrative
mechanisms  are  vorking.
The  estimated  budget  is  1150,039.
Mexico:  Self-Financing  Family  Planning  Project
Funding  from: USAID  Enterprise  Program
Source:  La  Academia  Hexicana  de  Investigacion
en  Demografia  Nedica  Proposal
Tvo  organizations  are  involved  in this  project:  La  Academia  Mexicana  de
Investigacion  en Demografia  Medica  (The  Mexican  Academy  for  Research  in
Medical  Demography),  a private  non-profit  research  group,  and  PROTA
(Proteccion  Anticonceptiva)  (Contraceptive  Protection),  an  organization  to  be
specially  created  for  this  project  and  which  vill  consist  of a  group  of at
least  five  associates,  an  advis,ry  board  and  a  president.  The  Academia  vill
function  as the  recipient  of  donations  of funds  and  con.-aceptives,  and  PROTA
will  develop  the  necessary  infrastructure  to  actually  ofstribute  the
contraceptives.
The  principal  idea  behind  this  project  is  that  the  continuity  of use  of
contraceptives  is  crucial.  The  project  thus  has  chosen  to  concentrate  on the
IU-  because  of this  high  level  of  continuity  and  its  effectiveness.  The
objectives  of the  project  are  to  improve  the  efficiency  of  private  family
planning  in-distributing  IUDs,  to  promote  the  project'  self-sufficiency,  and
to  gather  statistical  information  on IUD  users.
PROTA  vill implement  the  project  through  two  avenues: doctors  in the
Social  Security  system  (IMSS)  vho  also  have  private  practices,  and  family
doctors  vith  exclusively  private  practice.  PROTA  will  provide  tvo  services:
1) training  for  the.  doctors  on family  planning  in  general  and  IUD  insertion  in
particular,  and  2) the  provision  of IUDs  and  informational  material  for  both
doctors  and  patients.  An extensive  study  suggests  that  a total  of about  3600
doctors  will  participate,  of  whom  997  to  1703  vould  require  training.  PROTA
vill  be  providing  the  IUDs  to  the  doctors  in  private  practice  at the  lovest
possible  cost,  but  will  rely  on the  doctors  to  take  responsibility  to  ensure
that  the  total  fee  charged  to  the  recipient  (i.e.,  including  the  doctor's  fee)
is  as low  as possible.
The  proposal  gives  two  alternative  methods  for  charging  the  partieipating
doctors. In  Alternative  A, the  IUDs  will  be  given  free  of  charge  to  all
doctors  associated  with the  IMSS  and  assesses  a charge  or  donation  from  the
private  sector  doctors. In  Alternative  B the  obstetrician-gynecologists
within  the  IhSS  would  also  be.  charged,  the  assumption  being  that  the  incomes
of IhSS  recipients  are  higher  than  the  social  security's  general
practitioners.A-18
Because  a survey  vith  the  users  vould  be too  delicate  and  too  costly,  a
careful  controlled  evaluation  is  planned.  A random  number  of  doctors  vill  be
asked  to  provide  information  on  vhat  the  users  paid  for  the  consultation,  the
IUD  and  the  IUD  insertion.
The  project  vould  cover  four  years  and  vould  begin  in the  urban  Mexico
Valley  for  the  first  two  years,  gradually  expanding  to  include  the  rest  of the
country.
The  budget  for  the  first  year  is  US  $150,096  (using  an exchange  rate  of
470  pesos  to the  dollar). Equipment  costs  vere  not  included,  hovever,  because
it  vas  unclear  whether  these  might  be  covered  by the  Enterprise  Project.
Peru:  Blectrolima  and  Milpo  Family  Planning  Projects
Funding  from: TIPPS  Project  (USAID)
Source:  TIPPS  Proposal
TIPPS  has  designed  a project  to  interest  private  companies  in  family
planning. The  project  consists  of a country  assessment,  a business  analysis
(employee  survey  and  cost-benefit  analysis)  and  dissemination  of results  of
the  analysis. It  should  be  noted  that  the  TIPPS  project  does  not  provide
actual  family  planning  services,  but  rather  provides  a business  analysis  to
chairmen  and  Chief  Executive  Officers  (CEOs)  of  companies,  vhich  then  may
elect  to  offer  services.
The  first  "subprojects"  vere  at  Electrolima  and  Milpo  in  Peru. TIPPS
conducted  business  analyses  at these  companies  and  presented  the  results  to
the  Board  of  Directors  at each. Electrolima  decided  to  offer  family  planning
services  to  its  11,500  employees  and  dependents;  Milpo  decided  to  offer  family
planning  as part  of  a comprehensive  package  of prevent,ve  services  to  its
6,000  employees  and  dependents.
The  basis  of the  business  analysis  is  a cost-benefit  model  vhich  analyzes
fertility  behavior,  estimates  potential  family  planning  demand  and  projects
future  fertility  behavior  under  present  conditions  and  higher  contraceptive
prevalence.  Benefits  include  reduced  maternity  costs,  treatment  of  abortion
complications,  and  cost  of dependent  care,  among  other  things. Results  of the
business  analysis  indicate  positive  benefit/cost  ratios  at the  two  subprojects
(nine  to  one  at Hilpo,  five  to  one  at  Electrolima).  The  cost  at  Hilpo  for
four  years  of service  is  estimated  at $38,000.  The  cost  at  Electrolima  ranges
from  $23,800  to  $50,300,  depending  on  which  of three  models  is  used.
Employees  and spouses  at  both  companies expressed  desire  for  smaller  families
and  access  to family  planning  services.
After  determining  the  results  of the  business  analysis,  TIPPS  held two
conferences  for  CEOs  of  major  Peruvian  companies  to  disseminate  information.
After  the  two-day  regional  conference,  two  companies  (representing  a total  of
3,840  vorkers)  requested  assistance  in  implementing  a family  planning  program,
and three  companies  (9,478  vorkers)  requested  training  for  company  personnel.
TIPPS  expects  a large  spin-off  impact  from  its  project:  the  mining  industry  (
with  600,000  vorkers  and  dependents)  vill  "lead  the  vay"  in  offering  familyA-19
pl2nning. TIPPS  has  also  arranged  for  local  PVOs  (National  Family  Planning
Associations)  to  provide  fee-for-service  and  pre-paid  services  to  private
companies.
St.  Lucias  Contraceptive  Distribution  in  Factories  in  St.  Lucia
Funding  from: USAID  Operational  Research  Project
Source:  PIP  Excerpt  from  Landry,  Louisy  and  George  (1986)
Family  planning  services  In the  vork  place  can  be  convenient  and
effective. Between  1983  and  1984,  two  contraceptive  delivery  systems  were
tested  in factories  In  St.  Lucia. In the  experimental  factories  an  employee
in  each  vas  selected  and  trained  to  sell  oral  contraceptives,  condoms,  and
foam  and  to  ansver  questions  and  make  referrals.  A nurse  visited  twice  a
month  to  provide  back-up. In  other  factories  the  visiting  nurse  vas  the  only
source  of supplies  and  services. In the  factories  vith  an  employee  as
distributor,  contraceptive  prevalence  Increased  from  32 to  38  percent,  whereas
in the  factories  served  only  by the  nurse  use  actually  decreased  slightly.
NEAR EAST
Egypt:  HISR  Spinning  and  Weaving  Company
Hospital  Family  Planning  Research  Centre
Funding  from: Unknown
Sources  Presentation  by  Dr.  Sayed  Etman  --
International  Conference  on  Family  Planning
(New  Delhi,  1972)
In  1962,  two  family  planning  centers  were  instituted  for  the  workers  of
MISR  Spinning  and  Veaving  Company:  one  in  its  hospital  (which  serves  30,000
vorkers)  and  the  other  in the  company  workers'  village.  A committee  of
workers  was formed  to  encourage  participation  in  a variety  of family  planning
activities:  leaflet  distribution,  conferences,  lectures  and  plays. In 1967,
the  same  procedure  vas  used  in  73  villages  in the  Gharbia  province.  The
program  was  evaluated  in  1972  and  again  in 1980;  results  were  presented  by Dr.
Etman.
In 1976,  it  vas  determined  that  79.6  percent  of the  women  vho  had  aceess
to the  project  were  fecund. Of these,  38.1  percent  used  contraceptiven--84.8
percent  using  the  pill. Of those  who  were  not  using  family  planning,  bO
percent  wished  to  become  pregnant,  but  were  not  opposed  to family  planning.
In 1980,  it  was  determined  that  only  40.7  percent  of family  planners  used  the
pill,  compared  to  67.3  percent  in  1976.  Tubal  sterilization  was  used  more
frequently:  increasing  from  3  percent  of users  in 1973  to  8.9  percent  in 1980.
IUD  use  rose  from  24.9  percent  in  1976  to  47.6  percent  in  1980. Condom  use
decreased  from  1.9  percent  in 1976  to .5  percent  in  1980.
There  are  no indications  about  where  contraceptives  are  obtained,  how
much they  cost to  acceptors,  or other  specifics  about  the  clinics.A-20
Egypt:  Tanta  Industrial  Family  Planning  ProJect
Funding  froms  Pathfinder  Fund
Sources  Gharbiza  Family  Planning  Association
Under  a  project  proposed  in  1983,  Pathfinder  provided  $49,659  for  a
special  site  on  the  premises  of  the  Oil  and  Soap  Factory  in  Tanta  that  was
renovated  and  equipped  te  n-ovide  family  planning  services  to  factory  workers
and  their  families.  A  baseline  survey  was  conducted  to  determine  contracep-
tive  prevalence  at  the  factory.  A  project  supervisory  committee,  composed  of
the  factory  chairman,  the  association  director,  government  represertatives,
religious  leaders  and  a  doctor  was  to  meet  monthly  during  the  project  to
supervise  and  make  recommendations.  The  project  staff  received  a five  day
orientation  and  was  to  include  a  gynecologist,  internist,  nurse  social  worker,
financial  officer  and  secretary.
Services  provided  were  to  include  family  planning  group  sessions,
individual  counselling,  contraceptive  distribution  (barrier  methods,  pills,
IUDs),  referral  for  sterilizations,  MCH  and  other  general  health  services.  The
area  in  vhich  services  will  be  provided  is  rural,  agricultural,  and  mid  to  low
income.  The  project  will  serve  a  population  of  4,000  factory  workers  and  will
provide  services  during  working  hours.  The  objectives  are  to  obtain  baseline
data  on  contraceptive  prevalence,  to  provide  group  I  & E  sessions  to  1,500
participants  and  to  provide  contraceptives  to  2,000  nev  acceptors:  1,600  pill
users,  200  IUD  insertions,  100  female  barrier  users  and  100  condom  users.
Progress  reports  will  be  submitted  including  results  of  a  KAP  study,  a
time  schedule  for  implementing  all  project  activities,  a  quarterly  statistical
report  on  all  services  provided.  A  contraceptive  prevalence  survey  vill  be
conducted  at  the  end  of  the  project  and  compared  with  the  baseline  survey.
No  mention  is  made  of  contraceptive  prices  to  users,  or  where
contraceptives  will  be  obtained.
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The private sector might meet more of the  through commercial channels), and stimulants to
demand for contraception, thereby reducing  private sector investment in family planning.
government's subsidies for contraception.
Few of the experiments have been evalu-
The private sector is already involved in  ated, but some arrangements appear to be
many facets of family planning - from research  appropriate and effective in raising contraceptive
and development to production and to distribu-  prevalence. Moreover, steps could be taken to
tion and delivery.  It is the major source of  improve and expand the methods that donors
contraceptive resupply methods (oral contracep-  and national governments adopt to promote
tives and condoms) in most countries. And it is  greater private sector investment in family
an important source of more permanent methods  planning service delivery.
terilization and IUDs) in a few countries.
Clearly needed is an evaluation of existing
Some public efforts have been exerted to  programs and projects. More needs to be known
iarness and collaborate with the private sector.  about what determines consumer reliance on
These include incorporating family planning  private as opposed to public sector sources of
with employee health benefit packages (the most  services, the cost and cost-effectiveness of
common experience), social marketing projects  different interventions, and the limits of the
where a subsidized contraceptive is distributed  private sector in meeting contraceptive demand.
This paper is a product of the Population, Health, and Nutrition Division, Popula-
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